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This thesis describes the development and evaluation of new automated Question
Answering (QA) methods tailored to clinical comparison questions that give clinicians
a rank-ordered list of MEDLINE® abstracts targeted to natural language clinical drug
comparison questions (e.g. ”Have any studies directly compared the effects of Piogli-
tazone and Rosiglitazone on the liver?”).
Three corpora were created to develop and evaluate a new QA system for clini-
cal comparison questions called RetroRank. RetroRank takes the clinician’s plain text
question as input, processes it and outputs a rank-ordered list of potential answer can-
didates, i.e. MEDLINE® abstracts, that is reordered using new post-retrieval ranking
strategies to ensure the most topically-relevant abstracts are displayed as high in the
result set as possible.
RetroRank achieves a significant improvement over the PubMed recency baseline
and performs equal to or better than previous approaches to post-retrieval ranking re-
lying on query frames and annotated data such as the approach by Demner-Fushman
and Lin (2007).
The performance of RetroRank shows that it is possible to successfully use natural
language input and a fully automated approach to obtain answers to clinical drug com-
parison questions. This thesis also introduces two new evaluation corpora of clinical
comparison questions with “gold standard” references that are freely available and are
a valuable resource for future research in medical QA.
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Clinicians wishing to practice evidence-based medicine need to keep up with a vast
amount of ever changing research to be able to use the current best evidence in indi-
vidual patient care (Sackett et al., 1996). This can be difficult for time-pressed clini-
cians, although methods such as systematic reviews, evidence summaries and clinical
guidelines can help to translate research into practice. Computer technology, in the
form of clinical search engines or electronic clinical decision support systems, can
be used to facilitate the retrieval and presentation of clinical evidence, but there are
still limits concerning its usability and accessibility when timely guidance is of the
essence. In a survey commissioned by Doctors.net.uk, 97% of doctors and nurses said
that they would find a Question Answering (QA) Service useful, where they can ask
questions in their own words (Bryant and Ringrose, 2005). Studies have also shown
that clinicians often want answers to particular questions, rather than getting informa-
tion on broad topics (Chambliss and Conley, 1996; Ely et al., 1999, 2005). Clinicians
commonly want to know how one thing compares with another. In the initial corpus
of clinical questions collected from the National Library of Health (NLH) Question
Answering Service (http://www.clinicalanswers.nhs.uk), a manual QA service
with the aim of providing answers in a clinically relevant time frame using the best
available evidence, approximately 17% of the 4580 questions in their repository on
the 20th of July 2007 concerned comparisons of different drugs, treatment methods or
interventions as in (1.1).
(1.1) Have any studies directly compared the effects of Pioglitazone and Rosiglita-
zone on the liver?
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Answering such comparison questions automatically presents an interesting challenge
as it is not enough to simply search for the drug names or interventions in the question.
First, relevance also demands a basis of the comparison in regards to which the drugs or
interventions are compared. Second, a post-retrieval ranking step is needed to find out
which of the retrieved abstracts are the most relevant for providing a concise answer to
a clinician.
Despite the frequency of comparison questions one cannot yet call upon a method
especially designed to answer them, as one can for non-comparison clinical queries.
Existing general medical search engines such as askMEDLINE (Fontelo et al., 2005) or
Entrez PubMED do not perform well on the retrieval of relevant abstracts for clinical
comparison questions (cf. Section 6.3). This shows that a different approach is needed.
Manual QA services can only handle a limited number of questions at one time
and there is no real-time response. It is also too expensive to run manual clinical QA
services on a large scale. Unlike manual QA services such as the now defunct NLH QA
service, automated QA methods have the potential advantages of cost-effective, real-
time answers and no limit on the number of questions that can be asked and answered.
The aim of this PhD project is to develop and test new automated QA methods
tailored to clinical comparison questions that give clinicians a rank-ordered list of
MEDLINE® abstracts targeted to clinical questions framed in natural language. Three
corpora were created to develop and evaluate a new QA system for clinical compari-
son questions called RetroRank. RetroRank takes the clinician’s plain text question as
input, processes it and outputs a rank-ordered list of potential answer candidates, i.e.
MEDLINE® abstracts. The rank-ordered list is reordered using several post-retrieval
ranking strategies to ensure the most topically-relevant abstracts are displayed as high
in the ranking as possible. While it would be possible to generate answers in form
of extractive summaries from the top-ranked results, displaying a rank-ordered list of
abstracts rather than answers consisting of extractive summaries will give clinicians
the flexibility to make an informed decision based on their medical knowledge and
experience.
The main contribution of this thesis is a new automated QA system, RetroRank,
for natural language queries, which is tailored to clinical comparison questions and
implements new post-retrieval ranking strategies. RetroRank achieves a significant im-
provement over the PubMed baseline and performs equal to or better than previous ap-
proaches to post-retrieval ranking relying on query frames and annotated MEDLINE®
data such as the approach by Demner-Fushman and Lin (2007). In addition, two new
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evaluation corpora of clinical comparison questions with “gold standard” references
were created that are freely available for use in future research in medical QA.
The structure of the thesis is as follows:
Chapter 2 provides background knowledge about the information needs of clini-
cians and the domain of Evidence Based Medicine (EBM) as well as an overview of
Information Retrieval (IR) and Question Answering (QA) techniques and existing clin-
ical QA services and applications that provide a background for the current research.
Chapter 3 gives an overview of the characteristics of clinical comparison questions
and shows the types of different comparative constructions that appear in clinical ques-
tions. Also the lexical items indicative of comparison questions are introduced, which
will be used for the creation of Corpus 1 (Section 4.1).
Chapter 4 describes the creation and preprocessing of the three corpora of clinical
questions. Corpus 1 (NLH QAS) is used for the manual exploration of the best strat-
egy for abstract retrieval in Chapter 5 and for the system development of the automated
abstract retrieval component of RetroRank in Chapter 6. Corpus 2 (Essential Evidence
Plus POEMs) is used for the evaluation of the retrieval component in Chapter 6 ac-
cording to the same criteria used for the evaluation of askMedline by Fontelo et al.
(2005) and for developing the post-retrieval ranking strategies described in Chapter
7. Because Corpus 2 only has one “gold-standard” reference for each clinical ques-
tion, it cannot be used for calculating standard information retrieval (IR) metrics such
as Mean Average Precision (MAP). To evaluate the final version of RetroRank with
standard IR metrics, Corpus 3 (Cochrane Systematic Reviews) was collected, which
provides a number of “gold standard” references for each question.
Chapter 5 presents the initial experiment on manual query construction, abstract
retrieval and evaluation. The aim of this chapter is to describe different search strate-
gies for clinical comparison questions that were tried to determine the best one and to
evaluate it using human judges. The findings in this chapter were used to develop the
automatic QA system RetroRank introduced in Chapter 6.
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Chapter 6 describes the implementation and evaluation of the query construction
and abstract retrieval component of RetroRank. The retrieval component of RetroRank
was developed on Corpus 1 (Section 4.1) and evaluated in terms of retrieval accuracy
using Corpus 2 (Section 4.2).
Chapter 7 introduces different post-retrieval ranking strategies which were used to
rerank the MEDLINE® abstracts retrieved for each question in Corpus 2 and Corpus
3. The goal is to display the most relevant abstracts as high in the result set as possible
and to outperform the recency ordering performed by PubMed. Because recency does
not equate to relevance, post-retrieval ranking is an important feature in a system that
is geared towards providing the most relevant abstracts at the top of the result list to
enable clinicians to find the most relevant information in a quick and reliable way.
Chapter 8 describes the implementation and evaluation of the post-retrieval ranking
module of RetroRank. The post-retrieval ranking component was developed and tested
on Corpus 2 (Section 4.2) and fully evaluated on Corpus 3 (Section 4.3). The evalua-
tion shows how the different post-retrieval ranking strategies perform on the different
corpora and in comparison to the post-retrieval ranking system developed in Demner-
Fushman and Lin (2007). It is shown that the automatic ISI-citation based strategies
and the Expert Voting strategy are a significant improvement over the PubMed recency
baseline and are a strong contender to the strategies based on query frames and anno-
tated data developed by Demner-Fushman and Lin (2007).
Chapter 9 gives a summary and conclusion of the work described in this thesis and
an outlook on future work.
Chapter 2
Background
Because of the interdisciplinary nature of this research the disciplines of Natural Lan-
guage Processing and Clinical Medicine need to be described, but a comprehensive
overview of each is beyond the scope of this work. To provide a foundation and moti-
vation for the research undertaken in this thesis, the goal of this chapter is to provide
background knowledge about the information needs of clinicians and the domain of
Evidence Based Medicine (EBM) as well as an overview of Information Retrieval (IR)
and Question Answering (QA) techniques and existing clinical QA services and appli-
cations.
2.1 Information Needs of Clinicians
The information needs of clinicians have been a topic of research for decades. One
of the earliest works is the study of Covell et al. (1985) that researched the informa-
tion needs of doctors during a half day, or four hours, of typical office practice. His
findings are similar to the findings of other studies reported in this section. Since then
a variety of methodologies such as interviews, self reports and observation have been
used to determine the information-seeking behaviour of clinicians. Studies mainly fo-
cus on the type of information need, the number of questions arising while tending to
patients, the preferred source type for information, i.e., printed resources, electronic re-
sources, advice from colleagues and the percentage of questions pursued and answered
(Demner-Fushman, 2006; Davies, 2011).
Health professionals have different types of information needs. A review by Smith
(1996) identified the following six different categories of information needs:
• Information on particular patients.
5
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• Data on health and sickness within the local population.
• Medical knowledge.
• Local information on doctors available for referral.
• Information on local social influences and expectations.
• Information on scientific, political, legal, social, management, and ethical changes
that will affect both how medicine is practised in a society and how doctors will
interact with individual patients.
In this research the need for medical knowledge will be addressed. Medical knowl-
edge can be obtained from a number of sources ranging from textbooks to electronic
databases such as MEDLINE®, and the challenge lies in finding the relevant informa-
tion and applying it to the individual patient (Smith, 1996). According to the compre-
hensive survey by Davies (2007) the top categories for medical knowledge are knowl-
edge about treatment or therapy (average 38%), diagnostic methods (average 24%) and
drug therapy or about drugs themselves (average 11%).
Medical knowledge falls into two categories, namely background knowledge and
foreground knowledge (Richardson and Wilson, 1997). The term “background knowl-
edge” refers to general knowledge on a condition or disease and leads to wh-type ques-
tions such as What are the symptoms of liver failure?, What treatment options exist for
joint pain? or What causes fever and rash? Background knowledge questions can be
answered well from textbooks or systematic reviews.
Foreground knowledge is directly related to a patient and concerns issues such as
diagnosis, treatment and prognosis, e.g., the choice of therapeutic interventions or de-
termining the best test for a condition (Davies, 2011; Demner-Fushman, 2006). These
kinds of question can also be answered by secondary sources such as up-to-date sys-
tematic reviews if the question is frequent enough to warrant one. If the question does
not address a common enough problem, electronic sources such as MEDLINE® that
index clinical trials and observations might provide an answer. The average number of
foreground knowledge questions per patient is 0.24 according to a recent survey using
clinical librarians in the UK as data collectors during clinical meetings (Davies, 2009).
This number is similar to the number reported by Ely et al. (1999) which was 0.32
questions per patient considering only foreground questions. Clinical librarians be-
lieve the real number of questions is higher, though, because there are more questions
asked via email and on the phone than during the clinical meetings (Davies, 2009).
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Printed resources such as drug handbooks or medical textbooks are very popular in the
medical community and often still preferred over electronic resources. When physi-
cians were asked to rank the aids they use in clinical decision making, a survey from
2007 reports that text sources were ranked first, humans, i.e., colleagues, were ranked
second, and electronic resources were ranked third (Davies, 2007). A new survey
from 2011 shows that US and Canadian clinicians ranked electronic resources first,
while clinicians in the UK still rank them third and prefer asking colleagues or con-
sulting printed resources (Davies, 2011). However, printed resources are not the best
choice where up-to-date information is concerned because there is a time delay be-
tween editing and publication of at least six months (Davies, 2007; Ebell, 2009). Also,
the amount of time it takes to read through a wealth of printed resources to find the
relevant information is generally not compatible with a clinician’s busy schedule.
The electronic resources clinicians most frequently use are MEDLINE® (81.4% in
the US and 76.5% in the UK) and Cochrane Systematic Reviews (70.2% in the US
and 74.5% in the UK). MEDLINE® contains unfiltered information (Grandage et al.,
2002), whereas the Cochrane Library provides filtered evidence-based systematic re-
views (Davies, 2011). Previous studies found that between 71% and 88% of clini-
cal questions are appropriate for MEDLINE® and that for approximately 50% of the
questions information can be found which clinicians deem relevant (Demner-Fushman,
2006). Evidence Based Medicine (EBM) resources such as the Cochrane Library were
found to answer only about 20% of more complex clinical questions that involve more
than one concept such as a drug dose (Davies, 2007).
There is a reluctance towards using electronic resources because they present mul-
tiple problems for clinicians. Converting a clinical question into a searchable strategy
can be challenging and the use of inappropriate search terms, spelling errors, wrong
connectors or drug brand names rather than generic names leads to the retrieval of in-
complete or non-useful information (Verhoeven et al., 1995; Davies, 2007). Ely et al.
(2002) summarises the obstacles clinicians face when searching for evidence-based
answers related to patient care as “inadequate time to search for information, failure
of the resource to address the topic, and inadequate synthesis of multiple bits of evi-
dence into a clinically useful statement” (Ely et al., 2002). Because of the problems
encountered “doctors often decided not to pursue their questions because they doubted
the existence of useful information in available resources” (Ely et al., 2002). Gorman
and Helfand (1995) found that clinicians pursued less than a third of their questions.
A study by Ely et al. (2005) found that answers to 55% of questions were pursued by
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clinicians.
There is a general consensus that the most useful information is relevant, valid, and
easy to access and apply (Slawson et al., 1994; Smith, 2002). As Ely et al. (2002) states
“Practising doctors do not have time to search multiple sites or scroll through long
text. Nor do they have time to search multiple textbooks or perform literature searches
for most of their questions. They need to pick the right resource the first time, the
information in that resource needs to be readily found, and all the information must be
there. Although it remains to be shown, we believe that systems designed to overcome
the obstacles we identified will improve the asking and answering of questions and
potentially patient outcomes.”
The need for a service or system to aid in the question answering process is con-
firmed in a survey commissioned by Doctors.net.uk, in which 97% of doctors and
nurses said that they would find a Question Answering (QA) service that allows them
to ask questions in their own words useful (Bryant and Ringrose, 2005). This research
is a step towards an automated way of fulfilling that need and increasing the usefulness
of MEDLINE®.
2.2 Evidence Based Medicine
Evidence Based Medicine (EBM) is “the conscientious, explicit and judicious use of
current best evidence in making decisions about the care of individual patients” (Sack-
ett et al., 2000). Practising EBM involves integrating one’s individual clinical exper-
tise with the best available clinical evidence gained from systematic research to decide
upon the best treatment for a patient. The best clinical evidence is up-to-date informa-
tion from EBM sources such as systematic reviews which are overviews of synthesized
primary research for particular clinical research questions.
In order to apply the best evidence while making decisions, the question needs
to be clearly defined, the necessary information located and checked for validity and
relevance, and the information summarized (Demner-Fushman, 2006). The four main
clinical tasks in EBM concern etiology, diagnosis, therapy and prognosis. Richardson
et al. (1995) identified four components that are key elements in a clinical question:
(Patient/Problem): What is the patient/problem being addressed?
(Intervention): What is the intended intervention?
(Comparison): What is the intervention compared to?
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(Outcome): What are the outcomes?
These components are known as the PICO framework and are important for ques-
tion and search strategy formulation as well as for assessing clinical information.
Another important component of the EBM model is the quality and strength of the
clinical evidence. A grading scale was developed by Ebell et al. (2004) to assess the
quality, quantity, and consistency of clinical evidence for outcomes that help patients
to live longer and better lives, e.g., improvement of symptoms, better quality of life
or reduced mortality. This is known as “patient-oriented evidence”. The taxonomy
differentiates between the strength of a body of evidence and the quality of individual
research studies. According to Ebell et al. (2004) a body of evidence can have one of
three grades ranging from A to C with A being the best.
Grade A evidence is good quality, consistent patient-oriented evidence. Grade A
evidence usually comes from high quality double- or triple-blind randomized clinical
trials or from meta-analysis of controlled studies. Grade B evidence stems from incon-
sistent or limited-quality studies such as non-randomized controlled studies. Grade C
evidence is disease-oriented rather than patient-oriented evidence that is mainly based
on consensus, usual practice or opinion.
In addition, three levels of evidence in individual studies were defined. Level 1
denotes good-quality patient-oriented evidence which can be found in systematic re-
views, meta-analysis and high quality randomized controlled trials and cohort studies.
Level 2 denotes limited-quality patient-oriented evidence from less stringent clinical
trials and cohort studies, and Level 3 consists of other evidence from Grade C resources
(Ebell et al., 2004; Demner-Fushman, 2006).
2.3 MEDLINE®, PubMed and Entrez PubMed
2.3.1 MEDLINE®
MEDLINE® is the US National Library of Medicine’s (NLM) database of life sciences
and biomedical information. It currently contains approximately 18 million citations
and abstracts from approximately 5,500 biomedical journals worldwide since 1950
and is viewed as the authoritative source of clinical evidence by clinicians, biomedical
researchers, and other professionals in the field. Nearly 70,000 new citations were
added in 2010 1. Its status as the authoritative source for clinical evidence makes it an
1http://www.nlm.nih.gov/pubs/factsheets/medline.html
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ideal source for abstracts suitable for answering clinical questions.
Each MEDLINE® citation includes basic information about the citation such as
the article title, the author name(s), the publication name and type, the publication date
of the article, the date it was indexed in MEDLINE®, the publication language and
the abstract of the indexed paper. About 88% of all abstracts are in English. These
abstracts serve as potential answer candidates for the RetroRank system.
Each MEDLINE® citation is also indexed with Medical Subject Headings2 (MeSH)
from NLM’s controlled vocabulary thesaurus. It contains approximately 26,000 de-
scriptors stored in a hierarchical structure so that it can be searched at different levels
of detail. There are also over 177,000 entry terms that help in locating the most ap-
propriate MeSH Heading, e.g., “Acetylsalicylic Acid” is an entry term for “Aspirin”.
MeSH terms are assigned by over 100 indexers with degrees in the life sciences and
extensive training by the NLM. The MeSH vocabulary is continually updated and re-
vised to reflect the most accurate information possible. An example for the use of
MeSH terms is given in Section 5.1.
MEDLINE® can be searched via PubMed, the NLM’s gateway, or other third party
search engines.
2.3.2 PubMed
PubMed3 is a boolean search engine that allows users to search the abstract text and
metadata fields such as MeSH terms. PubMed can be searched using MeSH terms,
author names, title words, text words or phrases, journal names or any combination of
these. It also provides “Clinical Queries” search filter templates for narrowing down
a query to studies based on etiology, diagnosis, prognosis, or treatment of a particular
disease (Haynes et al., 1994). These templates are fixed boolean query fragments such
as MeSH term restrictions that are appended to the user’s query. To use the ”Clinical
Query” templates, the search keywords are entered on the PubMed Clinical Queries
website http://www.ncbi.nlm.nih.gov/pubmed/clinical/ and the appropritate
filter and the scope of the query (sensitive/broad or specific/narrow) are chosen. Ex-
ample (2.1) shows the Clinical Queries query translation for the therapy question“What
are the effects of using beta interferon in the treatment of multiple sclerosis?” using
the “Therapy” and “Narrow” filters.
2http://www.nlm.nih.gov/pubs/factsheets/mesh.html
3http://www.nlm.nih.gov/pubs/factsheets/pubmed.html
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(2.1) (multiple sclerosis beta interferon) AND (Therapy/Narrow[filter])
Therapy/Narrow corresponds to the PubMed equivalent:
(randomized controlled trial[Publication Type] OR (randomized[Title/Abstract] AND
controlled[Title/Abstract] AND trial[Title/Abstract])).
2.3.3 Entrez PubMed
Entrez PubMed4 is a text-based search and retrieval system for PubMed®. Entrez
PubMed provides access to MEDLINE® and other bio(medical) databases. It was de-
veloped by the National Center for Biotechnology Information (NCBI) at the National
Library of Medicine (NLM) which is part of the U.S. National Institutes of Health
(NIH) 5. While it is not a QA system, it can be used to answer questions, which are
simply treated as text strings. Figure 2.1 shows the search interface and an extract of
the answers for the question:
(2.2) How safe and effective are aspirin and warfarin therapy in the prevention of
stroke in patients with atrial fibrillation?
Figure 2.1: Entrez PubMed interface
4http://www.ncbi.nlm.nih.gov/Entrez/
5http://www.ncbi.nlm.nih.gov/entrez/query/static/overview.html
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The results page of Entrez PubMed also offers a search for related articles and
shows the query translation from the free text question to PubMed® search terms. The
query translation for Example (2.2) is shown in Example (2.3), which illustrates the
standard way PubMed® performs query translations.
(2.3)
safe[All Fields] AND effective[All Fields] AND (“aspirin”[MeSH Terms] OR “aspirin”[All Fields])
AND (“warfarin”[MeSH Terms] OR “warfarin”[All Fields]) AND (“therapy”[Subheading] OR “ther-
apy”[All Fields] OR “therapeutics”[MeSH Terms] OR “therapeutics”[All Fields]) AND (“prevention
and control”[Subheading] OR (“prevention”[All Fields] AND “control”[All Fields]) OR “prevention
and control”[All Fields] OR “prevention”[All Fields]) AND (“stroke”[MeSH Terms] OR “stroke”[All
Fields]) AND (“patients”[MeSH Terms] OR “patients”[All Fields]) AND (“atrial fibrillation”[MeSH
Terms] OR (“atrial”[All Fields] AND “fibrillation”[All Fields]) OR “atrial fibrillation”[All Fields])
Entrez PubMed searches for all words in an input text string except for those found
on the PubMed stop word list that includes question words such as “how”, “when”,
“which”, etc. (see Appendix C). This approach leads to low accuracy as will be
discussed in the evaluation of askMEDLINE against Entrez PubMED (Section 2.3.3)
and in the evaluation of Entrez PubMed on clinical comparison questions (Section 6.3).
The NCBI also offers a set of Entrez programming tools called E-Utilities6. The
two main components of the E-Utilities tools are ESearch, which searches and retrieves
primary PubMed IDs (PMIDs) and term translations and EFetch, which produces ab-
stracts from Entrez PubMed. A full list of E-Utilities tools is available at: http:
//eutils.ncbi.nlm.nih.gov. The EUtilities are used by askMEDLINE (Fontelo
et al., 2005) and in the retrieval component of RetroRank described in Chapter 6.
2.4 Clinicial Information Retrieval and Question Answer-
ing
There are several services for and approaches to clinical question answering as well as
research on identifying and extracting comparative constructions, but so far no methods
have been developed for automatically answering clinical comparison questions. This
section presents work on comparative sentence mining by Jindal and Liu (2006a,b),
work by Fiszman et al. (2007) concerning the interpretation of comparative structures
6http://eutils.ncbi.nlm.nih.gov/
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in biomedical texts, and the work on clinical question answering by Demner-Fushman
and Lin (2005, 2006, 2007) and Demner-Fushman (2006). It also introduces existing
clinical question answering services and applications to give a background for my
research.
2.4.1 Comparative Sentence Mining
In 2006, Jindal and Liu published two papers describing the study of comparative
sentence mining. By “comparative sentence” Jindal and Liu denote sentences that
express “an ordering relation between two sets of entities with respect to some common
features” (2006b). Jindal and Liu focus on evaluative texts giving subjective opinions
from the internet such as customer reviews, forum discussions and news articles. They
define comparative sentence mining as a two-step task. The first step is to identify
comparative sentences in the text. The second step is to extract comparative relations
from the sentences that have been identified. The term comparative relation is defined
as follows (Jindal and Liu, 2006b):
A comparative relation captures the essence of a comparative sentence
and is represented with the following:
(relationWord, features, entityS1, entityS2, type)
where relationWord: The keyword used to express a comparative relation
in a sentence.
features: a set of features being compared.
entityS1 and entityS2: Sets of entities being compared. Entities
in entityS1 appear to the left of the relation word and entities in entityS2
appear to the right of the relation word.
type: non-equal gradable, equative or superlative.
An entity is defined as the name of a person, a product brand, a company, a location,
or similar, which is compared in a comparative sentence, and a feature is defined as
a part or property of the compared entity. Entities and features can only be nouns or
pronouns. This means that for a sentence like “Canon’s optics are better than those of
Sony and Nikon”, the system is expected to extract the following relation:
(better, {optics}, {Canon}, {Sony, Nikon})
Chapter 2. Background 14
The relationWord is better, the feature in this example is optics and the entities
being compared are Canon optics compared to Sony’s and Nikon’s.
Jindal and Liu distinguish between four different types of comparison: non-equal
gradable, equative, superlative, and non-gradable, with the following definitions Jin-
dal and Liu (2006b):
1. Non-equal Gradable: Relations of the type greater or less than that express a
total ordering of some entities with regard to certain features. This type also
includes user preferences.
2. Equative: Relations of the type equal to that state two entities are equal with
respect to some features.
3. Superlative: Relations of the type greater or less than all others that rank one
entity over all others.
4. Non-Gradable: Sentences which compare features of two or more entities, but
do not explicitly grade them.
Jindal and Liu only focus on the first three types, which they call gradable com-
paratives, because they express an explicit ordering between the comparison entities
(2006b). These correspond to scalable adjectives introduced in Section 3.1.
Jindal and Liu identify comparative sentences by using an approach which involves
class sequential rules (CSR) and naïve Bayesian classification (Jindal and Liu, 2006a).
For extracting the comparative relations described above, they propose a type of rules
called label sequential rules (LSR) of the form X⇒ Y. Both X and Y are sequences
where X is a sequence produced from Y by replacing some of its items with wildcards
which can match any item (Jindal and Liu, 2006b). The rules are based on POS tags
and a small set of additional keywords generated by training on hand-labelled data. All
nouns and pronouns in comparative sentences are marked up as belonging to one of
the categories entityS1, entityS2, feature, and non-entity feature (i.e. nouns or pronouns
that do not refer to features or entities).
The data used by Jindal and Liu (2006b) was labelled by two annotators. Out of
a total of 3248 sentences, 285 were labelled as non-equal gradable, 110 as equative,
and 169 as superlative. The other sentences did not contain comparisons. In total, the
annotators labelled 488 instances of entityS1, 300 instances of entityS2, and 348 fea-
tures. The overall F-score for the extraction task is 72%, which shows a considerable
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improvement to the F-score of 58% achieved by the baseline CRF system developed by
Sarawagi (2004). Jindal and Liu (2006b) claim that LSR achieved around 80% F-score
for entityS1, about 70% for entityS2, and around 60% for features. The relationWords
were not extracted by rules and therefore the extraction results are not reported.
Jindal and Liu’s work (2006b) is not in the clinical domain and focuses only on
comparative sentences, not on comparative questions but their method could be applied
to questions as well. There are problems with their approach to extracting comparative
entities, though. Jindal and Liu’s method only extracts both entities correctly when
they appear on the left and right of a relationWord instead of determining the entities
by a semantic approach. Entity1 and entity2 are also only determined by their relative
position in a sentence assuming the argument to the left (entity1) is greater than the
argument to the right (entity2) as it would be in a mathematical “greater than” relation.
This is problematic, however, because sentences in natural language do not adhere to
a strict ordering but can have a variety of forms. Just because an entity is mentioned
first, it does not have to be the one that is higher on a comparative scale. The same is
true for clinical comparison questions. Jindal and Liu’s approach could be applied to a
question like Example (2.4).
(2.4) Is Ibuprofen better than aspirin for treating a headache?
In which case the following could be extracted:
(better, {headache}, {Ibuprofen}, {Aspirin})
However, for a question like Example (2.5), the proposed method would yield an incor-
rect result, because the left side of the relationWord is empty and therefore Ibuprofen
would not be recognised as entity1.
(2.5) What is better for treating a headache: Ibuprofen or Aspirin?
A similar problem arises in Example (2.6):
(2.6) Is Ibuprofen or Aspirin better for treating a headache?
In this case both Ibuprofen and Aspirin are on the left side and the right side of the
relationWord is empty, meaning that Aspirin would not be recognised as entity2.
Another problem with Jindal’s and Liu’s approach (2006a) is that Jindal and Liu
only look for adjectives or adverbs as relationWords, i.e. better, faster, quicker, but
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comparisons can also be expressed by comparative cues such as compare as illustrated
in Example (2.7) and introduced in Section 3.2.
(2.7) How does Ibuprofen compare to Aspirin for treating headaches?
Because compare is not one of the relationWords that is searched for, neither drug
would be recognized as an entity.
2.4.2 Interpretation of Comparative Structures
(Fiszman et al., 2007) describes work on automatically interpreting comparative con-
structions in MEDLINE® abstracts. They use an extension of an existing semantic
processor, SemRep (Rindflesch and Fiszman, 2003; Rindflesch et al., 2005), from the
Unified Medical Language System resources to construct semantic predications for
the extracted comparative expressions. In this paper, Fiszman et al. (2007) concentrate
on extracting two different “comparative structures in which two drugs are compared
with respect to a shared attribute”, which frequently occur in reports on clinical trials
for drug therapies. A shared attribute is, for example, a drug’s efficacy in treating a
certain condition. The drugs’ relative merits in achieving their purpose is expressed
by positions on a scale which is denoted by adjectives or nouns. The compared terms
are expressed by co-joined noun phrases and their shared characteristic is a predicate
outside of the comparative structure. Words like than, as, with and to are cues for iden-
tifying compared terms, the comparison scale and the relative position of the compared
entities on the scale.
The first comparative structure (comp1) identified by Fiszman et al. (2007) includes
a form of the word compare and is a comparison between a primary therapy and a
secondary therapy. The second structure (comp2) compares the relative merits of a
primary and secondary therapy using scalable adjectives. The first step is to generate a
semantic interpretation of these comparative structures and the second step is to iden-
tify the elements of the comparative structures based on their semantic predications.
Fiszman et al.’s comp1 structures can be identified by a form of the word com-
pare. They compare two terms mostly without ranking them on a scale. If a scale is
mentioned, it is indicated by a noun such as efficacy. However, Fiszman et al. do not
extract a scale for comp1 structures because the position on a scale is never mentioned.
Example (2.8) illustrates a comp1 structure.
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(2.8) To compare misoprostol with dinoprostone for cervical ripening and labor
induction. (Example (3) in (Fiszman et al., 2007))
Comp2 structures are more complex, comparing two terms using scalable adjectives
which indicate the ranking on a scale. Example (2.9) illustrates both terms at an equal
position on the scale:
(2.9) Azithromycin is as effective as erythromycin estolate for the treatment of
pertussis in children. (Example (5) in (Fiszman et al., 2007))
Comp2 structures express equality or inequality. For structures expressing inequality a
distinction can be made between the expression of superiority, where the primary term
is ranked higher than the secondary term (Example (2.10)), and inferiority, where the
primary term is ranked lower than the secondary term (Example (2.11)).
(2.10) Naproxen is safer than aspirin in the treatment of the arthritis of rheumatic
fever. (Example (6) in (Fiszman et al., 2007))
(2.11) Sodium valproate was significantly less effective than prochlorperazine in
reducing pain or nausea. (Example (7) in (Fiszman et al., 2007))
To develop the comparative processing, Fiszman et al. extracted sentences from 10,000
MEDLINE® citations reporting the results of clinical trials. From these sentences, the
most frequent patterns were extracted and used to enhance SemRep argument identi-
fication. These patterns only list the obligatory components but allow modifiers and
qualifiers. Here is an example pattern for comp1:
C2: compare Term1 with/to Term2 (Fiszman et al., 2007)
A full list of these patterns can be found in Appendix B.
SemRep finds underspecified semantic propositions in biomedical text based on a
syntactic analysis and domain knowledge from the UMLS including the Metathesaurus
and the Semantic Network 7. Fiszman et al. focus on the group Chemicals & Drugs
from the Semantic Network. SemRep assumes a comp1 structure when it encounters
a form of the word compare and looks to the noun phrase on the right preceded by
with, to, and, or versus, which serve as cues for indicating the compared terms. If the
head has a corresponding concept having a semantic type in the Chemical & Drugs
7http://www.nlm.nih.gov/research/umls/
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group, it is identified as Term2. Then the algorithm looks to the left of the identified
term to find a noun phrase that also has a semantic type in the same group and if such
a noun phrase is found it identifies it as Term1. The predicate for comp1 structures
is COMPARED WITH. Example (2.13) shows the processed sentence from Example
(2.12):
(2.12) To compare the efficacy and tolerability of Hypericum perforatum with imi-
pramine in patients with mild to moderate depression. (Example (13) in
(Fiszman et al., 2007))
(2.13) Hypericum perforatum COMPARED WITH Imipramine (Example (14) in
(Fiszman et al., 2007))
In addition to identifying the compared terms, a scale must be identified in comp2
structures as well as the positions of the terms on the scale. The algorithm for comp2
patterns looks for one of the cues such as than and maps the heads of the noun phrases
to the right and left the same way as for comp1 patterns. The scale name is found by
looking at the secondary compared term and locating the first adjective to its left of
which the nominalization according to the SPECIALIST lexicon 8 is used as the name
of the scale, e.g., effective (include arrow) Effectiveness. The relative positions on the
scale are determined by contrasting equality and inequality. The primary compared
term is considered to be higher on the scale unless it is preceded by less or is infe-
rior. The representation for comp2 structures is shown in Example (2.15) for Example
(2.14).
(2.14) Losartan was more effective than atenolol in reducing cardiovascular mor-
bidity and mortality in patients with hyptertension, diabetes, and LVH. (Ex-
ample (20) in (Fiszman et al., 2007))
(2.15) Losartan COMPARED WITH Atenolol
Scale: Effectivness
Losartan HIGHER THAN Atenolol (Example (21) in (Fiszman et al., 2007))
A test set of 300 sentences containing comparative structures were extracted from
MEDLINE® abstracts published later than the ones that were used to develop the
methodology. The sentences were annotated with their PubMed ID, names of the two
8http://lexsrv3.nlm.nih.gov/Specialist/Home/index.html
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drugs, the scale and their relative position on the scale. After removing duplicates, 287
sentences with 288 comparative structures remained. There are 203 comp1 structures
and 85 comp2 structures. The overall F-score for SemRep’s performance on the test
set is 81%. The F-score for drug extraction is also 81%, comp1 structures are retrieved
with 98% precision but only 74% recall, and comp2 structures with 92% precision and
only 62% recall. The results show a high precision for all tasks, but 26% of comp1
structures and 38% of comp2 structures remain unidentified. This is mainly due to
empty heads and word sense ambiguity.
Like Jindal and Liu’s work (2006a; 2006b), Fiszman et al. (2007) do not focus on
questions. While their method could also be applied to questions, the same problem
mentioned in the discussion of Jindal and Liu (2006b) applies. The algorithm takes its
targets by looking at the noun phrases to left and right of a cue indicating a comparison.
Therefore, it would also misinterpret questions in which both compared entities occur
on the right side of the cue or both entities occur on the left side of the cue as shown in
Examples (2.16) and (2.17).
(2.16) What is better for stroke prevention: Aspirin or Warfarin?
(2.17) Is Aspirin or Warfarin more efficient for preventing stroke?
In addition, comparisons that are split across clauses or sentences, such as Examples
(2.18) and (2.19) which do not fit the pattern for recognizing comp1 and comp2 struc-
tures, cause problems for the algorithm:
(2.18) Although Warfarin may be used for preventing stroke, it is not as good as
aspirin.
(2.19) Warfarin can be used for preventing stroke. However Aspirin is better.
There is also an essential limitation to SemRep. SemRep’s comparative module
is based on scalar comparative constructions. Non-scalar comparisons, e.g., compar-
isons like “Is x the same intervention as y” or “How does drug x differ from drug y”
cannot be extracted using SemRep. This means that a different method is necessary in
order to process non-scalar comparisons as well as scalar comparisons that cannot be
recognized because of their structure, e.g., both compared entities are to the right side
of the comparative cue.
Problems also occur for “Wh-” or “anything” questions. “Wh-words” or “any-
thing” do not have a type that can be mapped by the SemRep algorithm.
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(2.20) What drug is better than X for treating Y?
(2.21) Is there anything better than X for treating Y?
2.4.3 Addressing Clinical Questions
In 2006, Demner-Fushman and Lin published a paper on answering clinical questions
of the type “What is the best treatment for X” by using a hybrid approach consisting of
information retrieval and summarization. This question type was chosen because stud-
ies of clinician’s behaviour have shown that this class of question frequently occurs in
the clinical setting (Ely et al., 1999). My own data confirms this finding (cf. Section
4.1). Demner-Fushman and Lin use answer extraction for identifying short answers,
semantic clustering for grouping results, and extractive summaries to generate support-
ing evidence. The first step is to identify the drugs that are searched for. The second
step is to cluster abstracts for these drugs using semantic classes from the UMLS on-
tology. As a third and final step, a short summary is generated for each abstract, which
gives supporting evidence.
Demner-Fushman and Lin’s research follows the paradigm of EBM (Sackett et al.,
2000). The PICO framework introduced in Section 2.2 underlies the question answer-
ing research by Demner-Fushman and Lin (2005, 2006) and Demner-Fushman (2006).
Clinical questions as well as MEDLINE® abstracts are translated into the PICO for-
mat using specific purpose-designed extractors. There is one for the Population, one
for the Problem, one for the Intervention/Comparison and one for the Outcome. The
translation of abstracts to the PICO format relies on the availability of an annotated
corpus of MEDLINE® abstracts (Demner-Fushman and Lin, 2005).
Demner-Fushman and Lin (2006) try to balance clinicians’ need for conciseness
and completeness, which results from time pressure and the necessity to completely
examine all relevant evidence, by giving hierarchical answers which support multi-
ple levels of drill-down. An example for the question “What is the best treatment for
chronic prostatitis?” is shown in Figure 2.2. “Best treatment” is used in the sense
of “most studied treatment”. It lists two drug categories that are relevant to the treat-
ment of the disease with associated clusters of extractive summaries of MEDLINE®
abstracts. If needed the full abstract text or even the electronic version of the study can
be retrieved.
Demner-Fushman and Lin focus primarily on synthesising correct answers from
a set of search results consisting of MEDLINE® citations. Given this set of search
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Figure 2.2: System response to the question “What is the best treatment for chronic
prostatitis?” cited from Demner-Fushman and Lin (2006).
results, answer generation is a three step process.
The first step is answer extraction. Demner-Fushman and Lin created an extrac-
tor to identify the drugs, or interventions in EBM terminology, under study which is
based on MetaMap (Aronson, 2001), a programme that automatically identifies enti-
ties which correspond to UMLS concepts. Drugs mainly fall under the semantic type
of PHARMACOLOGICAL SUBSTANCE. All entities with a corresponding UMLS
concept are marked as candidates and scored on their position in the abstract, the fre-
quency and other features.
In a second step, the retrieved MEDLINE® abstracts for the identified interven-
tions are grouped into clusters based on the main interventions in the abstracts. This
is done with a variant of the hierarchical agglomerative clustering algorithm by Zhao
and Karypis (2002). This algorithm uses semantic relationships from the UMLS (Uni-
fied Medical Language System) for computing similarities between interventions. In
Figure 2.2, temafloxacin and ofloxacin are in the same cluster because they are both
hyponyms of anti-microbials according to the UMLS ontology.
During the third step, a short extractive summary is generated for each MEDLINE®
abstract in the cluster. It has three elements: The main intervention, the abstract title
and the outcome sentence with the highest score. The outcome sentence gives the
findings of a clinical study. The “Outcome Extractor” used is based on former work
by Demner-Fushman and Lin (2005, 2006).
The system was tested on a set of 30 questions from the June 2004 edition of
Clinical Evidence (CE), a periodic report from the British Medical Journal (BMJ),
which summarises the best know drugs for some dozen diseases. The first author
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used PubMed to retrieve the best possible MEDLINE® abstracts by generating manual
queries which were formulated to take advantage of MeSH (Medical Subject Head-
ing) terms, a manually assigned controlled vocabulary that encodes a large amount of
knowledge about the content of an abstract. Abstracts were limited to “drug therapy”
and clinical trials.
Demner-Fushman and Lin evaluate the system in two ways. The first evaluation is a
manual, factoid-style evaluation with a focus on short answers. The second evaluation
is an automatic one with ROUGE9 based on the CE abstracts which are taken as refer-
ence summaries. The baseline for both evaluations are the main interventions from the
first three MEDLINE® abstracts retrieved by the manual PubMed queries (PubMed).
The two test conditions for the first evaluation are the three main interventions
from the first abstract from the largest clusters (Cluster), and the main interventions
from the first abstract from three selected by an oracle, the first author (Oracle). The
oracle condition is the upper-bound, given the results of expert manual querying. For
the baseline PubMed®, 20% of the drugs were evaluated as beneficial, for the Cluster
condition the number is 39%, and for the Oracle condition 40%. 60% of the PubMed®
answers were judge as good in comparison to 83% for the Cluster condition and 89%
for the Oracle condition.
The test conditions for the automatic evaluation consist of the baseline from the
first evaluation. The three other conditions are a cluster round robin selecting the first
abstract by size from the top three clusters, an oracle cluster order, selecting three
abstracts from the best cluster, and an oracle round-robin, selecting the first abstract
from each of the top three clusters. The results for the cumulative evaluation after three
rounds are 52.3% for the baseline, 52.6% for the cluster round robin, 59.7% for the
oracle cluster order and 58.6% for the oracle round-robin.
Both evaluations show Demner-Fushman and Lin’s system outperform the PubMed®
baseline. There a certain limitations however. The system depends on a set of high
quality search results, based on manually generated queries. The system also does not
perform semantic processing for determining the efficacy of drugs, but can only recog-
nise topics by matching terms to the UMLS ontology and find outcome statements in
the retrieved abstracts. The clusters are ordered by size, which means the most com-
monly discussed drug is selected as the best drug. This assumption is not valid but the
authors have observed that drugs that are studied more are more likely to be beneficial.
Selecting the most studied drug as the best drug might work as far as useful an-
9http://berouge.com/default.aspx
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swers for the best drug are concerned, but “best” does not necessarily equate to “most
studied” in clinical superlative questions. Demner-Fushman and Lin (2006)’s approach
cannot be used to answer questions such as Examples (2.22) and (2.23), because look-
ing for the most studied drugs will not provide an answer to the question of which drug
has the fewest side effects or is safest to use.
(2.22) Which drug for treating X has the fewest side effects?
(2.23) Which drug is safest to use for treating X?
Demner-Fushman and Lin (2006) and Demner-Fushman (2006) deal with small sets
of well-formed clinical questions, 30 and 50 questions respectively. In order to deal
with a large corpus of clinical questions of the comparative form, which are not asked
in compliance with the PICO format, a different approach than Demner-Fushman and
Lin’s might be preferred to translating the comparative questions into the PICO format
for identifying all relevant parts of the comparison.
2.4.4 Answering Clinical Questions with Knowledge-Based and Sta-
tistical Techniques
Demner-Fushman and Lin (2007) present a system based on the knowledge extractors
developed in Demner-Fushman and Lin (2005, 2006), which use knowledge-based and
statistical techniques to identify different elements of MEDLINE® abstracts. These
elements are the input for an algorithm that scores “the relevance of citations with
respect to structured representations of information needs” within the framework of
Evidence Based Medicine (Demner-Fushman and Lin, 2007). The system reorders
an initial list of abstracts retrieved by PubMed to bring relevant abstracts into higher
ranks. It is evaluated on real-word clinical questions and performs significantly better
than previous systems used by clinicians up to the date of Demner-Fushman and Lin
(2007)’s research. The same task will be performed by RetroRank as described in
Chapter 8, and an evaluation of the results compared to the results of Demner-Fushman
and Lin (2007) will be shown.
Demner-Fushman and Lin (2007) use carefully hand-crafted queries and structured
PICO frames (c.f. Section 2.4.3) instead of natural language questions as the input to
their clinical QA system. Example (2.24) shows a clinical question and Example (2.25)
the extracted query frame.
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(2.24) In children with an acute febrile illness, what is the efficacy of single-med-
ication therapy with acetaminophen or ibuprofen in reducing fever?
(2.25)
Search Task: therapy selection




The query encodes the search task and the corresponding PICO structure.
In a frame-based query interface the burden of translating a query lies with the
clinician. A possible advantage is that the query needs to be well thought through to
make sure all important elements are captured. This avoids poorly worded queries,
which are one of the obstacles to finding anwers (Ely et al., 2005). It also eradicates
the need for a linguistic analysis of the queries.
To generate an answer, the MEDLINE® abstracts retrieved for a query are trans-
lated into the PICO format as well using the specific purpose-designed extractors for
the Population, the Problem, the Intervention/Comparison and for the Outcome. The
“Outcome” serves as the basis for the answer, because clinicians are mostly interested
in the outcome that states the finding of a study. The translation of abstracts into the
PICO format relies on the availability of an annotated corpus of MEDLINE® abstracts
(Demner-Fushman and Lin, 2005).
The system architecture is as follows:
• Query formulator: Converts a clinical question in form of a PICO frame into a
PubMed query. PubMed returns a list of MEDLINE® abstracts which is analysed
using the knowledge extractors.
• Semantic matcher: Takes the PICO query frames and the annotated MEDLINE®
abstracts as input and implements the EBM scoring algorithm. The output is a
ranked list of abstracts.
• Answer Generation: Takes the ranked list of abstracts and generates an extrac-
tive summary from the “Outcome” section.
In order to develop the scoring algorithm, a corpus of 50 clinical questions was
manually created from clinical questions from the Journal of Family Practice and the
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Parkhurst Exchange. All questions were manually classified into one of the four clin-
ical tasks (Therapy, Diagnosis, Prognosis and Etiology). In the final preparation step
the questions were translated into PICO frames. Table 2.1 shows the composition of
the corpus.
Therapy Diagnosis Prognosis Etiology Total
Development 10 6 3 5 24
Test 12 26 3 5 26
Table 2.1: Composition of the clinical question collection (Demner-Fushman and Lin,
2007).
Example (2.26) shows an example therapy question. Therapy questions are the
type of questions the research in this thesis is concerned with.
(2.26) Does quinine reduce leg cramps for young athletes? (Therapy)
search task: therapy selection
primary problem: leg cramps
co-occurring problems: muscle cramps, cramps
population: young adult
intervention: quinine
The P in PICO was broken up into population, primary problem, and co-occurring
problems. This plays an important role for the scoring algorithm which treats those
three facets differently. The relevance of an article includes “contributions from match-
ing PICO structures, the strength of evidence of the citation, and factors specically
associated with the search tasks (and indirectly, the clinical tasks)” (Demner-Fushman
and Lin, 2007). Each score reflects the factors a clinician takes into consideration when
examining a MEDLINE® abstract. The assignment of numeric scores and weights is
based on intuition.
The first component of the EBM scoring algorithm is based on the score of an ab-
stract which is based on the extracted PICO elements. SPICO is broken into components
according to the following formula:
SPICO = Sproblem + Spopulation + Sintervention + Soutcome
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(Demner-Fushman and Lin, 2007)
• Sproblem: The score equals 1 if the problems of the query frame and the primary
problem in the abstract match exactly based on their unique UMLS concept ID.
A partial string match gets a score of 0.5. If there is no overlap, the score is -1.
If the problem extractor cannot identify a problem in the abstract but the query
contains one, a score of -0.5 is given.
• Spopulation & Sintervention: The overlap between the query frame elements and the
corresponding elements from the abstract is measured and a point is given for
each matching intervention and population.
• Soutcome: The value assigned to the highest-scoring outcome sentence in the ab-
stract as given by the “Outcome Extractor”. Outcomes are omitted in the query
representation because they are rarely specified in the corpus. The inherent qual-
ity of the outcome statements in an abstract is considered independent of the
query, because it is assumed that “given a match on the primary problem, all
clinical outcomes are likely to be of interest to the physician” (Demner-Fushman
and Lin, 2007).
The second component of the EBM scores is based on the strength of evidence,
which is calculated in the following way:
SSoE = S journal + Sstudy + Sdate
(Demner-Fushman and Lin, 2007)
• S journal: A score of 0.6 is assigned to articles published in a core and high-impact
journal, otherwise the score is 0.
• Sstudy: A score of 0.5 is assigned for clinical trials, a score of 0.3 is assigned
for observational studies, non-clinical publications receive a score of -1.5 and 0
otherwise.
• Sdate: Sdate = (yearpublication−yearcurrent/100), which favours more recent arti-
cles.
The third and final component of the scoring algorithm is based on manually as-
signed MeSH terms for each search task. For each clinical task a list of positive and
negative relevance indicators was collected. The score Stask is assigned by:




(Demner-Fushman and Lin, 2007)
The function α(t) maps a MeSH term to a positive score if the term is a positive
indicator for that particular task type, or a negative score if the term is a negative
indicator for the clinical task. A list of indicators can be found in Demner-Fushman
and Lin (2007).
The EBM scoring algorithm is evaluated in terms of a document reranking task.
For each question in the test collection, PubMed queries were manually crafted to
fetch an initial set of MEDLINE® abstracts. The query formulation was performed by
the first author, who is a medical doctor. She also verified that each set of retrieved
abstracts contained at least some relevant documents. The top 50 results for each of
the 50 queries were retained. Some queries retrieved less than 50 abstracts so that the
total number of retrieved abstracts was 2,309. Generating a “good” PubMed query is
not trivial and took on average 40 minutes per question. Determining the relevance
of the retrieved abstracts is also not trivial and requires a medical degree according to
Demner-Fushman and Lin (2007). Only topical relevance has been assessed for the
abstract set. This process and the associated problems have been solved in the research
in this thesis, which uses natural language queries and does not require a doctor to
evaluate the relevance of the retrieved abstracts because the corpora used for evaluation
have “gold standard” references for each question. Using an automated approach has
no negative effects on system performance as will be shown in Chapter 8.
Each citation in (Demner-Fushman and Lin, 2007) was assigned one of four labels:
• Contains answer: The citation directly contains information that answers the
question.
• Relevant: The citation does not directly answer the question, but provides topi-
cally relevant information.
• Partially relevant: The citation provides information that is marginally relevant.
• Not relevant: The citation does not provide any topically relevant information.
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(Demner-Fushman and Lin, 2007)
The relevance assessment process took about 2 hours per questions or 100 hours in
total.
Four different systems were compared:
• PubMed baseline (simple ordering by recency)
• A term-based reranker computing overlap between the question and citation
weighted by the outcome score from the sentence where the overlap occurs.
• The EBM Scorer described above.
• A combination of the term-based reranker and the EBM scorer normalised using
weighted linear interpolation.
The development questions were used for debugging and for tuning weights by
trying all possible values for the combination system.
The system was evaluated using the following metrics:
• Mean Average Precision (MAP): The average of the precision values after each
relevant document is retrieved (Baeza-Yates, Ricardo A. and Ribeiro-Neto, B.,
1999).
• P@10: The fraction of relevant documents in the first ten results.
• Mean Reciprocal Rank (MRR): Measures how far down on a list the first rele-
vant abstract is.
• Total Document Reciprocal Rank (TDRR): The sum of the reciprocal ranks
of all relevant documents. Unlike MRR it captures the ranks of all relevant
documents.
The systems were evaluated under a lenient and a strict condition. Under the le-
nient condition documents from the categories “contains answer” and “relevant” were
considered relevant. Under the strict condition only documents from the category
“contains answer” were considered. Here only the tables for the strict evaluation are
reported because they correspond to the evaluation of the RetroRank system in this
thesis.
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Dev P@10 MAP MRR TDRR
PubMed 0.153 0.105 0.385 0.653
Term 0.24 0.183 0.527 0.974
EBM 0.328 0.264 0.693 1.371
Combo 0.34 0.26 0.656 1.315
Test P@10 MAP MRR TDRR
PubMed 0.069 0.045 0.19 0.328
Term 0.15 0.092 0.346 0.632
EBM 0.196 0.129 0.433 0.765
Combo 0.219 0.138 0.494 0.851
Table 2.2: Performance of all systems across all clinical tasks (Demner-Fushman and
Lin, 2007).
Table 2.2 contains the strict evaluation for performance across all clinical tasks for
the development and test set.
Table 2.3 shows the results for both sets and for all systems on the therapy task
under the strict condition. This task is comparable to the task for the QA system in this
thesis.
The EBM-based reranker and combination reranker significantly outperforms the
PubMed baseline for all metrics. In almost all cases, the EBM and Combo ranking
algorithms perform significantly better than the term-based one. The results of both
tables will be further discussed in the evaluation of RetroRank in Chapter 8.
While the results of (Demner-Fushman and Lin, 2007) show a significant improve-
ment over the PubMed baseline, the system involves a lot of manual labour in terms of
query frame generation, annotating MEDLINE® abstracts to train the PICO extractors
and assessment of the query results by a doctor to determine the relevant abstracts,
while also leaving the burden of translating a clinical question into PICO frames to a
clinician if the system was used later on. These problems have been addressed and an
automated solution has been implemented in the RetroRank system developed in this
research.
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Therapy Dev
P@10 MAP MRR TDRR
PubMed 0.13 0.088 0.35 0.61
Term 0.23 0.205 0.409 0.872
EBM 0.35 0.314 0.675 1.434
Combo 0.35 0.301 0.569 1.282
Therapy Test
P@10 MAP MRR TDRR
PubMed 0.18 0.061 0.282 0.495
Term 0.192 0.082 0.368 0.7
EBM 0.233 0.109 0.397 0.807
Combo 0.258 0.12 0.556 0.969
Table 2.3: Performance of all systems across on the therapy task (Demner-Fushman
and Lin, 2007).
2.5 Clinical Question Answering Services and Applica-
tions
There are several clinical QA services and applications. Some of the services such
as ATTRACT, which is provided by the Welsh National Public Health Service, are
manual and the questions are primarily dealt with by clinical librarians or health-
care professionals, while others are automated systems with web interfaces such as
askMEDLINE. This section describes the systems that are most relevant to the current
research.
2.5.1 The National Library of Health Question Answering Service
(NLH QAS)
The NLH Question Answering Service (QAS) was an on-line service that clinicians
in the UK could use to ask questions, that were then answered by a team of clinical
librarians from TRIP Database Ltd.10, founded by Jon Brassey and Dr Chris Price. The
10http://www.tripdatabase.com/index.html
Chapter 2. Background 31
NHS QAS service was discontinued in 2008 but its archive of questions and answers
was integrated into ATTRACT 11 run by Jon Brassey. The questions and their answers
from the NLH QAS were retained at the website and indexed by major clinical topics
(e.g., cancer, cardiovascular disease, diabetes, etc.) so that clinicians could consult the
QA archive to check whether information relevant to their own clinical question was
already available and if not to pose a new question on-line.
Clinical librarians responded to a question with a list and/or summary of articles
that may address it, found via searches of PubMed®, Cochrane or TRIP. Although
the service provided useful answers there are some limitations to manual QA services
provided by professional staff. For example, they can only handle a limited number
of questions at one time and there is no real-time response. QA services delivered
by librarians also do not provide interpretative summaries or evidence-based guidance
because of lack of clinical knowledge and time (Vincent, 2006; Ward, 2005), so the
responsibility for selecting the right information and judging the validity of the answers
still lies with the clinicians. Section 4.1 discusses the use of the NLH QAS as a source
for collecting an initial corpus of clinical comparison questions (Corpus 1).
2.5.2 The Essential Evidence Plus POEM Archive
Essential Evidence Plus12 is owned by the publisher John Wiley & Sons and its purpose
it to provide tools to health care professionals that give them the most relevant and
valid information currently available. One of their services is InfoPOEMs founded by
Drs. Barry, Ebell and Slawson in 1990. POEM stands for “Patient-Oriented Evidence
that Matters”. POEMs are summaries of essential evidence-based research filtered
for their relevance to patient care. They consist of a clinical question, a bottom line
which summarises the main point of the synopsis, a citation for a reference article, the
study type and setting, and a summary of the reference article by a physician. Figure
2.3 shows an example POEM. The reference incuded in a POEM serves as the “gold
standard” reference for evaluating the accuracy of RetroRank.
In Section 4.2 the use of the POEM archive for creating Corpus 2 is discussed.
11http://www.attract.wales.nhs.uk/
12http://www.essentialevidenceplus.com/
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Figure 2.3: Example POEM.
2.5.3 The Cochrane Database of Systematic Reviews (CDSR) from
the Cochrane Library
The Cochrane Library13 is an online collection of six databases that contain high-
quality, independent evidence on the effectiveness of healthcare treatments and inter-
ventions, as well as methodology and diagnostic tests to inform healthcare decision-
13http://www.thecochranelibrary.com/view/0/index.html
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making (Collaboration, 2011). One of these databases is the Cochrane Database of
Systematic Reviews (CDSR), the leading resource for systematic reviews in evidence-
based health care. It contains over 4,500 systematic reviews and 2,000 protocols de-
scribing the research methods and objectives for reviews in progress. The Cochrane
reviews are high-quality, peer-reviewed systematic reviews of primary research in hu-
man health care and health policy. Systematic reviews are critical assessments of clin-
ical evidence for a particular clinical question such as “How efficient and safe are
corticosteroids in the treatment of pneumonia?”14. They include a comprehensive lit-
erature search, assess the quality of studies and report the results in a systematic way
(Ebell et al., 2004). The reviews are updated regularly to ensure they present the most
up-to-date evidence.
Each systematic review is published in several versions that differ in the amount of
detail. The shortest form of a systematic review is called the “Summary”. The “Sum-
mary” has three sections. The first section names the type of review, e.g., Intervention
Review and gives the title of the review. It also shows the authors and their affilia-
tions. It lists the editorial group, e.g., “Cochrane Pregnancy and Childbirth Group”,
the publication status and the date when the review was last assessed as being up-to-
date. It also gives the citation key for the review. An example is presented in Figure 2.4
showing the systematic review with the title “Magnesium sulphate versus diazepam for
eclampsia”.
The second section of a “Summary” is called the “Abstract”, and it has seven parts.
The first part is a “Background” section detailing the topic of the review. The sec-
ond part is an “Objectives” section, which explains the purpose of the review and
says which drugs or interventions are compared to each other and in what regard, i.e.,
safety, efficacy and cost-effectiveness. The third part is a “Search Strategy” section,
which describes which sources were used to find relevant studies. The fourth part is a
“Selection Criteria” section, which says which study types were included, e.g., clinical
randomised trials comparing the two drugs in question for the relevant disease. The
fifth part is a “Data Collection and Analysis” section, which describes the criteria used
in collecting and analysing the data used for the review. The sixth part is the “Main
Results” section, which gives the results of all the studies that were considered rele-
vant for the drug comparison. The seventh part is the “Author’s Conclusion”, which
contains a summary of the main results and draws a conclusion. An example of the
14http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD007720/frame.
html
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Figure 2.4: Header of a Systematic Review.
“Abstract” section is shown in Figure 2.5.
At the end of every “Summary” review is a “Plain Language Summary” section.
This section repeats the title of the review, describes the disease(s), contains a short
description of the compared drugs and describes the main benefits and side effects of
the drugs. An example is shown in Figure 2.6.
The second version available of each systematic review is called the “Standard”
version. The “Standard” version provides a greater level of detail. In addition to all
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Figure 2.5: Abstract section of a Systematic Review.
the information in the “Summary” version, it also contains the objectives and methods
used in the included studies, a description of each study and the results, a discussion
section, a detailed data analysis section and a full list of all references retrieved for
conducting the systematic review, as well as a table detailing the characteristics of
each study and an explanation of why the study is or is not relevant for the systematic
review.
The references mentioned in the reviews fall into three categories:
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Figure 2.6: Plain language summary of a Systematic Review.
1. References to studies included in the review.
2. References to studies excluded from the review.
3. References to studies awaiting assessment.
The third version of each systematic review is an even more detailed, extended
version of the “Standard” review, containing additional detail in all sections except for
the abstract.
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For the research reported in this thesis, the references from the category of “Ref-
erences included” in the review will be used as “gold standard” data for development
and testing of the post-retrieval ranking system described in Chapter 8 in this work.
The corpus collection is described in Section 4.3.
2.5.4 askMEDLINE
askMEDLINE15 by Fontelo et al. (2005) is a search tool that allows clinicians and
researchers to search MEDLINE® using free-text natural language questions via a web
interface similar to that of Entrez PubMed and shown in Figure 2.7. askMEDLINE
retrieves relevant MEDLINE® articles and provides links to journal abstracts, full-text
articles and related items as illustrated in Figure 2.8. It evolved from a search tool in the
PICO format which was more cumbersome and difficult to use by busy clinicians and
uses the MeSH vocabulary, which provides a reliable means of retrieving information
that uses different terms for the same concept.
Figure 2.7: askMedline search interface.
Unlike Entrez PubMED, which simply searches for all words in the input text string
except for those found on the PubMed stop word list (Appendix C), askMEDLINE
employs a multi-round search strategy. During the first round the parser ignores punc-
tuation marks and deletes words from a stopword list that contains PubMed stop words
and other words that Fontelo et al. (2005) found detrimental to the search. The list of
PubMed stop words can be found in Appendix C. The additional list of stopwords that
Fontelo et al. use does not appear to have been published.
After the stopwords have been removed, the modified query is sent to the PubMed
Entrez’ E-Utilities described in Section 2.3.3. Terms with the label “All Fields” which
15http://askmedline.nlm.nih.gov/ask/ask.php
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Figure 2.8: Extract of askMEDLINE results for the question: “How safe and effective are
aspirin and warfarin therapy in the prevention of stroke in patients with atrial fibrillation?”
are defined as neither MeSH subject nor MeSH subheadings are checked against the
“MeSH Backup vocabulary” which includes words classified as “other eligible entries”
such as MeSH descriptors. If an “All Fields” word is in the backup vocabulary, it
remains in the query; if it is not, it is deleted.
The remaining terms are sent back to PubMed, again through E-Utilities with “Hu-
man” and “English” language limits added, restricting the search to studies about hu-
man subjects published in English. If the journal retrieval count after the first round is
between 1 and 50,000, the first 20 results are displayed in the browser and the search
process ends. Results 21 to n can be found on subsequent pages. If no references were
found in the first round or if the number of retrieved references was larger than 50,000,
the search process enters a second round.
In the second round, two different strategies are employed depending on whether
the search was too narrow because too many terms were included in the search and/or
too many filters used, or whether the search was too broad because too few terms were
included in the search.
In the first case, the “All Fields” words are removed from the query even though
they are in the backup vocabulary and only MeSH Terms and Subheadings remain. In
the second case, the “All Fields” words that were removed from the search in the first
round, because they were not found in the backup vocabulary, are put back into the
query, which means the query now contains all MeSH terms and all “All Fields” terms
from the original question.
Chapter 2. Background 39
For both cases, the updated query is sent to Entrez E-Utilities again and the re-
trieved journal articles are displayed in the browser. The search process stops when
the retrieval count is between 1 and 50,000 as in the first round. If the second round
still does not produce search results, the process enters a third round.
During the third round, terms from another list of “No-Go Terms” are added to the
query. The list of “No-Go Terms” includes common MeSH abbreviations, acronyms
and words like, “method”, “affect”, and “lead”, and other terms that could result in a
successful search and is updated with new terms as they are encountered.
The modified query is again sent to E-Utilities and the retrieved journal articles are
displayed. A retrieval count between 1 to 50,000 ends the search process and the first
20 articles are displayed to the user on the first page. If more than 20 articles were
retrieved, the rest can be found on subsequent pages. If askMEDLINE only retrieves
one to four articles, a search is automatically done for articles related to the top two
articles. All original articles and the first 25 related articles of the first two are retrieved
and the first 20 are displayed in the browser.
(Fontelo et al., 2005) have compared askMEDLINE’s performance to the perfor-
mance of Entrez PubMed introduced in Section 2.1. In this assessment, the accuracy
and relevance of retrieved citations was determined using the “gold standard” reference
from POEMs (see Section 2.5.2) and CATs (Critically Appraised Topics) from the Uni-
versity of Michigan, Department of Pediatrics, Evidence-Based Pediatrics website16.
Unlike POEMs, CATs can have more than one cited reference that can be used as a
“gold standard”.
(Fontelo et al., 2005) used 95 POEM questions in this comparative assessment. The
first pass checks whether the gold standard reference is among the retrieved abstracts.
Here, askMEDLINE found 62.1% (59/95) of the articles cited in POEMs, while Entrez
retrieved 13.7% (13/95). For CATs, askMEDLINE found 64.2% (18/28) and Entrez
retrieved 3.6% (1/28). After including related articles, askMEDLINE found 11.6%
more gold standard references and Entrez another 8.4%. For CATs, 10.6% (Entrez
3.6%) more gold standard references were retrieved after including related articles.
After rephrasing three questions, askMEDLINE found two more matches while Entrez
retrieved none. Rephrasing added 14.3% to askMEDLINE’s accuracy for CATs (7.1%
to Entrez). In total, askMEDLINE correctly matched 75.8% of the cited references in
POEMs and 89.2% of the references cited in response to CATs questions after the first
three steps, while Entrez correctly matched 22.1% of the POEM references and 14.3%
16http://www.med.umich.edu/pediatrics/ebm/cat.htm
Chapter 2. Background 40
of the CAT references.
In cases, where askMEDLINE did not find the specific cited reference for 20
POEM questions, it found journal citations that were deemed relevant and would be
useful in answering the question. For Entrez, references for an additional 16 POEM
questions were considered relevant. For CATs askMEDLINE found 2 citations that
were deemed relevant, while Entrez found none. The overall POEM retrieval fail-
ure for askMEDLINE is 3.1% and 61% for Entrez. The overall CAT retrieval failure
foraskMEDLINE is 3.6% and 85.7% for Entrez.
Both askMEDLINE and Entrez PubMed (c.f. Section 2.3.3) will serve as the basis
for comparison for my abstract retrieval system as two of the few free-text, natural
query search engines specifically developed for MEDLINE®/PubMed queries. Nei-
ther systems was developed with clinical medication comparison questions in mind,
and it will be shown in Section 6.3 that their performance drops significantly when
dealing with comparison questions. A new clinical QA system, AskHermes17, was
made available online in late 2010. Due to its unavailability at the time this research
was undertaken, it was not considered in the system comparison.
2.6 Summary
This chapter gave an overview of the disciplines involved in this research and pro-
vided knowledge about the information needs of clinicians and the domain of Evi-
dence Based Medicine (EBM), as well as an overview of Information Retrieval (IR)
and Question Answering (QA) techniques in the clinical domain and existing clinical
QA services and applications that provide the background for the current research. The
retrieval and post-retrieval ranking performance of RetroRank will be evaluated against





The goal of this chapter is to introduce the concept of comparative constructions and
the lexical items and phrases indicative of comparison questions, which are used for
the creation of Corpus 1 as described in Section 4.1.
3.1 General Purpose and Form in Questions
Comparative constructions are a common phenomenon in the English language and
a description can be found in all books on English grammar. This chapter provides
a general description of comparisons based on The Cambridge Grammar of the En-
glish Language by Huddleston and Pullum (2002) as well as examples of the different
comparative constructions occurring in clinical questions.
Comparative questions express relations based on similarities or differences be-
tween entities. In this research, the term entity refers to drugs and treatment methods
or interventions. Comparisons of different entities often occur in questions asked by
physicians and in medical literature reporting results from clinical trials, comparative
studies, and systematic reviews.
Comparatives can be scalable or non-scalable and both groups can express equality
or inequality between the compared entities. Scalable adjectives and adverbs describe
attributes that can be measured in degrees and scalability refers to the possibility to
place an adjective or adverb on a scale to express the degree to which it applies. Non-
scalable adjectives and adverbs cannot be measured in degrees. Equality refers to con-
structs where two or more compared entities are equal in respect to a shared quality,
whereas inequality emphasises the difference between entities in respect to a certain
quality. My clinical comparison question corpora contain questions of all of the above
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Scalability Equality Example
+ + As efficient as x
- + Same intervention as x
+ - Better treatment than x
- - Drug x differs from drug y
Table 3.1: Features of comparatives.
mentioned combinations of scalability and equality. Table 3.1 gives an example show-
ing the four possibilities for drugs and interventions:
Comparison can take a comparative form, a superlative form, or neither as in the
“same” and “different from” examples. The comparative form is used to compare two
entities with respect to a certain attribute. The superlative form compares or contrasts
one entity with a set of other entities and expresses the end of a spectrum. The follow-
ing examples illustrate the difference:
Comparative form: Is Ibuprofen better than Paracetamol for treating pain?
Superlative form: Is Ibuprofen the best treatment for pain?
3.2 Lexical Items Indicating Comparative Constructions
Comparisons are conveyed in many ways by lexical items and phrases. These lexical
items and their respective part-of-speech tags were used to extract a subset of compar-
ison questions from a clinical QA corpus. (In chapter 4.2, it is described how.) In the
three corpora used in this research, the following lexical items and phrases occur as
indicators of comparison questions:
1. Comparative adjectives and adverbs:
Regular adjectives and adverbs:
ADJ/ADV -er (e.g. safer [than]1 drug/intervention x] [for y]
Irregular adjectives and adverbs:
e.g. worse/better [than] or as good as drug/intervention x] [for y]
Analytical adjectives and adverbs:
1Than is optional. For example see A or B: What is safer?
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e.g. less/more ADJ/ADV [than drug/intervention x][for y]
2. Superlative adjectives and adverbs:
Regular adjectives and adverbs: ADJ/ADV -est (eg.safest) x [for y]
Irregular adjectives and adverbs: e.g. worst/best x [for y]
Analytical adjectives and adverbs: e.g. least/most ADJ/ADV x [for y]
3. Verbs, nouns and coordinating conjunctions:
Verbs: compared to/with, differ from
Nouns: comparison, difference
Coordinating conjunctions: versus/vs, or, and, instead of
3.3 Summary
This chapter introduced comparative constructions and the lexical items and phrases
indicative of comparison questions, which are used for the creation of Corpus 1 de-
scribed in Section 4.1.
Chapter 4
Creating Three Corpora of Clinical
Comparison Questions
This chapter describes the creation and preprocessing of the three corpora of clini-
cal questions. The three corpora described in this chapter serve different purposes.
The NLH QAS corpus (Corpus 1) described in Section 4.1 was used for the initial
MEDLINE® retrieval experiment to be described in Chapter 5 and for developing and
testing the automated retrieval component of RetroRank to be described in Chapter
6. However, a different set of questions was necessary for evaluating the automated
system according to the same criteria used in the askMEDLINE and Entrez PubMed
evaluation published in Fontelo et al. (2005). Therefore, the corpus of the Essential
Evidence Plus POEM questions (Corpus 2) in Section 4.2 was collected, along with
the “gold standard” reference for each question. Corpus 2 was also used for devel-
oping the post-retrieval ranking strategies described in Chapter 7. Because Corpus 2
only has one “gold-standard” reference for each clinical question, it could not be used
to calculate Mean Average Precision (MAP) or Mean Rank Precision (MRR) for the
post-retrieval ranking module of RetroRank. Therefore, a third corpus, the Cochrane
Systematic Review Corpus (Corpus 3), was collected. This corpus provides multiple
“gold-standard” references for each clinical question, which allows a system evalua-
tion using the standard IR metrics.
4.1 Corpus 1
A programme was developed to automatically extract all questions and answers avail-
able on the 20th of July 2007 from the NLH clinical question answering service (QAS)
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website at http://www.clinicalanswers.com introduced in Section 2.5.1. This
data was used to create two separate XML files containing the questions and the an-
swers.
A simple XML format brackets the major structures of the text. During this process
a total of 4,580 unique Q-A pairs of different degrees of difficulty and complexity for
34 medical fields was collected, representing questions asked and answered over a
36 month period. These questions and answers form the corpus of clinical questions
which were used during the initial retrieval experiment described in Chapter 5 and for
developing the automated retrieval component of RetroRank described in Chapter 6.
The corpus can be expanded with new questions from ATTRACT (cf. Section 2.5.1)
if more data is necessary. Figure 4.1 and 4.2 illustrate examples of the format of the
question and answer files created from the NLH QAS:
Figure 4.1: Example question file.
Figure 4.2: Example answer file.
After creating this initial corpus, the research was narrowed down to clinical com-
parison questions, because they are a common kind of question clinicians have and no
methods yet exist that specifically address this kind of clinical question in medical QA.
To create a subcorpus containing only comparison questions, the TnT tagger (Brants,
2000) was used to POS-tag the initial corpus with the Penn Treebank tagset. The TnT
tagger implements smoothing by interpolation and handles unknown words by using
N-Gram models on word suffixes. The tagger was trained on the Wall Street Journal
(WSJ) corpus which comes with “gold standard” POS tags, since there was no match-
ing training data available for the domain. Some comparative constructions may have
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been missed because of the lack of a suitable training corpus and POS tagging errors.
However a manual analysis yielded approximately the same number of comparative
questions. A very small number of the POS tags of the comparative sentences had to
be manually corrected. The following is an example for a tagged comparison sentence:
(4.1) Which/WDT is/VBZ better/JJR for/IN investigation/NN of/IN dementia/NN
-/:CT/NNP or/CC MRI/NNP ?/.
To create a corpus of clinical comparison questions, the tagged corpus was searched
for the POS tags of the lexical items introduced in Chapter 3.2, i.e., the tags JJR
(comparative adjective), JJS (superlative adjective), RBR (comparative adverb), RBS
(superlative adverb), and the lexical items from Section 3.2 indicating comparisons,
namely the nouns comparison and difference, the verbs compared to/with and differ
from and the coordinating conjunctions versus and instead of. Or was disregarded be-
cause its comparative sense only occurred in sentences already retrieved by looking for
comparative and superlative adjectives and adverbs.





CC (versus, instead of) 18
VBN (compared to/with, differ from) 45
NN (comparison, difference) 85
Total 742
Table 4.1: Number of lexical items indicating comparisons.
Duplicates of questions containing more than one tag which was a comparison in-
dicator were removed. The subcorpus of comparison questions contains 742 out of
the total corpus of 4580 Q-A pairs shown in table 4.1. This subset comprises approxi-
mately 17% of the original set.
A small number of false positives were found during manual post-processing, as
not all words tagged as superlatives signal comparisons. Rather they are part of id-
iomatic expressions, such as best practise, or proportional quantifiers (Huddleston
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and Pullum, 2002) such as Most NSAIDs’. Scheible (2008) distinguishes eight differ-
ent classes in which the superlative construction is used in English but only five of the
eight classes involve true comparisons.
4.2 Corpus 2
In order to evaluate the retrieval component of RetroRank according to the same cri-
teria used in the askMEDLINE evaluation described in Section 2.5.4, 30 medication
comparison questions were collected from the Essential Evidence Plus POEM archive1
described in Section 2.5.2. Further questions and their associated POEM reference
summaries can be collected for additional testing and evaluation.
The POEM corpus was collected by searching for a number of frequent lexical
items indicating comparisons (i.e. better, safer, compared to, etc.) that were identified
in Corpus 1 and saving the retrieved comparison questions and the associated POEMs
in separate files. Example (4.2) shows the first question from the POEM corpus.
(4.2) How safe and effective are aspirin and warfarin therapy in the prevention of
stroke in patients with atrial fibrillation?
The full list of questions can be found in Appendix D. The questions were later pro-
cessed using TTT2 and a Java pipeline which will be described in Chapter 6.
Only POEM questions were used. CATs were not used, as in the evaluation of
askMedline by Fontelo et al. (2005), because CATs do not contain a sufficient number
of medication comparison questions.
4.3 Corpus 3
A third corpus with “ gold standard” references was needed to evaluate the post-
retrieval ranking methods introduced in Chapter 7. While Corpus 2 served as a starting
point for developing post-retrieval ranking methods, it has the limitation of only listing
one “gold standard” reference for each question. This presents a problem for a com-
parable system evaluation because calculating the Mean Average Precision (MAP),
Mean Rank Precision (MRP), Binary Preference (Bpref) and recall requires more than
one “gold standard” reference per question in order to see at which positions the “gold
1http://www.essentialevidenceplus.com/content/poems
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standard” references are ranked and how many of the total number of “gold standard”
references were retrieved.
To create the post-retrieval ranking evaluation corpus, systematic reviews from
Cochrane Library (Section 2.5.3) were used. A manual search of the Cochrane Li-
brary identified systematic reviews involving drug comparisons. Because the titles of
the systematic reviews are not in question form, a comparison question was created
from the title and the description of the aim of the systematic review from the “Objec-
tives” section. The ID of the Cochrane review was also recorded to provide a key for




Magnesium sulphate versus for eclampsia.
Objectives
The objective of this review was to assess the effects of magnesium sulphate com-
pared with diazepam when used for the care of women with eclampsia. Magnesium
sulphate is compared with phenytoin and with lytic cocktail in other Cochrane re-
views.
Question
What are the effects of magnesium sulphate versus diazepam for eclampsia?
Table 4.2: Creating a comparison question from Cochrane Systematic Reviews.
A total of 45 questions were collected. The full list of questions and their IDs can
be found in Appendix F.
An API, which is part of the RetroRank post-retrieval ranking module described in
Section 8.2.1, was developed to download the systematic reviews and the references
from the category of “References included” (c.f. Section 2.5.3) for the comparison
questions and recorded IDs. The “References included” form the “gold-standard” for
each question. Using third party judgements in form of the references in the Cochrane
reviews has the advantage of having access to “gold standard” references carefully cho-
sen by domain experts. However, it has to be noted that the judgements are incomplete
and some potentially relevant references might not be included.
Downloading and caching the Cochrane systematic reviews results in a local corpus
that can be scanned and updated based on new queries. This allows further questions
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and their associated Cochrane abstracts to be collected for additional testing and eval-
uation.
4.4 Summary
This chapter introduced three different corpora of clinical comparison questions. Cor-
pus 1 created from the NLH QAS served as a starting point for testing different retrieval
strategies for clinical comparison questions and for developing the retrieval compo-
nent of RetroRank, the clinical QA system developed in this research. Corpus 2, col-
lected from the Essential Evidence Plus POEM archive, and Corpus 3, collected from
Cochrane Systematic Reviews, served as “gold standard” corpora for further system
development and for the evaluation of RetroRank on standard IR metrics described in
Chapter 8.
Chapter 5
Initial Experiment in MEDLINE®
Abstract Retrieval
In order to develop RetroRank, the automated QA system described in Chapter 8, an
initial retrieval experiment was carried out via the OVID® portal to see if MEDLINE®
abstracts are a useful resource for answering comparison questions such as “Is drug A
better than drug B for treating X?”, and to discover the best search strategy for clinical
comparison questions. Comparison questions differ from other clinical queries for
which systems like askMedline (c.f. Section 2.5.4) were developed and the assumption
is that different retrieval strategies are needed for achieving the best possible results.
Intermediate searches, which would have been performed internally by a search
engine, are included in this chapter to illustrate the impact of adding the basis of the
comparison and the use of a publication type limit on the number of retrieved abstracts.
The findings of the initial experiment are implemented in the retrieval component of
RetroRank described in Chapter 6.
5.1 Strategies for Retrieving MEDLINE® Abstracts
For the experiment, different strategies to achieve the best possible retrieval of relevant
abstracts were tried out with the assistance of Marshall Dozier, a medical librarian from
the University of Edinburgh Information Service Department. We also experimented
with applying the publication study type limit comparative study, which has different
effects depending on whether the drugs mentioned in the query are well-studied or not.
For popular, well-studied drugs, looking for the drug names often leads to hundreds
of returned abstracts, most of which are not relevant. By including the basis of the
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comparison and limiting the study type to comparative studies, the number of returned
abstracts for a set of 30 questions drops on average to 15% of the size of the original
set of returned abstracts. For Example (5.1) a search for the combination of both drug
names retrieved 593 abstracts. Including the basis of the comparison decreased the
number to 139 abstracts. After constraining the results to comparative studies, the
number of retrieved abstracts dropped to 24, which is a reduction of 83%.
For less-studied drugs, the difference in number of abstracts retrieved by including
the basis of the comparison and limiting the search to the comparative study publica-
tion type is smaller compared to the number retrieved by only looking for the drug
names, because fewer abstracts exist for these drugs, but the relevance of the returned
abstracts improves as considerably as for the more studied drugs. (Recall was not anal-
ysed during the explorations because for answering clinical questions the relevance of
the retrieved abstracts is more important than retrieving all possible abstracts.)
There were a small number of cases where including the basis of the comparison
lead to the return of no relevant abstracts. In this case, different strategies from the one
discussed above should be considered.
The search strategy for well-studied drugs is described and illustrated with Exam-
ple question (5.1). The basic search strategy for less-studied drugs is the same with the
exception that the comparative study limit is removed when no abstracts are retrieved.
(5.1) Is lansoprazole better than omeprazole in treating dyspepsia?
Titles and abstracts were searched for each of the compared entities (lansoprazole and
omeprazole) and the basis of the comparison (dyspepsia). The results were combined
to return only abstracts that contained both entities as well as the basis of the compar-
ison, and were comparative studies. An example abstract for Question (5.1) is shown
in Figure 5.1 The most common sources that were excluded by constraining the search
to comparative studies are reviews, clinical trials, evaluation studies, and case reports.
These may contain relevant information but the initial focus was on the study type that
was most likely to increase precision. (As the evaluation in Section 5.2 shows, the
restriction to comparative studies is insufficient to guarantee relevance and can prove
too narrow.)
Often the basis of the comparison is related to symptoms which are not explicitly
mentioned in the question but which are still relevant. For example, in the abstract
shown in Figure 5.1 heartburn is mentioned as well as dyspepsia and the terms are of-
ten used interchangeably to refer to the same condition of a burning feeling in the chest
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Figure 5.1: Example question (5.1) and MEDLINE® abstract. The compared entities
are highlighted in yellow and the basis of the comparison is highlighted in green.
and similar symptoms caused by food digestion problems. In order to recognise that
different terms are actually related to the same disease and belong to the same hierar-
chy, advantage was taken of OVIDs ability to map the entities to their corresponding
MeSH (Medical Subject Headings) terms and to “explode” the MeSH terms to include
all of the narrower, more specific subheadings during the search. Figure 5.21 shows
an extract of the MesH hierarchy that the basis of the comparison, dyspepsia, from
example (5.1) belongs to, and it shows that heartburn belongs to the same hierarchy
and is related and relevant. Mapping the terms in a query to MeSH terms appears to be
a useful step in finding related concepts as shown in Lu et al. (2009). This approach
1http://www.nlm.nih.gov/mesh/MBrowser.html
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corresponds to using WordNet2, a lexical database for English, which organizes words
into sets of synonyms called synsets, for query expansion in information retrieval such
as in Voorhees (1994); Gonzalo et al. (1998).
Figure 5.2: Extract from the MesH hierarchy for dyspepsia.
The initial explorations identified the most successful retrieval approach as search-
ing for the compared entities and the basis of the comparison by searching for each
element in the title and abstract section of MEDLINE® abstracts and combining the
results, so that only abstracts which contain both entities and the basis of the compari-
son were retrieved.
2http://wordnet.princeton.edu/
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5.2 Judging the Relevance of MEDLINE® Abstracts
A initial experiment was carried out to evaluate the relevance of the abstracts retrieved
from MEDLINE® via Ovid® using the strategies described in the previous section.
The evaluation was done in terms of precision. Recall could not be assessed because
the number of relevant abstracts that could have been retrieved is unknown. The ex-
perimental subjects were eight 4th year medical students, who evaluated the abstracts
retrieved for twelve clinical comparison questions in which two drugs were compared
to each other with respect to a particular attribute. The questions differ in syntactic
structure, but they all contain comparisons of two drugs. Table 5.1 shows the list of
questions which are a subset of Corpus 1 described in Section 4.1.
1 Is there any evidence to suggest that torasemide is better than furosemide as a diuretic?
2 Is lansoprazole better than omeprazole in treating dyspepsia?
3 Are there any studies comparing topical diclofenac gel with ibuprofen gel?
4 Effectiveness of Decapeptyl in treatment of prostate cancer in comparison to Zoladex?
5 Which is more effective ibuprofen or diclofenac for arthritis pain for pain relief?
6 Is calcium citrate better absorbed and a more effective treatment for osteoporosis than calcium carbonate?
7 Have any studies directly compared the effects of Pioglitazone and Rosiglitazone on the liver?
8 Is Famvir (famciclovir) better than acyclovir for Herpes zoster?
9 Is it true that men on captopril have a better quality of life than men on enalapril?
10 What is the first choice for Type 2 diabetes patients: sulphonylurea or metformin?
11 Is there any evidence as to which is more effective at preventing malaria: Malarone or Doxycyline?
12 In conjunctivitis which is better chloramphenicol or fucithalmic eye drops?
Table 5.1: Questions used in the experiment.
The material presented to the medical students in the experiment was created as
follows: The drug names and the basis of the comparison from the natural language
questions were manually mapped to their corresponding MeSH terms and used to re-
trieve abstracts via OVID® using the final strategy described in Section5.1.
For any question, the maximum number of abstracts given to the student judges was
15, comprising up-to-15 of the most recent abstracts. In total, each judge evaluated 103
abstracts. Each abstract was assigned by each judge into one of three categories, based
on the criteria given after the category label:
1. Relevant: Both drugs from the question or their generic names are mentioned in
the abstracts, the drugs are directly compared to each other, and the disease or the
attribute with respect to which they are being compared is also mentioned and is the
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same as stated in the question or synonymous to it (e.g., heartburn and dyspepsia
would both count as right because they are closely related).
2. Not Relevant: The drugs or their generic names are not mentioned in the abstract,
the drugs are not compared, and/or the disease or the attribute with respect to which
they are being compared is wrong (as in different from what is stated in the question,
e.g. effect on blood pressure instead of use as a painkiller).
3. Somewhat Relevant: The drugs or their generic names are mentioned but there are
no single sentences indicating a comparison between them or the disease is not
mentioned. If the wrong disease is mentioned, the abstract should be labeled not
relevant.
The judges were also asked to explain the reason for their choice of labels. The
inter-annotator agreement between the judges was computed using a variant of the
kappa statistic for multiple annotators (Fleiss, 1971). The null hypothesis was rejected
and it was ensured that the observed agreement is not accidental.
Overall inter-annotator agreement for all three categories measured by the kappa
statistic was moderate at 0.58 for a total of 103 judgements. 47 judgements were
in the “somewhat relevant” category. If annotator agreement is only assessed on the
remaining 56 judgements from the two categories “relevant” and “not relevant”, kappa
is 0.97, which represents almost perfect agreement.
5.3 Results and Discussion
Graph 5.3 shows the percentage of abstracts that were judged relevant by the eight
judges for each question. The numbers of retrieved abstracts for each question were:
15 abstracts for Question 1, 5, 8 and 10, 9 abstracts for question 7 and 11, 7 abstracts
for Question 2, 5 abstracts for Question 9, 4 abstracts for Question 6 and 12, 3 abstracts
for Question 3 and 2 abstracts for Question 4.
Question 1, 9 and 12 show a very high percentage of relevant abstracts (a precision
of 73%, 80% and 100% respectively), whereas no relevant abstracts were retrieved for
questions 4, 5 and 11, and only one relevant abstract (out of 15) for question 10. An
abstract was considered relevant when at least five of the eight judges considered it
relevant.
The main sources for these disparate results based on both the explanations given
by the student judges and discussions with our medical librarian are the following:
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Figure 5.3: Percentage of abstracts judged relevant by the majority of the judges for
each of the twelve questions. The label on the top of each bar is the actual percentage.
Approximately 30% (31 of 103) of the abstracts were labeled “not relevant” by
the judges because they lacked any direct evidence of a comparison e.g., at least one
sentence that explicitly compares the two drugs in question, even though the drugs
are mentioned in the abstract and the study is a comparative study (as indicated in
its MeSH indices). This is illustrated in Example (5.2) for Question 1, which shows
the three sentences from one of the abstracts retrieved for Question 1 that explicitly
mention the two drugs:
(5.2) Piretanide and furosemide have a constant extrarenal elimination and thus
accumulate in renal failure.[...] Elimination of torasemide is independent of
its renal excretion. Thus in renal failure, torasemide is the only loop diuretic
in which the plasma concentration is strictly dose dependent.
About 10% (10) of the abstracts were judged to be irrelevant because the drugs were
compared as part of a treatment regime in combination with other drugs, as in Abstract
4 for Question 6 in which calcium citrate and calcium carbonate are compared co-
administered with different preparations of sodium fluoride. In two cases (2% of the
abstracts), doses of a given drug were compared against other dosages instead of the
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drugs themselves, e.g., 30 mg lansoprazole versus 20mg omeprazole.
A major factor for “not relevant” judgements was the time frame. This was relevant
when retrieving abstracts about well-established drugs that have been in existence for
a long time, such as ibuprofen or diclofenac. All but one of the 18 abstracts retrieved
for the two questions about these two drugs were irrelevant, even though the two drugs
were explicitly mentioned in the abstract. The problem is that they were grouped to-
gether as conventional non-steroidal anti-inflammatory drugs (NSAIDs) and compared
to newer NSAIDs or different pain medication. Such abstracts could only be excluded
by analysing the abstracts themselves.
The final source of “not relevant” judgements was a problem with the judges and
not with the abstracts. In Question 2 regarding dyspepsia, two out of seven abstracts
were judged irrelevant because the drugs were not explicitly compared regarding dys-
pepsia but only regarding H. pylori, which is one of the possible causes for dyspepsia.
Also abstracts retrieved for Question 7 about the effect on lipid profiles were wrongly
categorised by roughly a third of the judges as not being relevant to the liver.
The two main problems discovered during the experiment concern abstracts lacking
sentences in which the drugs are directly compared to each other and the retrieval
of irrelevant abstracts for well-established drugs, which are used as a reference for
comparing newer drugs to, instead of containing direct comparisons of the drugs in
question.
5.4 Summary
In this experiment, the focus was on the compared entities and the basis of the compar-
ison. Using a publication type limit decreases the size of the set of retrieved abstracts
and potentially increases relevance but can prove problematic for less-studied drugs,
for which only a small number of abstracts exists in the first place.
The experiment has shown that searching for the drugs, the basis of the comparison,
and studies of the publication type comparative study is a first step towards retrieving
abstracts that can serve as answer candidates for clinical comparison questions, but it
also insufficient to guarantee the relevance of the retrieved abstracts, and the compar-
ative study limit can be too restrictive.
These findings have been taken into account for creating the automated system for
the process of identifying and extracting the elements of a comparison question as well
as the process of retrieving MEDLINE® abstracts described in Chapter 6. Because the
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criteria that make a document relevant can be either applied during the abstract retrieval
process or during a post-retrieval ranking phase, it was decided to use a less restricted
retrieval strategy focusing only on the drug names and the basis of the comparison,
which works well for both well and less-studied drugs, to achieve the best possible
retrieval and to use post-retrieval ranking, which will be introduced in Chapter 8, to
ensure that the most relevant abstracts are displayed in the top of the result set so that
a bigger result set does not present a problem.
Chapter 6
Automatic Query Construction and
Abstract Retrieval
In this chapter the implementation and evaluation of the query construction and ab-
stract retrieval component of RetroRank is described. The findings of the initial ab-
stract retrieval experiment described in Chapter 5 were taken into account for system
development. Section 6.1 describes the question processing with LT-TTT2. Section 6.2
describes the Java pipeline used for keyword extraction and abstract retrieval. Section
6.3 shows an evaluation of the retrieval system. The retrieval component of Retro-
Rank was developed on Corpus 1 described in Section 4.1 and evaluated on Corpus 2
described in Section 4.2.
6.1 LT- TTT2
The first step in creating a system for the automatic retrieval of relevant MEDLINE®
abstracts involved processing the plain text questions with LT-TTT2 to automatically
mark-up the diseases and drugs in the questions with disease and drug XML tags. LT-
TTT21 performs shallow linguistic processing. e.g., turning the text into XML format,
tokenisation, sentence splitting, part-of-speech tagging, lemmatizing, chunking and
rule-based named entity recognition (NER).
LT-TTT2 contains different lexicons to perform rule-based NER for people, loca-
tions, dates and common English words. To tailor LT-TTT2 to medical QA, a disease
lexicon, a drug lexicon for recognising existing drugs, and a drug stem lexicon for
recognising new drugs were added. Also grammars and rules were written for the
1http://www.ltg.ed.ac.uk/software/lt-ttt2
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lexicons to be able to perform rule-based NER on clinical comparison questions.
The disease lexicon was created from the UMLS Metathesaurus by modifying the
UMLS disease file at ftp://ftp.ebi.ac.uk/pub/software/textmining/corpora/
diseases/. The original file contained 276,155 entries in the format displayed in Fig-
ure 6.1.
Figure 6.1: UMLS disease file.
The first column “p1=” lists the UMLS Metathesaurus concepts related to the dis-
ease. Alternate names for the same concept (synonyms, lexical variants, and trans-
lations) are linked together in the Metathesaurus, e.g., Jejunal syndrome in line 5
is associated with another Metathesaurus entry, which is indicated by its two IDs
(“C0013288” and “C0032763”) in the first column. The second column “p2=” shows
the semantic type of a disease and the disease name. For implementing a disease lexi-
con for lexical lookup only the disease names are relevant.
After extracting the disease names and removing duplicate entries, 229,698 entries
were left. The remaining disease names were put into alphabetical order, converted
to lower case and annotated with LT-TTT2 lexicon specific XML tags. An example
extract of the final disease lexicon is shown in Table 6.1.
The lexicon was created as an expanded lookup list including all lexical variants
rather than normalized terms to ensure maximum matching capacity during lexical
lookup. Every entry in the lexicon is treated as a separate name and RetroRank per-
forms phrase matching against the longest possible entry when recognising words in
the clinical questions as possible diseases, e.g., “allergic rhinitis” rather than “rhinitis”
or “chronic obstructive pulmonary disease” rather than “pulmonary disease” or just
“disease”. This method has the limitation that only exact matches are found but it still
achieves very high accuracy (96.67% diseases in the evaluation questions were cor-
rectly recognised in the first round) because of the very large size of the lexicon and
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<lexicon>
<lex word=“abdomen tumor”/>
<lex word=“abdomen tumor desmoid type”/>
<lex word=“abdomen tumour”/>
<lex word=“abdomen tumour desmoid type”/>
<lex word=“abdomen wall abscess”/>
<lex word=“abdomen wall abscess recurrent”/>
<lex word=“abdomen wall tumor myxoid type”/>
<lex word=“abdomen wall tumour myxoid type”/>




Table 6.1: Extract from the LT-TTT2 disease lexicon.
the fact that it includes different spelling variants as well as singular and plural forms
of each disease.
The drug lexicon was created from the Internet Drug Index RxList2. A total of
2,945 drug names was collected from the index on the 21st of September 2009. The
RxList was founded by pharmacists in 1995 and offers detailed and current informa-
tion on drugs from reliable sources like the FDA. The list was later supplemented by
using the Merck Drug Names: Generic and Trade index3 to ensure a more complete
coverage. Drugs sold by different companies may have several trade names and it is
important to have both the generic name and the trade names in a comprehensive drug
lexicon. A total of 2,072 generic and brand drug names was collected on the 5th of
November 2009 from the Merck index. The two drug lists were merged and after the
removal of duplicates, 3,299 entries remained in the final drug lexicon. Each entry
represents a drug name and each word in the clinical questions is matched against the
entries in the drug lexicon as done in the matching process used for the recognition of
diseases. An extract from the drug lexicon is shown in Table 6.2.
A link between a generic drug name and its possible brand names in the drug lex-
icon was not made in the current research. During the abstract retrieval process, each
drug is mapped to its corresponding MeSH term, which is automatically “exploded”
analogously to the example described for diseases in Section 5.2. This means that
2http://www.rxlist.com/drugs/alpha_z.htm
3http://www.merck.com/mmhe/appendixes/ap3/ap3a.html
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<lexicon>





Table 6.2: Extract from the LT-TTT2 drug lexicon.
RetroRank relies on the information included in the MeSH hierarchy for finding rel-
evant related drugs. For example, the MeSH hierarchy for the drug “Sumatriptan”4
includes the fact that it belongs to the sulfonamide group and lists the other generic
drugs that belong to the same group. However, “Sumatriptan” is only associated with
one of its brand names “Imigran” in the MeSH data. Its second brand name, “Imitrex”,
is not associated with “Sumatriptan” in the MeSH data.
Because a drug lexicon can only include drug names that are known at the time the
lexicon was created, a solution for recognizing drugs that have been missed because
they are not in the lexicon, e.g., new drugs, was implemented using WHO drug word
stems5. Drug word stems are parts of a drug name such as “-sartan” in the drug “losar-
tan” or “-prazole” in the drug name “omeprazole”. Research by Segurabedmar et al.
(2008) has shown that the use of word stems based on the nomenclature rules recom-
mended by the WHO International Nonproprietary Names (INNs) Program6 helps in
identifying drugs that have been missed by other methods. INNs are generic, unique
names that are globally recognized. These names are built using word stems indicat-
ing certain pharmaceutical substances and it is possible to recognize new drug names
because the stems are part of their name. A extract of the most recent 2009 list of the
words stems and associated substances is published by the WHO and can be found in
Appendix E.
There are prefix, postfix (suffix) and infix stems and a grammar was written to
recognise each type. For suffix recognition each word in the clinical question is treated
as sequence of characters and regular expressions are used to check for a sequence of
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the suffix lexicon, it is marked up in the following way indicating that the word is a
drug and contains a certain suffix:
(6.1) <drug suffix=‘gatran’>ximelagatran</drug>
For prefixes and infixes, it is checked whether a word treated as a sequence of char-
acters matches a stem found on the prefix or infix list and if this happens a word gets
marked up as a drug and the prefix or infix is shown as can be seen in Example (6.2).
(6.2) <drug prefix=‘fos’>fosamax</drug>










Table 6.3: Extract from the LT-TTT2 WHO suffix stem lexicon.
A post-process checks whether the marked-up drugs are included in a lexicon of
ordinary English words and if so the drug tag gets removed. This is important to filter
out false positives for drug names caused by the WHO stem recognition process in
cases were the stems are ambiguous and can be part of ordinary English words as
well as drug names, e.g., the stem “-al” is very general and occurs in many ordinary
English words such as “marginal” or “temporal”. Another example are words such as
“suggest” or “restriction”. The word “suggest” contains the infix “gest” and the word
“restriction” contains the infix “estr”.
The accuracy of the rule-based name entity disease recogniser is 96.67% on Corpus
2 and 98.5% on Corpus 3. The accuracy of the rule-based named entity drug recogniser
using solely the drug lexicon is 95% for Corpus 2 and 81% for Corpus 3. Using
WHO stem recognition in addition to the drug lexicon increases the accuracy for drug
recognition to 98.75% for Corpus 2 and to 98.33% for Corpus 3. A total of 87 drugs
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were identified using the WHO rules of which 13 were not included in the drug lexicon.
A system diagram highlighting the main steps for question processing with LT-
TTT2 is in shown in Figure 6.2.
Figure 6.2: System diagram of the main processing steps of LT-TTT2.
A list of plain text questions is loaded into LT-TTT2. The questions are then turned
into XML format, tokenised, lemmatised, POS-tagged and NER-tagged. During the
NER step drugs and diseases are bracketed with drug and disease tags. The LT-TTT2
output before further post-processing for the question (6.3) is shown in Example(6.4).
(6.3) Is eletriptan more effective and at least as safe as sumatriptan for the treatment
of acute migraine headache?
(6.4)
<p><s id=“s7”><w l=“be” pws=“yes” c=“w” id=“w784” p=“VBZ”>Is</w>< w l=“eletriptan”
pws=“yes” c=“w” id=“w787” p=“NN” drug=“true”>eletriptan</w><w pws=“yes” c=“w”
id=“w798” p=“RBR”>more</w> <w pws=“yes” c=“w” id=“w803” p=“JJ”>effective</w>
<w pws=“yes” c=“w” id=“w813” p=“CC”>and </w><w pws=“yes” c=“w” id=“w817”
p=“IN”>at</w<w pws=“yes” c=“w” id= “w820”p=“JJS”>least</w><w pws=“yes” c=“w”
id=“w826” p=“RB”>as</w> <w pws=“yes” c=“w” id=“w829” p=“JJ”>safe</w><w
pws=“yes” c=“w” id=“w834” p=“IN”>as</w><w l=“sumatriptan” pws=“yes” c=“w”
id= “w837” p=“NN” drug=“true”>sumatriptan</w> <w pws=“yes” c=“w” id=“w849”
p=“IN”>for</w><w pws=“yes” c=“w” id=“w853” p=“DT”>the</w><w vstem=“treat”
l=“treat-ment” pws=“yes” c=“w” id=“w857” p=“NN”>treatment</w><w pws=“yes” c=“w”
id=“w867” p=“IN”>of</w><w pws=“yes” c=“w” id=“w870”p=“JJ”>acute</w><w
disease=“true” l=“migraine” pws=“yes” c=“w” id=“w876” p=“NN”>migraine</w><w
disease=“true” l=“headache” pws=“yes” c=“w” id=“w885” p=“NN”>headache</w><wc=“.”
sb=“true” pws=“no” id=“w893” p=“.”>?</w></s></p>
Example (6.4) contains the following fields:
<p>...</p>: Each sentence is wrapped with paragraph elements which are required
for the tokenisation step.
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<s>...</s> and <w....>...</w>: The tokeniser segments the character data content
in <p> elements into <w> (word) elements, and identifies sentences which are
wrapped into <s> elements.
“id”: “id” is an attribute of <w> or <s> elements. For <w> elements it shows a
unique id for each word. For <s> elements it shows a sequential number of the
sentences that are processed.
“l”: The “l” attribute shows the lemma of a word. Only word types that can be
lemmatised have this element.
“c”: The “c” attribute is used to encode the word type which is only relevant for
internal purposes. c=“abbr” would indicate the word is an abbreviation, for example.
“pws”: The “pws” attribute encodes white space. pws=“yes” means that there is a
white space between a word and the word before.
“sb”: The “sb” attribute indicates a final full stop at the end of a sentence to
differentiate it from possible internal full stops. The “pws” and “sb” attributes are
relevant for the NER component.
“p”: “p” encodes the POS tag of a word, e.g., NN for a proper noun, JJ for an
adjective, IN for a preposition, etc. The POS tags are Penn Treebank POS tags.
“drug” and “disease”: These attributes encode drug and disease names within the
NER component. They get the value “true” when a drug or disease is recognised and
are not displayed when their value is “false” because a word is not recognized as a
drug or disease. In Example (6.4) the drugs eletriptan and sumatriptan are encoded
with drug tags and the disease migraine headache is marked up with disease tags.
The experiment in Chapter 5 showed that the drug names (which are the compared
entities) and the disease name (the basis of the comparison) are a good starting point
for retrieving potentially relevant abstracts. Also, the performance of Entrez PubMed
(cf. Section 2.3.3) shows that sending additional terms, such as “safe” or “effective” in
the case of Example (6.3), has detrimental effects on accuracy during abstract retrieval.
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Therefore all additional markup except for the sentence ID, the drug and the disease
tags is removed during a second post-processing step with XLST stylesheets. The final
output for question (6.3) is shown in Example (6.5). If a drug is recognised by both the
initial lexical lookup in the drug lexicon and by checking for the WHO word stems,
the drug tags get nested as can be seen in Example (6.5) for the drugs eletriptan and
sumatriptan. This only serves an informative purpose and does not make a difference
for later keyword extraction. Each part of a disease is wrapped in its own disease
tag for the reason that keywords in the initial E-Utilities ESearch query are treated as
single keywords and not as compound keywords e.g., migraine headache needs to be
split up into migraine + headache instead of “migraine headache”.
(6.5)
<p><s id=“s7”>Is <drug><drug suffix=“triptan”>eletriptan</drug> </drug> more effective and
at least as safe as <drug><drug suffix=“triptan”>sumatriptan</drug></drug> for the treatment of
acute <disease>migraine</disease><disease> headache</disease></s></p>
The XML-tagged question file is then passed on to the Java pipeline for keyword
extraction and abstract retrieval.
6.2 Java Pipeline
The second program component is a Java pipeline that processes the tagged questions
generated by LT-TTT2 and retrieves MEDLINE® abstracts. Figure 6.3 shows the sys-
tem diagram for the Java pipeline.
Figure 6.3: System diagram of the Java pipeline.
At the start the XML-tagged questions generated with LT-TTT2 are loaded into the
Java pipeline. From Example (6.5) the Keyword Extractor extracts the drug and dis-
ease entities (eletriptan, sumatriptan, migraine and headache). The Query Constructor
translates these keywords into an E-Utilies ESearch query URL (see Section 2.3.3) to
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search for associated PubMed IDs (PMIDs) in PubMed. Example (6.6) shows an ex-
ample query URL for the question keywords. The example query URL in (6.6) does
not include any additional search limits such as restricting the search to humans or a
certain date range. The ESearch query will retrieve a list of PMIDs of MEDLINE®




The Abstract Retriever constructs an E-Utilities EFetch query that retrieves the
MEDLINE® abstracts from PubMed for the PMIDs retrieved by the ESearch query.
The MEDLINE® abstracts are saved as text files. An example EFetch query URL is
shown in Example (6.7). The first three PMIDs retrieved by the ESearch query from




The next section shows the performance of RetroRank on 30 clinical comparison
questions from Corpus 2 and compares it to two existing abstract retrieval systems.
6.3 System Evaluation using Corpus 2
The performance of the retrieval component of RetroRank was assessed in terms of
accuracy using 30 medication comparison questions taken from Corpus 2, which was
collected from the Essential Evidence Plus POEM archive introduced in Section 3.2.2
(see Appendix D for the full question list). This enabled RetroRank to be evaluated
using the same criteria used in the askMEDLINE evaluation described in Section 2.5.4.
The 30 POEM questions were first processed with LT-TTT2 and the output file was
then used for retrieving relevant MEDLINE® abstracts for each question with the Java
Pipeline.
RetroRank produces two different abstract result sets. This is done to evaluate
the impact of a publication type limit filter and to assess whether an additional filter
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is a good idea. One set (“All Studies”) is retrieved without applying any publication
type limits. The other is limited to the publication type Comparative Studies (“Comp
Studies”). Table 6.4 shows the total number of MEDLINE® abstracts retrieved for the
two result sets. Later analysis will show that the study type limit is too restrictive to
allow for optimal performance.
Number of abstracts retrieved
“All Studies” 3425
“Comp Studies” 883
Table 6.4: Number of retrieved abstracts for the two result sets.
Number of abstracts retrieved
askMEDLINE 2001
Entrez PubMed 35778
Table 6.5: Number of retrieved abstracts for askMEDLINE and Entrez PubMed
askMEDLINE (Section 2.5.4) and Entrez PubMed (Section 2.3.3) are both assessed
on the same set of questions to determine what is gained by the approach to specialized
retrieval for comparison questions in this research. The total number of retrieved ab-
stracts for each of the two systems in shown in Table 6.5. Even though Entrez PubMed
retrieved about ten times as many abstracts as RetroRank for “All studies”, the accu-
racy is very low as will be shown in the analysis below.
The accuracy of all three retrieval systems (RetroRank, askMEDLINE and En-
trez PubMED) was determined using the “gold standard” reference from Corpus 2 for
the 30 comparison questions. If the retrieved MEDLINE® abstract set for a question
contains the “gold standard” POEM reference, the abstract retrieval process for that
question is considered successful. Table 6.6 shows the results for all three systems.
RetroRank (“All Studies”) achieved an accuracy of 70% for the condition with-
out a publication type limit, which corresponds to the condition for the other systems
which do not include a publication type limit. This means for 21 out of the 30 ques-
tions the “gold standard” reference was among the set of retrieved MEDLINE® ab-
stracts. askMEDLINE found 53.3% of the cited articles while the accuracy of Entrez
PubMed is just 30%. The statistical significance of the results was determined using
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“Gold-standard” retrieved “Gold-standard” not retrieved No reference retrieved
RetroRank (“All Studies”) 21/30 (70%) 7/30 (23.3%) 2/30 (6.7%)
RetroRank (“Comp Studies”) 16/30 (53.3%) 10/30 (33.3%) 4/30 (13.3%)
askMEDLINE 16/30 (53.3%) 13/30 (43.3%) 1/30 (3.3%)
Entrez PubMed 9/30 (30%) 12/30 (40%) 9/30 (30%)
Table 6.6: Accuracy for the comparison questions in Corpus 2.
the Wilcoxon signed-rank test. The performance of RetroRank was significantly better
than the performance of Entrez PubMed (p < 0.005). While the difference in perfor-
mance between RetroRank and askMEDLINE was not found statistically significant
(p > 0.1), it still represents a marked improvement.
The “gold standard” reference was not among the retrieved abstracts for 23.3%
(7/30) of the questions for RetroRank (“All Studies”), 43.3% (13/30) of the questions
submitted to askMEDLINE and 40% (12/30) questions submitted to Entrez PubMed.
The overall retrieval failure for RetroRank (“All Studies”) was 6.7% compared to 3.3%
for askMEDLINE and 30% for Entrez PubMed.
The accuracy of 53.3% of askMEDLINE on the set of 30 clinical comparison ques-
tions was lower than the accuracy of 62.1% reported by Fontelo et al. (2005) for their
set of POEM questions, which might be due to the fact that the askMEDLINE algo-
rithm was not developed for comparison questions. On the other hand, Entrez PubMed
performed better here than in Fontelo’s study where it only achieved 13.7% accuracy,
although it still achieves the lowest accuracy of all systems.
The accuracy of RetroRank for “Comp studies” is 53.3% which is 16.7% lower
than the accuracy of “All Studies”. This indicates that the inclusion of the publica-
tion type “comparative study” during retrieval has detrimental effects. The retrieval
failure for RetroRank (“Comp Studies”) is 13.3% which is another indicator that this
publication type limit during retrieval is too restrictive.
6.4 Error Analysis
In three cases, RetroRank fails to retrieve the “gold standard” citation whereas askMEDLINE
does. In one case the “gold standard” reference was retrieved by both askMEDLINE
and Entrez PubMed. Example (6.8) is a question for which both of the other systems
retrieved the correct reference.
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(6.8) In adults or children with moderate to severe atopic dermatitis, is either tacrolimus
(Protopic) or pimecrolimus (Elidel) more effective than topical corticosteroids?
(Question 2 in Corpus 2)
The query terms RetroRank used were: tacrolimus, Protopic, pimecrolimus, Elidel,
corticosteroids, atopic, dermatitis, and the PubMed limit Humans, restricting the re-
sults to studies about humans. askMEDLINE retrieved the correct abstract during the
1st retrieval round. This can be determined because the retrieval process terminates
when the retrieval count is between 1 and 50,000 and a total of 45 abstracts was re-
trieved during this questions. The askMEDLINE algorithm is detailed in Section 2.5.4.
However, too many elements of the askMEDLINE algorithm are not specified to make
an informed guess about what element lead to successful abstract retrieval, e.g., the
content of the personal stop word list and the content of the MeSH backup vocabulary
is not published.
Entrez PubMed successfully retrieved the “gold standard” abstract by mainly us-
ing the same query terms used in RetroRank. However, the query included the ad-
ditional terms: moderate, severe, effective and topical as well as the limits adult(s)
and child(ren), because all words that are not PubMed stop words get included in the
search. Using adult(s) and child(ren) instead of the limit humans does not lead to re-
trieving the “gold standard” citation. The terms moderate, severe, effective and topical
are not MeSH terms but occur in the “gold standard” abstract and one or more of them
might have led to the successful retrieval. The overall performance of Entrez PubMed
with many query terms is rather low, however, and there are several cases where too
many query terms led to retrieval failure. Therefore this approach has not been adopted
for RetroRank.
Example (6.9) is a question for which askMEDLINE retrieved the “gold standard”
reference but neither RetroRank nor Entrez PubMed did.
(6.9) Is ximelagatran as effective as warfarin in preventing stroke in patients with
nonvalvular atrial fibrillation? (Question 15 in Corpus 2)
RetroRank used the following query terms: ximelagatran, warfarin, stroke, nonva-
lvular, atrial, fibrillation which all occur in the reference citation shown in Example
(6.10)
(6.10) Executive Steering Committee on behalf of the SPORTIF III Investigators.
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Stroke prevention with the oral direct thrombin inhibitor ximelagatran com-
pared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF
III): randomised controlled trial. Lancet 2003; 362: 1691-98.
The only real difference between the query terms contained in the “gold standard” ref-
erence and in the reference about the same study retrieved by RetroRank (see Figure
6.4) is the spelling of the term nonvalvular (non-valvular in the reference citation).
The reference retrieved by RetroRank refers to the same trial but is not the “gold stan-
dard” reference. Although the associated abstract actually answers the question even
though it is not the reference citation, a trial with a different spelling of nonvalvular
makes the crucial difference in retrieving the “gold standard” abstract, and shows that
it would be beneficial to search for different spellings of the query terms. This will be
further discussed in Chapter 9. Entrez PubMED used the same query terms RetroRank
used including the same spelling of nonvalvular and also failed to retrieve the correct
reference.
Figure 6.4: Gold standard reference for Question 15.
Example (6.11) is the third question RetroRank failed to retrieve the “gold-standard”
reference for. Entrez PubMED also failed to retrieve the correct reference and retrieved
no references at all, whereas RetroRank retrieved ten references of which at least one
seems relevant to the question.
(6.11) Is losartan comparable to captopril in CHF? (Question 22 in Corpus 2)
The problem in this case is that CHF was not associated with the disease heart failure
which occurs in the “gold standard” reference because an error occurred during the
query translation process of the E-Utilities ESearch module. The query translation
shown in Example (6.12) shows that CHF was wrongly mapped to “Congest Heart
Fail” [Journal] instead of “Congestive Heart Failure” [All Fields].
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(6.12)
<QueryTranslation>
(“losartan”[MeSH Terms] OR “losartan” [All Fields]) AND (“captopril”[MeSH Terms]
OR “captopril” [All Fields]) AND (“Congest Heart Fail”[Journal] OR “chf” [All Fields])
AND “humans”[MeSH Terms] AND 1950/01/01 [EDAT] : 2010/03/31[EDAT]
</QueryTranslation>
The same error occurred during the Entrez PubMED search where the query trans-
lation is shown in Example (6.13). Entrez PubMED retrieved no references at all which
seems to be due to the inclusion of the term comparable which restricts the search too
much during retrieval.
(6.13)
(“losartan”[MeSH Terms] OR “losartan”[All Fields]) AND comparable [All Fields]
AND (“captopril”[MeSH Terms] OR “captopril”[All Fields]) AND (“Congest Heart
Fail”[Journal] OR “chf”[All Fields])
6.5 Summary
The evaluation and error analysis of RetroRank has shown that searching for only drugs
and diseases achieves an accuracy of 70% on the test corpus, which is a significantly
better result than the two other retrieval systems achieved. Additional query terms may
prove successful for some queries but lead to worse performance overall as can be see
for the accuracy of PubMed. Therefore this approach will not be adopted for abstract
retrieval for RetroRank. Limiting the search to the publication type Comparative Study
during retrieval was found to be too restrictive to allow for good performance and has
therefore been abandoned.
In the next chapter different post-retrieval ranking strategies to rerank the retrieved
abstracts according to different criteria will be tested and evaluated. The goal is to
improve on the recency ordering retrieved by MEDLINE®.
Chapter 7
Post-retrieval Ranking Strategies
This chapter introduces different post-retrieval ranking strategies which will be used to
re-rank the MEDLINE® abstracts retrieved for each question in Corpus 2 and Corpus
3 in order to display the most relevant abstracts as high in the result set as possible.
During retrieval from MEDLINE®, retrieved abstracts are ordered by recency with the
most recent abstract displayed first. This order forms the baseline for the evaluation
of the different ranking strategies described in Chapter 8. Because recency does not
equate to relevance, post-retrieval ranking is an important feature in a system that is
geared towards providing the most relevant abstracts at the top of the result set to
enable clinicians to find the most relevant information quickly and reliably.
7.1 Ranking Strategies
7.1.1 Rank by Reverse Chronological Time Order (“recency”)
The baseline for the post-retrieval ranking module of RetroRank is the simple default
ordering by date as returned by PubMed. The PubMed IDs (PMIDs) are sorted in
descending chronological order with the last indexed abstract at the top of the result
set. PMIDs are consistent with Entrez Dates (EDAT) but not with Publication Dates
(PDAT). That is, they are indexed by the date the citation was added to MEDLINE®,
which does not have to be the date the article was published. However, this approach
is consistent with the default order displayed in PubMed and is the order encountered
by clinicians performing a MEDLINE® search. Therefore it was chosen as a baseline
for RetroRank.
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7.1.2 Term Frequency (“tf”)
Term count, or raw term frequency, refers to the number of times a query term occurs in
each retrieved MEDLINE® abstract. The term frequency (tft,d) of term t in document
d is defined as the number of times that t occurs in d (Manning and Schütze, 1999).
The underlying assumption is that documents with a higher percentage of query terms
are more relevant to the query than documents with a lower percentage of query terms.
This has also been found during a manual analysis of the “gold standard” abstracts
in Corpus 2. However, it is hard to determine how much more relevant a document
is when the percentage of query terms goes up because there is no linear relationship
between the number of query terms and relevancy. To overcome this problem log-
weighted term frequency is used instead of raw term frequency. The log frequency
weighting of term t is:
wt,d = 1+ log10 tft,d
The score for a document-query pair equals the sum over all terms t in both the




If none of the query terms is present in the document the score is 0.
Term frequency only considers how frequent query terms are in a document but
not how frequent they are over the whole corpus. To capture this information the next
strategy is needed.
7.1.3 Term Frequency/Inverse Document Frequency (“tf/idf”)
Rare terms contain more salient information than frequent terms, which is why it is
important to remove words from the corpus that are frequent but low in information
content such as stop words (Appendix C). A document containing rare terms such as
the query terms is likely to be relevant to the query and rare terms should therefore
receive a higher weight. To statistically determine the importance of a word to a docu-
ment in a corpus the tf/idf (term frequency/inverse document frequency) is used. tf/idf
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offsets the frequency of a word in a document by the frequency of the word in the
corpus.
As mentioned above, term frequency simply refers to the number of times a term
appears in a document, which is usually normalized to prevent a bias towards longer
documents. The inverse document frequency (idf) is a measure of the general im-
portance of the term (obtained by dividing the total number of documents (N) by the
number of documents containing the term (dft), and then taking the logarithm of that
quotient). Idf for a term t is defined in the following equation (Manning and Schütze,
1999)
idft = log10 N/dft
The tf-idf weight of a term is the product of its term frequency (tf) weight and its
inverse document frequency (idf) weight (Manning and Schütze, 1999).
wt,d = (1+ log10 tft,d) x log10 N/dft
The tf-idf weight increases with the number of occurrences of a term within a
document and with the rarity of the term in the collection. This means that during
post-retrieval ranking documents with a high number of occurences of query terms are
ranked higher than documents with a low number of occurences of query terms. While
this seems reasonable, it will need to be determined in Chapter 8 how well the strategy
performs in terms of ranking the relevant documents higher in the result set.
7.1.4 PercentLast (“Last20%”)
A manual analysis of the “gold standard” abstracts from Corpus 2 introduced in Sec-
tion 4.2 has shown that the last section of the abstract often contains the most relevant
information in form of outcome statements for answering drug comparison questions.
The last section is called “Conclusion(s)” in structured abstracts but also often exists in
the final four or five sentences in unstructured abstracts despite not being officially des-
ignated. This finding is consistent with the finding in Demner-Fushman and Lin (2007)
that “outcome statements are typically found in the conclusion of a structured abstract
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(or near the end of the abstract in the case of unstructured abstracts)”. The evaluation
in Chapter 8 shows how well the strategy performs on the test and development data
and in comparison to the results of Demner-Fushman and Lin (2007).
7.1.5 Citation Indices
The following two strategies re-rank abstracts based on an external, human-evaluated
source namely citation indices. They set out to prove the assumption that articles that
have been frequently cited provide better quality and therefore more relevant clinical
evidence. According to Bernstam et al. (2006), citation-based algorithms can iden-
tify important articles more effectively than vector-based algorithms such as tf/idf or
Boolean queries. This will be shown in the evaluation in Chapter 8.
7.1.5.1 Google Scholar Citation Index (“google”)
The first source for citation count information is Google Scholar1. Google Scholar
is freely available without a subscription and provides a fast and easy-to-use entry
point. It covers a wide range of sources including articles, theses, books, and abstracts.
Google Scholar ranks documents by weighing the full text of each document, where
it was published, who it was written by, as well as how often and how recently it has
been cited in other scholarly literature. It automatically extracts citation information
from reference lists of scientific documents. The automated approach causes a number
of problems ranging from problems with typographical errors in the source documents
to parsing errors of the reference due to non-standard formats (Harzing and van der
Wal, 2008). It also includes grouping errors for identical citations, which result in
duplicates, inflated citation counts and problems with correctly identifying authors
(Jasco, 2006, 2008).
To obtain the Google Scholar citation count, RetroRank passes the abstract title
and author names to Google Scholar and screenscrapes the citation count. The full im-
plementation is described in Section 8.1.1. Google Scholar does not support searching
by PMID, which would have been a more reliable way of identifying the right article
and related citation count, because searching for the title and author names sometimes
leads to more than one result if an article has been published in different languages
or is a reprint for example. RetroRank choses the first result, but it is possible that
another result could be the right one. This problem was addressed by using the ISI ci-
1http://scholar.google.co.uk/
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tation count described in Section 7.1.5.2, which allows searching for articles by PMID
and thereby removes any possible ambiguities that arise from searching by title and
authors only.
7.1.5.2 ISI citation index (“isi”)
The second source for citation count information is the Thomson Reuters ISI Web of
Science (WoS)2, which is the most recognized and trusted database for peer-reviewed
journal content. It can only be accessed with a paid license available through an institu-
tional subscription for example. The journal selection process is based on publication
standards, quality of the citation data and expert judgements (Garfield, 1990). It only
contains citations to articles published in ISI-indexed journals (Roediger, 2006). Un-
like Google Scholar it does not include citations to books, book chapters, theses, con-
ference papers or papers in non-ISI journals (Harzing and van der Wal, 2008). While
Google Scholar often has better citation coverage than ISI in disciplines like social
sciences or humanities, its coverage in the natural and health sciences is less compre-
hensive and ISI often provides higher citations counts for these disciplines (Harzing
and van der Wal, 2008). This becomes evident in the evaluation of the two citation
count strategies in the system evaluation in Chapter 8.
The ISI WoS was queried using an OpenURL query searching for each article’s
PMID as part of Thomson Reuters Links Article Match Retrieval Service3. If a match
is found, the citation count is returned as well as a link to the full record. The imple-
mentation of the query process is described in greater detail in Section 8.1.1.
7.1.6 Cosine Minimum Span Weighting (“msw”)
One retrieval method that is widely used in question answering systems is passage-
based retrieval, because experience has shown that most questions can be answered
with short text segments that span only a sentence or two. This method takes the prox-
imity between query terms into account to rank documents higher where the terms are
closer together and lower where the terms are further apart. However, passage-based
retrieval has been shown to have poorer performance compared to full-text retrieval
in most cases, most likely because a range of parameters, such as passage size or the
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To make use of the intuition that term proximity is a useful indicator for relevance
which dates back to the work of Luhn (1958), while remedying the problems asso-
ciated with passage-based retrieval, Monz (2004) developed a new proximity-based
approach to document retrieval that combined full-document retrieval with proximity
information. This approach performed significantly better than full-document retrieval
alone. A proximity-based approach does not need to take the parameters regarding
passage length into account because it does not check whether terms occur in the same
passage but rather looks at the distance between terms regardless of the position in the
document.
In this research a new strategy of proximity-based ranking was developed which
consists of minimum span weighting (MSW) in combination with cosine document
normalization stemming from the original approach by Monz (2004). His approach
is based on “the minimal size of a text excerpt that covers all terms that are common
between the document and the query, the number of common terms vs. the number of
query terms, and the global similarity between the document and the query” (Monz,
2004). All of these components are parametrized to produce a final similarity score.
A minimal matching span is the smallest section of a document that contains all the
query terms. The minimal span is used to calculate the similarity between the query
terms and a MEDLINE® abstract.
MSW has three determining factors:
1. Document similarity: Document similarity is computed using cosine similarity.
similarity = cosθ =
A ·B
||A||||B||
Cosine similarity emphasises the relationship between a query and a document
and uses negative and positive information about how related a document is to
a query in equal measures. The closer two documents are related to each other
the smaller the angle between the vectors. Completely unrelated documents are
orthogonal to each other.
The approach in this research using the cosine similarity differs from that in
Monz (2004), who uses Lnu weighting introduced in Buckley et al. (1995),
which is more optimal for full text documents with subtopics. Buckley et al.
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(1995) showed that cosine similarity would penalise full text documents con-
taining multiple subtopics of which only some could be relevant to the query.
The irrelevant subtopics might dominate using the cosine weighting reducing
the overall ranking of the document. As MEDLINE® abstracts are short and
about a single topic, cosine similarity is a more optimal approach than Lnu.
2. Span size ratio: The number of unique matching query terms in a span of text
over the total number of tokens in that text span.
3. Matching term ratio: The number of unique matching terms over the number of
unique terms in the query after the removal of stop words.
The MSW score is the sum of the normalized original retrieval status value (RSV)
measuring global similarity and the spanning factor which measures local similarity.
For a query q, RSV is normalized with respect to the highest retrieval status value for




The spanning factor is determined by the span size ratio weighted by α, the match-
ing term ration weighted by β and overall similarity weighted by λ. Monz (2004)
determined the values of the three variables empirically using the TREC-9 data collec-
tion4. The values were set at α = 1/8, β = 1 and λ = 0.4 (Monz, 2004).











If |q∩d|= 1 then RSV (q,d) = RSV n(q,d).
Example (7.1) illustrates the MSW algorithm described above on two query terms
for a drug comparison question.
4http://trec.nist.gov/data/t9_filtering.html
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(7.1) Is Ibuprofen better than aspirin?
The query q is {ibupro f en,aspirin}. Assume there is a MEDLINE® abstract d which
matches the query terms at the following positions: posd(ibuprofen)={20,31,70} and
posd(aspirin)={34,80}. Then the minimal matching span (mms) = {31,34}, the span
size ratio is 2/(1+ 34− 31) = 0.5 and the matching term ratio is 2/2. The spanning
factor consists of the last two values and their normalisation factors α and β and is
0.51/8 ·2/2= 0.917. If the normalized similarity between the query q and the document
d is n(0 < n ≤ 1), for example n=0.8 and λ=0.4, the final msw-score for q and d
(RSV (q,d)) is 0.4 ·0.8+0.6 ·0.611 = 0.6866.
To scale up to more than two query terms, i.e. {ibupro f en,aspirin,headache}, it
is required to find the minimum distance between each term pair ({A,B} {A,C} and
{B,C}) and select the term position in each pair that is closest as shown in Example





Closest term position for all pairs: {31,34,40}→ {31,40}→ {40−31}= 9
Monz (2004)’s MSW approach results in identifying minimal spans containing a
correct answer in 64.1% to 71.8% of the cases where the document is known to contain
a correct answer. The evaluation in this thesis can only determine if a “gold standard”
was retrieved and at which position it is ranked in the set of MEDLINE® abstracts.
The cosine MSW strategy implemented in RetroRank only considers the proximity
of terms in the final 20% of each abstract because it has been empirically shown that
this approach yields the best results on the corpus. The approach was also restricted in
the sense of requiring all query terms to occur in a document rather than allowing for
a partial match similar to the approach of (Kwok et al., 2000). The results are shown
in Chapter 8.
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7.1.7 Backing Off (“tf/idf - isi back off”)
The seventh re-ranking strategy is tf/idf - isi backing off. If a “gold standard” abstract
does not have an ISI citation count and its rank therefore cannot be determinded, the
tf/idf - isi strategy backs off to the rank given by the term frequency/inverse document
frequency (tf/idf) strategy which was empirically proven to provide the second best
overall ranking strategy as far as individual strategies are concerned. Table 7.1 illus-
trates the substitution of “n/a” produced by the lack of an ISI citation with rank “3”
produced by the tf strategy.
“isi” rank “tf/idf - isi” rank
n/a 3
Table 7.1: tf/idf - isi back-off.
This strategy maximises the potential of using the best available individual strategy
by defaulting back to the second best strategy if the best strategy is not available.
7.1.8 Expert Voting (“voting”)
The last strategy, expert voting, serves as an expert system looking at each of the
following six ranking strategies to find the optimal ranking of the “gold standard”




4. Google citation count
5. ISI citation count
6. Cosine Minimum Span Weighting
The voting algorithm looks at each strategy in turn and adds the position assigned
to each document by each strategy to a list. The ISI citation count, which has proven to
be the best individual strategy from the evaluation of the development set, is weighted
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at λ = 3. λ was determined empirically. Each number is zero padded to be in the range
between [0, 10,000].
The individual metric rankings for each document are reordered in ascending order
as shown in Example (7.3)
(7.3) [3,10,50,1,2,1]−> [1,1,2,3,10,50]
The rank positions are padded out to biggest number to the 10n, in this case 10,000 be-
cause the maximum number of retrieved abstracts per document is 5,000. The padding
is important because otherwise a combination with lower rank positions would be




If the numbers are padded out, the lower ranking is reflected in a higher number as
shown in Example (7.5).
(7.5) [1,1,50,1]−> [1|00001|00001|00050]
[8,8,8,4]−> [4|00008|00008|00008]
The first number which reflects the better ranking is now smaller than the second num-
ber and gets precedence.
Example (7.6) illustrates how the documents are reranked with the voting algo-
rithm. For clarity, no padding is used in the example because the numbers are > 10.
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The new document ranking is determined by the ascending order of the new com-




Document number 2 is now first, followed by document 1, 4, 3 and 5.
One of the advantages of using the expert voting algorithm is that it is less sensitive
to outliers such as shown in Example (7.4), where the fourth strategy ranked the “gold
standard” 50th, whereas the other strategies ranked it 1st. Because of the reordering,
the strategies that produce lower ranks will get a lower weight and thereby lower pri-
ority since they will be given a less significant position in the final document reranking
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number.
7.2 Summary
This chapter described different post retrieval ranking strategies that will be tested and
evaluated in Chapter 8. The baseline strategy, “recency”, was introduced, followed by
the term frequency strategies “tf”, “tf/idf” and “Last20%”. Then the two strategies
using different citation indices, “google” and “isi”, were described before introducing
the vector-based minimum span approach “msw”. Lastly, two strategies that combine
other strategies were described. These are “tf/idf - isi voting” and “voting”. The next
chapter shows an evaluation of those strategies and illustrates their strength and weak-
nesses.
Chapter 8
Post-Retrieval Ranking with RetroRank
In this chapter the implementation and evaluation of the post-retrieval ranking mod-
ule of RetroRank is described. The post-retrieval ranking component was developed
on Corpus 2 (Section 4.2), which was used in Chapter 6 to assess the retrieval ac-
curacy of RetroRank and to compare the retrieval component’s performance to the
results achieved by askMedline and Entrez PubMed. While Corpus 2 was a valuable
resource for the initial system comparison, it has the limitation of only providing one
“gold standard” reference per question. Therefore, Corpus 3, which provides multiple
“gold standard” references per question was used for the full evaluation of RetroRank’s
post-retrieval ranking module. Having multiple “gold standards” available allows an
evaluation with standard IR metrics and a comparison with the post-retrieval ranking
system developed in Demner-Fushman and Lin (2007). It is shown that the automatic
ISI-citation count based strategies and the Expert Voting strategy are a significant im-
provement over the PubMed recency baseline and are a strong contender to the strate-
gies based on query frames and annotated data developed by Demner-Fushman and
Lin (2007).
8.1 Post-retrieval Ranking on Corpus 2
8.1.1 System Implementation
To evaluate the post-retrieval ranking strategies introduced in Chapter 7, the retrieval
component of RetroRank was augmented with a Python post-retrieval ranking module.
In the augmented version of RetroRank, the retrieval module was extended to store the
85
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MeSH terms in addition to the text and title of the abstracts. The post-retrieval ranking
module reranks the MEDLINE® abstracts retrieved for each question in Corpus 2 (c.f.











Create Gold Standard from PubMed IDs 
of POEM reference article.
[Gold Standard]
Retrieve PubMed IDs for all questions.
[PubMed ID | Question ID]
Retrieve abstracts.
[Abstracts | PubMed ID | Question ID]
Parse abstracts to build a database table.
[Question ID | Recency | TermCount | TermFrequency | PercentLast |Google| ISI 
| MSW | GoldStandard]
Calcuate "Backing Off" and "Expert Voting" and reorder table by ranking criteria.
Calculate "gold standard" position.
Get CitationCount from Google Scholar 
and ISI .
[Pubmed ID | Google | ISI]
5
Figure 8.1: System diagram of the RetroRank system.
In the first step, the post-retrieval ranking module parses a .csv file consisting of
the questions in Corpus 2 marked-up by LT-TTT2 (c.f. Section 6.1) and their question
IDs to create two maps. Maps are lists of key - value pairs. Table 8.1 shows Question
1 from Corpus 2. The rest of the questions can be found in Appendix D.
ID Question
1 How safe and effective are aspirin and warfarin therapy in the prevention of
stroke in patients with atrial fibrillation?
Table 8.1: Extract from the input file for the RetroRank post-retrieval module.
The first map consists of the question ID and the list of query terms (drugs and
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diseases). The map will be used for calculating the post-retrieval ranking strategies
in a later step. The second map consists of the question ID and the E-Utilities query
for the questions, which will be used for retrieving MEDLINE® abstracts and their
associated MeSH terms for each question.
The second step is to create a map with the PubMed IDs (PMIDs) of the “gold stan-
dard” articles by parsing a .csv file that contains the question ID and a “gold standard”
PubMed ID for each question. The “gold standard” articles in Corpus 2 are the articles
cited as the reference for each POEM. The references are a good “gold standard” be-
cause they have been carefully chosen by experts as the articles which best answer the
question.
The third step is to use the map of E-Utilities queries created in the first step to
retrieve all PubMed abstracts for the query terms in each question and to create a map
of the question IDs and the PMIDs retrieved per question. In the fourth step a map
consisting of the PMIDs and their associated abstracts is created.
The fifth step involves downloading the citation information for each abstract from
Google Scholar and the ISI Web of Knowledge and storing it in a map containing the
PMID and the citation count.
The six step involves parsing the abstracts. During this stage the following pro-
cesses take place:
• Stop words are removed using the PubMed stop word list (see Appendix C).
• The number of words and keywords is counted.
• The term frequency of the query terms is determined.
• The number of query terms in the last 20% of the abstracts is calculated.
• Cosine Minimum Span Weighting (“msw”) is calculated.
• The position of the abstracts ordered by recency as retrieved by PubMed is
recorded as a baseline.
• It is checked whether an abstract is a “gold standard”.
In addition a database table is created that contains the fields shown in Table 8.2.
There are as many rows for each question as there are PubMed abstracts and the ab-
stracts are ordered by recency.
The fields contain the following information:
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Question ID Recency tf tf/idf PercentLast Google CitationCount ISI Citation Count MSW GoldStandard
Table 8.2: Database table generated by parsing the abstracts in Corpus 2 and calculat-
ing the ranking strategies.
• “Question ID”: The question ID for each question.
• “Recency”: Contains a PubMed ID
• “tf” : Contains the absolute number of query terms per abstract.
• “tf/idf”: Contains the number of query terms divided by the number of words in
the abstracts over all words in the corpus.
• “PercentLast”: Contains the number of query terms in the last 20% of the ab-
stract.
• “Google CitationCount”: Contains the number of citations for each abstract as
given by Google Scholar.
• “ISI Citation Count”: Contains the number of citations for each abstract as given
by ISI.
• “MSW”: Contains the cosine adjusted minimal span weighting information.
• “GoldStandard”: Contains a “0” or “1”, where a “0” indicates the abstract is no
“gold standard” article for the question, and a “1” indicates that the abstract is on
the list of “gold standard” articles. The position of the “gold standard” articles is
recorded for the recency baseline. This is required to evaluate the post-retrieval
ranking strategies.
During the last step the “tf/idf - isi voting” and “voting” strategies are calculated
based on the results from step six and the table containing the abstract IDs is reordered
applying each of the different strategies. The position of the “gold standard” articles
after reranking is recorded to determine where the “gold standard” reference is after
ranking in comparison to its rank position in the baseline.
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8.1.2 Rank-ordered List of MEDLINE® Abstracts for Corpus 2
This section shows an example of the rank-ordered database tables of MEDLINE®
abstract PMIDs, which determine the order in which the abstracts would be displayed
to a clinician to serve as answer candidates for a clinical comparison question. The
abstracts for each PMID are saved in the database.
Table 8.3 shows the database table for the first ten PMIDs for the individual rank-
ing strategies1 for Question 26 from Corpus 2. The results are ordered by goldstan-
dard=“1”, meaning the “gold standard” PMID is displayed in the first result row. The
number in the recency column refers to a PMID’s original ranking position in the
PubMed recency baseline.
Question PMID goldstandard recency tf tf/idf Last20% google isi msw
s26 9691103 1 45 2.946 0.167 0 0 166 0
s26 19827443 0 2 0.000 0.000 0 0 0 0
s26 19821389 0 3 0.000 0.000 0 0 0 0
s26 19160212 0 4 2.099 0.071 1 0 0 0
s26 18646064 0 5 1.693 0.071 0 0 0 0
s26 18402168 0 6 1.000 0.004 0 4 0 0
s26 18271184 0 7 0.000 0.000 0 0 0 0
s26 18239407 0 8 1.000 0.010 1 0 12 0
Table 8.3: Database table for the first 10 PMIDs for Question 26 ordered by goldstan-
dard=“1”.
Before reordering the table by the different post-retrieval strategies, the “gold stan-
dard” (Position 45 in the PubMed baseline) would not be displayed to the clinician at
the top of the result set and she would need to look through a large number of possibly
irrelevant abstracts until she would get to the “gold standard” reference. Using the
post-retrieval strategies developed in this thesis, a new rank-ordered table is created
that reorders the retrieved abstracts to display the “gold standard” abstract as high in
the result set as possible. Table 8.42 shows the database table for the first ten PMIDs
after the table was reordered using the citation count information from the best indi-
vidual post-retrieval ranking “isi”. This step brings the “gold standard” reference to
the first position because it has the highest ISI citation count.
1“tf/idf - isi voting” and “voting” are calculated based on the results of the initial database table
shown in the example.
2The column headings for “recency” and “isi” have been changed to “Baseline Rank” and “ISI
citation count” respectively for clarity.
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Question PMID goldstandard Baseline Rank ISI citation count
s26 9691103 1 45 166
s26 8586030 0 51 66
s26 12182751 0 29 60
s26 12895211 0 22 40
s26 12381231 0 28 21
s26 11815767 0 34 18
s26 17877506 0 11 16
s26 9691110 0 44 14
s26 12786611 0 23 13
s26 11922560 0 33 13
Table 8.4: Database table for the top 10 PMIDs for Question 26 after applying the “isi”
post-retrieval ranking strategy.
Because only one “gold standard” is known for each question in Corpus 2, it can-
not be determined for certain without expert judges how relevant the abstracts in the
following positions are, but it can be assumed that a high citation count correlates with
high quality research and abstracts that are potentially relevant. The assumption that
more than one relevant abstract is displayed high in the result set by applying the post-
retrieval ranking strategies can be empirically proven on Corpus 3, which has multiple
“gold standard” references per question.
8.1.3 Results & Evaluation
The system retrieved a total of 3,425 MEDLINE® for the 30 questions in Corpus 2.
The “gold standard” reference was retrieved for 21 out of the 30 questions, which
results in a retrieval accuracy of 70% as shown in the previous analysis in Section 6.3.
Table 8.5 shows the ranking of the “gold standard” abstract for each ranking strategy.
The first column shows the question ID, the second column the number of abstracts
retrieved per question, the third column shows the “recency” baseline followed by the
columns for “tf”, “tf/idf”, “Last 20%”, “google”, “isi”, “msw”, “tf/idf - isi voting’
and “voting”. Results are shown both in terms of absolute improvement in rank over
the rank of “gold standard” in the baseline and in percentage of improvement over the
baseline. In the case of “n/a” none of the retrieved abstracts were the “gold standard”
reference.
The average rank of the “gold standard” abstract in the baseline is rank 95. The
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Question # of Abstracts recency tf tf/idf Last 20% google isi msw tf-isi voting voting
s1 524 344 345 74 97 404 2 48 2 8
s5 59 45 10 3 11 14 11 7 11 8
s6 79 77 62 55 59 1 1 41 1 1
s7 61 54 36 4 24 n/a 4 22 4 10
s9 34 29 4 8 4 2 2 3 2 2
s10 321 161 117 59 259 51 6 212 6 26
s11 452 109 36 33 8 60 49 13 49 33
s12 150 73 68 15 69 1 1 56 1 0
s13 3 1 2 1 2 n/a 1 1 1 0
s14 153 136 57 17 39 9 6 25 6 21
s16 41 30 4 19 4 22 11 1 11 3
s17 213 183 34 20 72 25 11 31 11 44
s18 48 16 13 5 40 2 3 36 3 7
s19 79 77 62 55 59 1 1 41 1 1
s20 60 55 29 6 15 4 1 5 1 3
s23 10 3 1 1 3 4 3 9 3 1
s24 286 222 140 20 188 79 68 90 68 66
s25 52 41 4 2 19 n/a 1 9 1 1
s27 153 121 87 19 63 27 9 78 9 35
s29 125 48 31 1 60 5 2 87 2 1
s30 163 163 93 2 122 1 1 66 1 0
Average Rank 94.667 58.810 19.952 57.952 39.556 9.238 41.952 9.238 12.905
Improvement
# of ranks 35.857 74.714 36.714 55.111 85.429 52.714 85.429 81.762
Improvement (%) 0.379 0.789 0.388 0.582 0.902 0.557 0.902 0.864
Table 8.5: Rank of 1st relevant abstract for each strategy for Corpus 2.
best individual ranking strategy, “isi”3, ranks the “gold standard” on rank 9 on average,
which is a 90.2% improvement over the baseline. Google Scholar’s citation count
information is far less helpful than ISI’s as is evident by the inferior performance of
the “google” strategy compared to “isi”. “google” ranks the “gold standard” reference
30 positions below “isi” on average and provides only a 58.2% improvement over the
baseline. While Google Scholar performs well in fields such as humanities or social
sciences, its coverage in the natural and health sciences is less comprehensive than that
of the ISI Web of Science (Harzing and van der Wal, 2008), and there is a big gap in
performance between the two strategies. This trend can also be observed on Corpus 3
(c.f. Section 8.2.3).
The second best strategy “voting”, which is based on a weighted combination of all
the individual ranking strategies, ranks the “gold standard” on position 13 on average,
which is a 86.4% improvement over the baseline.
3Because there is only one “gold standard” per question and the “gold standard” always received an
ISI citation count, “isi” and “tf-isi voting” are identical since it was not necessary to back off to “tf/idf”
to make up for a lack of citation count information.
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For Corpus 2, “tf/idf”, which favours abstracts with a high amount of rare terms
in regards to the whole corpus, performs better than “tf” or “Last20%” providing a
78.9% improvement over the baseline. “tf” and “Last20%”, which are strategies that
only consider how frequent query terms are in a document but not how frequent they
are over the whole corpus, only provide a 38% improvement over the baseline. “msw”,
which uses a vector-based approach using term proximity yields a 55.7% improvement
over the recency baseline and performs better than the pure term frequency based ap-
proaches “tf” and “Last20%”, but not as well as the term frequency/inverse document
frequency approach “tf/idf”.
Table 8.6 shows the Mean Reciprocal Rank (MRR) for each question which mea-
sures how far down on a list the first relevant abstract is. The higher the MRR, the
better the ranking strategy. The MRR for the baseline is very low at 7.9%, the MRR
for the most successful strategy “isi” is 48.4%. It can be seen that “google” performs
19.6% worse at 28.8% than the other citation-based strategy “isi”, which is consistent
with the results discussed at the beginning of this section and also holds true for Corpus
3 as will be shown in Section 8.2.
The MRR for the post-retrieval strategies based on term frequency is significantly
lower than the MRR for the strategies using citation count information. The results
vary between 8.9% for the worst strategy “Last 20%” and 26.2% for the best term
frequency based strategy “tf/idf”. Because all MEDLINE® abstracts retrieved for a
query are short texts, which contain all the query terms and share the same general
topic, it is harder to discriminate between abstracts using strategies that only rely on
the abstract content rather than strategies using external information like the citation
count. This is evident in the difference in the performance of the strategies relying on









tf/idf - isi voting 0.484
voting 0.330
Table 8.6: Mean Reciprocal Rank per ranking strategy for Corpus 2
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Because each question in Corpus 2 only has one “gold standard” reference, it is
not possible to evaluate the results for Corpus 2 according to other standard IR metrics
such as Average Precision (AP), Mean Average Precision (MAP) or Mean Rank Posi-
tion (MRP). A full evaluation of the post-retrieval ranking strategies will be given for
Corpus 3 in Section 8.2.
8.1.4 System Comparison
Table 8.7 compares the best retrieval strategy of RetroRank to the ranking of the “gold
standard” article achieved by askMedline and Entrez PubMed.
Question RetroRank Best Strategy “isi” askMedline Entrez
s1 2 n/a n/a
s5 11 2 6
s6 1 n/a n/a
s7 4 71 n/a
s9 2 7 n/a
s10 6 23 11
s11 49 1 1
s12 1 60 n/a
s13 1 1 n/a
s14 6 35 43
s16 11 6 n/a
s17 11 n/a 610
s18 3 10 1288
s19 1 n/a n/a
s20 1 n/a n/a
s23 3 1 n/a
s24 68 n/a 1194
s25 1 41 n/a
s27 9 n/a n/a
s29 2 n/a 1314
s30 1 139 n/a
Average Rank 9.238 30.538 558.375
Table 8.7: System comparison for the best ranking strategy “isi”.
askMedline and Entrez PubMed do not perform post-retrieval ranking but use dif-
ferent retrieval strategies which affect the ranking position of the “gold standard”.
askMedline (c.f. Section 2.5.4) uses a more restricted retrieval than RetroRank and
generally retrieves less articles, which means the “gold standard” automatically ap-
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pears in a higher position than in the baseline for RetroRank. EntrezPubMed (c.f.
Section 2.3.3) on the other hand uses a very unrestricted retrieval approach and re-
trieves a very large set of articles, which means the “gold standard” can appear in a
very low ranking position. Table 8.8 shows the number of abstracts retrieved for each
of the three compared systems.




Table 8.8: Number of retrieved abstracts per system for Corpus 2.
Table 8.7 shows that the average ranking position of the “gold standard” reference
is rank 9 in RetroRank, rank 31 in askMedline and rank 558 in Entrez PubMed4. It can
be seen that the best post-retrieval ranking strategy, “isi”, in RetroRank outperforms
both systems in displaying the “gold standard” in at the top of the result set in addition
to achieving a better retrieval accuracy than the other two systems (RetroRank 70%
accuracy, askMedline 53.3% accuracy and Entrez PubMed 30% accuracy (c.f. Chapter
6).
8.1.5 Error Analysis for Corpus 2
The following section shows an analysis of the questions on which RetroRank per-
formed worse than average or worse than askMedline or Entrez PubMed as far as the
ranking position of the “gold standard” reference is concerned (see Table 8.7). There
are two components that determine the performance of RetroRank. The first compo-
nent is the retrieval module, which deliberately employs a far less restrictive retrieval
strategy than the retrieval strategy used in askMedline or Entrez PubMed (c.f. Sec-
tion 2.5.4 and Section 2.3.3) to maximise retrieval accuracy and recall. The second
component is the post-retrieval module. The post-retrieval ranking strategies used in
RetroRank are very successful but still do not produce the best result for all questions.
The error analysis for Corpus 2 has the limitation that only one “gold standard”
reference is know for each question from the Essential Evidence Plus POEM archive
and no human evaluation by clinicians of the relevance of the retrieved abstracts is
4In the case of “n/a” none of the retrieved abstracts were the “gold standard” reference.
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available. Under real circumstances usually more than one MEDLINE® abstract pro-
vides a relevant answer to a drug comparison question and the abstracts ranked higher
than the “gold standard” may well provide relevant answers despite not being selected
as the “gold standard” abstract.
The three cases in which RetroRank fails to perform as well as askMedline regard-
ing the ranking position of the “gold standard” abstract are Question 5, Question 11
and Question 16 (c.f. Table 8.7). Question 11 is also noteworthy because it shows the
second worst performance for the best overall post-retrieval ranking strategy “isi”, the
worst being its performance on Question 24 (c.f. Table 8.5). In the examples the drugs
and diseases are highlighted in bold and additional vital information is highlighted in
italics for easier readability.
Example (8.1) shows Question 5 in which the intranasal corticosteroids budes-
onide and fluticasone propionate are compared to determine which has a higher effi-
cacy for treating allergic rhinitis.
(8.1) “Which nasal spray, budesonide (Rhinocort) or fluticasone propionate
(Flonase), is superior for once daily treatment of allergic rhinitis?” (Ques-
tion 5 in Corpus 2)
The “gold standard” abstract is shown in Example (8.2). It is an abstract of a random-
ized controlled trial published in the Journal of Allergy and Clinical Immunology in
1998 and has an ISI citation count of 32. It contains an explicit comparison between the
two drugs and provides a good and concise answer to the question. RetroRank ranks




Title: Comparison of the efficacy of budesonide and fluticasone propionate
aqueous nasal spray for once daily treatment of perennial allergic rhinitis.
Abstract:
BACKGROUND: Intranasal corticosteroids, such as budesonide and flutica-
sone propionate, are widely prescribed in the treatment of perennial allergic
rhinitis. Once daily budesonide dry powder and fluticasone propionate aque-
ous suspension have been found to provide similar efficacy in controlling symp-
toms of perennial allergic rhinitis.
OBJECTIVE: The purpose of this study was to assess the efficacy and safety of
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treatment with once daily budesonide aqueous nasal spray.
METHODS: This study involved a multicenter, blinded, randomized, parallel-
group, placebo-controlled trial of adults with perrenial allergic rhinitis. Patients
(n = 273) recorded daily nasal symptoms for 8 to 14 days (baseline) and 6 weeks
(treatment).
RESULTS: Budesonide decreased combined symptoms to a significantly greater
extent than did fluticasone (P =.03); both treatments significantly decreased mean
combined nasal symptoms scores compared with placebo. Of the 3 nasal symp-
toms assessed (ie, nasal blockage, runny nose, and sneezing), nasal blockage was
significantly (P =. 009) more decreased with budesonide compared with fluti-
casone. Both treatments also significantly improved runny nose and sneezing
compared with placebo. Improvement in combined nasal symptom scores of the
budesonide-treated group reached statistical significance within 36 hours com-
pared with placebo (P =.01); in those patients treated with fluticasone, significant
improvement compared with placebo was first observed within 60 hours. Adverse
events were mild and transient.
CONCLUSIONS: Once daily budesonide aqueous nasal spray, 256 microgram,
was significantly better in controlling the symptoms of perrenial allergic rhinitis
than once daily fluticasone propionate, 200 microgram, especially nasal block-
age. Both treatments were superior to placebo. Budesonide may have a faster
onset of action than fluticasone.
RetroRank’s best strategy “isi” ranks the abstract in Example (8.3) first, which is
the abstract for a review of inhaled and intranasal corticosteroids like the two drugs
in the question published in Drug Safety in 2000. The drugs are explicitly mentioned
but not directly compared to each other which makes the abstract less relevant than
the “gold standard” abstract which contains a direct comparison of budesonide and
fluticasone. While it presents a good overview of corticosteroids, it fails to address the
question in a concise manner.
(8.3)
PMID: 10915030
Title: Safety of inhaled and intranasal corticosteroids: lessons for the new mil-
lennium.
Abstract
Although inhaled and intranasal corticosteroids are first-line therapy for asthma
and allergic rhinitis, there has recently been an increasing awareness of their
propensity to produce systemic adverse effects. The availability of more potent
and lipophilic corticosteroids and new chlorofluorocarbon (CFC)-free formula-
tions has focused attention on these safety issues. The main determinant of sys-
temic bioavailability of these drugs is direct absorption from the lung or nose,
where there is no first-pass inactivation. Consequently, the systemic bioavailabil-
ity of inhaled corticosteroids is greatly influenced by the efficiency of the inhaler
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device. Thus, when comparing different inhaled corticosteroids it is imperative to
consider the unique drug/device interaction. The pharmacokinetic profile is im-
portant in determining the systemic bioactivity of inhaled and intranasal corticos-
teroids. For highly lipophilic drugs, such as fluticasone propionate or mometa-
sone furoate, there is preferential partitioning into the systemic tissue compart-
ment, and consequently a large volume of distribution at steady state. In contrast,
drugs with lower lipophilicity, such as triamcinolone acetonide or budesonide,
have a smaller volume of distribution. The systemic tissue compartment may
act as a slow release reservoir, resulting in a long elimination half-life for the
lipophilic drugs. For intranasal corticosteroids, a high degree of lipophilicity di-
minishes water solubility in mucosa and therefore increases the amount of drug
swept away by mucociliary clearance before it can gain access to tissue receptor
sites. This may reduce the anti-inflammatory efficacy in the nose, but might also
reduce the propensity for direct systemic absorption from the nasal cavity. The
hydrofluoroalkane (HFA) formulations of beclomethasone dipropionate are solu-
tions and exhibit a much higher respirable fine particle dose than do the CFC for-
mulations. Dose-response studies with one of the HFA formulations have shown
therapeutic equivalence at half the dosage, with little evidence of adrenal sup-
pression at dosages up to 800 microg/day. A lack of similar studies for another of
the available HFA formulations has led to a discrepancy in the recommendations
for equivalence. Although in vitro studies have pointed to a similar fine particle
distribution for the HFA and CFC formulations of fluticasone propionate, this
is not supported by in vivo data for lung bioavailability, suggesting that care will
be required when switching these formulations. Prescribers of inhaled and in-
tranasal corticosteroids should be aware of the potential for long term systemic
effects. The safest way to use these drugs is to ’step-down’ to achieve the lowest
possible effective maintenance dosage.
The abstract ranked second has 69 ISI citations and is for a randomized controlled
trial comparing intranasal corticosteroids to topical antihistamines in the treatment of
allergic rhinitis. The drugs from the question appear in the MeSH terms as intranasal
corticosteroids, however, like the first abstract, this abstract fails to supply a direct
comparison between the two drugs.
The abstract ranked third (Example (8.4)) is for a review published in Respiratory
Medicine in 1995 and has 66 ISI citations, which is twice as many as the “gold stan-
dard” abstract. It does provide a direct comparison between the drugs like the “gold
standard” reference, however it discusses the clinical potency of the drugs rather than
their use as a once daily treatment.
(8.4)
PMID: 7569173
Title: Fluticasone propionate–an update on preclinical and clinical experience.
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Outcome sentence: Results show that FP [Fluticasone propionate] has at least
twice the clinical potency of beclomethasone dipropionate and budesonide. This
appears to be achieved without an accompanying increase in systemic effects,
suggesting a therapeutic index which may be higher than other currently avail-
able inhaled corticosteroids.
askMedline displays the abstract in Example (8.5) on position 1, which provides
a better answer to Question 5 than the abstract ranked 1st by RetroRank. Because
askMedline uses a more restricted retrieval algorithm that includes query terms such




Title: Comparison of once daily fluticasone propionate aqueous nasal spray with
once daily budesonide reservoir powder device in patients with perennial rhini-
tis.
In conclusion it can be stated that the ISI citation count alone fails to achieve the
desired result of displaying the “gold standard” within the Top 10 of the result set
for Example (8.1) and that the abstracts ranked on the first three positions fail to pro-
vide a good answer. While different post-retrieval ranking strategies such as “tf/idf”
achieve a result similar to askMedline by ranking the “gold standard” reference 3rd,
askMedline’s performance suggests that drug dosage information plays an important
role in a query and could be a valuable addition to RetroRank’s retrieval module.
The second question for which RetroRank performs worse than askMedline is
Question 11 shown in Example (8.6). In Question 11 enoxaparin (ENOX) is com-
pared to unfractioned heparin (UFH) for patients with myocardial infarction.
(8.6) In patients with acute ST-elevation myocardial infarction who receive fibri-
nolysis and subsequent percutaneous intervention, is enoxaparin superior to
unfractionated heparin? (Question 11 in Corpus 2).
RetroRank retrieves 452 abstracts for this question, while askMedline retrieves 25 and
Entrez PubMed only 1. RetroRank uses the least restricted retrieval query out of the
three systems, which leads to a large result set in which the best post-retrieval strategy
“isi” ranks the “‘gold standard” reference 49th, while askMedline and Entrez PubMed
Chapter 8. Post-Retrieval Ranking with RetroRank 99
display it as the 1st search result. The main cause of the poorer performance of Retro-
Rank seems to lie with the large result set retrieved by the search query which is not
specific enough to exclude results that do not match the question exactly. Therefore
only one out of the eight post-retrieval ranking strategies brings the “gold standard”
reference in the Top 10 by ranking it 8th. The overall best strategy “isi” fails to bring
a “gold standard” to the top 10, because there a large number of abstracts retrieved
that have a very high citation count, while not being a “gold standard”. Many of the
retrieved abstracts provide good clinical evidence but are not specific enough to the
exact question.
Example (8.7) shows the title of the “gold standard” reference along with its con-
clusion section containing the desired drug comparison and matches the question very
well. It is a randomized controlled trial published in the Journal of the American Col-
lege of Cardiology in 2007 and has 45 citations in the ISI Web of Science.
(8.7)
PMID: 17560287
Title: Percutaneous coronary intervention in patients receiving enoxaparin or
unfractionated heparin after fibrinolytic therapy for ST-segment elevation my-
ocardial infarction in the ExTRACT-TIMI 25 trial.
[...]
CONCLUSION:
Among patients treated with fibrinolytic therapy for STEMI who underwent sub-
sequent PCI, ENOX administration was associated with a reduced risk of death
or recurrent MI without difference in the risk of major bleeding. The strategy
of ENOX support for fibrinolytic therapy followed by PCI is superior to UFH
and provides a seamless transition from the medical management to the interven-
tional management phase of STEMI without the need for introducing a second
anticoagulant in the cardiac catheterization laboratory.
Example (8.8) shows the reference ranked 1st by RetroRank, which has 975 cita-
tions in the ISI Web of Science and is a randomized controlled trial published in the
New England Journal of Medicine in 1997.
(8.8)
PMID: 9250846
Title: A comparison of low-molecular-weight heparin with unfractionated hep-
arin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous
Enoxaparin in Non-Q-Wave Coronary Events Study Group.
Abstract
BACKGROUND:
Antithrombotic therapy with heparin plus aspirin reduces the rate of ischemic
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events in patients with unstable coronary artery disease. Low-molecular-weight
heparin has a more predictable anticoagulant effect than standard unfractionated




At 14 days the risk of death, myocardial infarction, or recurrent angina was sig-
nificantly lower in the patients assigned to enoxaparin than in those assigned to
unfractionated heparin (16.6 percent vs. 19.8 percent, P=0.019). At 30 days, the
risk of this composite end point remained significantly lower in the enoxaparin
group (19.8 percent vs. 23.3 percent, P=0.016). The need for revascularization
procedures at 30 days was also significantly less frequent in the patients assigned
to enoxaparin (27.1 percent vs. 32.2 percent, P=0.001). The 30-day incidence
of major bleeding complications was 6.5 percent in the enoxaparin group and
7.0 percent in the unfractionated-heparin group, but the incidence of bleeding
overall was significantly higher in the enoxaparin group (18.4 percent vs. 14.2
percent, P=0.001), primarily because of ecchymoses at injection sites.
CONCLUSIONS:
Antithrombotic therapy with enoxaparin plus aspirin was more effective than
unfractionated heparin plus aspirin in reducing the incidence of ischemic events
in patients with unstable angina or non-Q-wave myocardial infarction in the
early phase. This benefit of enoxaparin was achieved with an increase in minor
but not in major bleeding.
The abstract ranked first by RetroRank provides high quality clinical evidence as is
evident in the high citation count and the high impact factor of the journal the trial was
published in, but unlike the “gold standard” reference the drugs are compared to each
other in combination with aspirin. Also fibrinolytic therapy and ST-segment elevation
are not mentioned in the main text of the abstract and are only visible in the MeSH
terms. To a layman it is hard to judge the relevance of this abstract because clinical
knowledge is needed to determine the connection between ST-segment elevation my-
ocardial infarction and non-Q-wave myocardial infarction. Given the quality of the
study it might still be a useful resource for a clinician, who has the expert knowledge
to determine its suitability.
Example (8.9) shows Question 16, in which ivermectin is compared to lindane for
treating scabies to find out if invermectin is more effective.
(8.9) Is ivermectin more effective than lindane for treating scabies? (Question 16
in Corpus 2).
RetroRank’s best strategy “isi” ranks the “gold standard” reference on position 11,
while askMedline displays it as the 6th result and Entrez PubMed does not retrieve it at
all. An extract of the “gold standard” reference is shown in Example (8.10). The “gold
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Title: Oral ivermectin in scabies patients: a comparison with 1% topical lindane
lotion.
Abstract
Scabies, which constitutes a significant proportion of the outpatient attendance
in tropical dermatology clinics, has so far been treated with lindane, crotamiton,
sulphur, permethrin, etc. Ivermectin, an orally administered drug, was tried in
scabies patients and compared with 1% topical lindane lotion to evaluate its ef-
fects and toxicity profile.
[...]
Oral ivermectin is an easy drug to administer. It is given as a single oral dose,
unlike lindane, which has to be applied topically. The compliance is accordingly
increased. Moreover, ivermectin induces an early and effective improvement in
signs and symptoms. Thus, it may be a better option for scabies than the tradi-
tional topical lindane lotion.
Example (8.11) shows an extract of the top ranked abstract in RetroRank, which
has 50 citations in the ISI Web of Knowledge, whereas the “gold standard” reference
only has 18 citations. The top ranked abstract in RetroRank is a randomized controlled
trial published in the Archives of Dermatology in 1999.
(8.11)
PMID: 10376691
Title: Equivalent therapeutic efficacy and safety of ivermectin and lindane in
the treatment of human scabies.
Abstract
OBJECTIVE:
To compare the therapeutic efficacy and safety of ivermectin and lindane for the
treatment of human scabies.
[...]
INTERVENTION: Patients received either a single oral dose of ivermectin
(150-200 microg/kg of body weight) or a topical application of 1% lindane solu-
tion. Treatment was repeated after 15 days if clinical cure had not occurred. [...]
CONCLUSIONS:
Ivermectin is as effective as lindane for the treatment of scabies. Ivermectin is
simpler to use and, therefore, is a promising tool to improve compliance and to
control infestations.
As can be seen from the excerpt, the abstract ranked first by RetroRank is relevant
and provides a good and concise answer to the question consistent with the “gold
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standard” reference. While it was not chosen as the “gold standard” for Question (8.9),
its high citation count suggests it provides good quality clinical evidence and could be
a good “gold standard” candidate. Question (8.9) is an example for a question for
which the “isi” strategy ranked the “gold standard” outside of the top 10 but where it
still provided a very good abstract at the top of the result set. While “isi” performed
worse than average for this question, the “gold standard” was ranked first by the ”msw”
strategy in RetroRank.
The question with the poorest performance of “isi” in Corpus 2 regarding the rank-
ing postition of the “gold standard” is Question 24 shown in Example (8.12). Retro-
Rank does however outperform both askMedline and Entrez PubMed on this question.
askMedline did not retrieve any abstracts for the question. Entrez PubMed displayed
the “gold standard” on position 1194, while the “isi” strategy in RetroRank ranks it at
position 69.
(8.12) Which inhaled corticosteroid is most effective in the treatment of persistent
asthma: fluticasone (Flovent) or beclomethasone (Beclovent, Vanceril)?
(Question 24 in Corpus 2).
Example (8.13) shows an excerpt from the “gold standard” reference, which is a ran-
domized controlled trial published in the Journal of Allergy and Clinical Immunolgy
in 1999 and has an ISI citation count of 27. The abstract ranked first by RetroRank is
from the same year but has a much higher citation count of 409.
(8.13)
PMID: 10329812
Title: A comparison of multiple doses of fluticasone propionate and beclometha-
sone dipropionate in subjects with persistent asthma.
Abstract
BACKGROUND:
Inhaled corticosteroids are recommended for the treatment of persistent asthma.
Comparative clinical studies evaluating 2 or more doses of these agents are few.
OBJECTIVE:
We sought to compare the efficacy and safety of 2 doses of fluticasone propionate
(88 micrograms twice daily and 220 micrograms twice daily) with 2 doses of
beclomethasone dipropionate (168 micrograms twice daily and 336 micrograms
twice daily) in subjects with persistent asthma.
[...]
CONCLUSION:
Fluticasone propionate provides greater asthma control at roughly half the dose
of beclomethasone dipropionate, with a comparable adverse event profile.
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Example (8.14) shows the abstract ranked first by RetroRank.
(8.14)
PMID: 10326936




To appraise the data on systemic adverse effects of inhaled corticosteroids.
METHODS:
A computerized database search from January 1, 1966, through July 31, 1998,
using MEDLINE, EMBASE, and BIDS and using appropriate indexed terms. Re-
ports dealing with the systemic effects of inhaled corticosteroids on adrenal gland,
growth, bone, skin, and eye, and reports on pharmacology and pharmacokinetics
were reviewed where appropriate. Studies were included that contained evaluable
data on systemic effects in healthy volunteers as well as in asthmatic children and
adults. A statistical meta-analysis using regression was performed for parameters
of adrenal suppression in 27 studies.
RESULTS:
Marked adrenal suppression occurs with high doses of inhaled corticosteroid
above 1.5 mg/d (0.75 mg/d for fluticasone propionate), although there is a con-
siderable degree of interindividual susceptibility. Meta-analysis showed signif-
icantly greater potency for dose-related adrenal suppression with fluticasone
compared with beclomethasone dipropionate, budesonide, or triamcinolone ace-
tonide, whereas prednisolone and fluticasone propionate were approximately equiv-
alent on a 10:1-mg basis. Inhaled corticosteroids in doses above 1.5 mg/d (0.75
mg/d for fluticasone propionate) may be associated with a significant reduction
in bone density, although the risk for osteoporosis may be obviated by post-
menopausal estrogen replacement therapy. Although medium-term growth stud-
ies showed suppressive effects with 400-microg/d beclomethasone dipropionate,
there was no evidence to support any significant effects on final adult height.
Long-term, high-dose inhaled corticosteroid exposure increases the risk for pos-
terior subcapsular cataracts, and, to a much lesser degree, the risk for ocular hy-
pertension and glaucoma. Skin bruising is most likely to occur with high-dose
exposure, which correlates with the degree of adrenal suppression.
CONCLUSIONS:
All inhaled corticosteroids exhibit dose-related systemic adverse effects, although
these are less than with a comparable dose of oral corticosteroids. Metaanalysis
shows that fluticasone propionate exhibits greater dose-related systemic bioactiv-
ity compared with other available inhaled corticosteroids, particularly at doses
above 0.8 mg/d. The long-term systemic burden will be minimized by always
trying to achieve the lowest possible maintenance dose that is associated with
optimal asthmatic control and quality of life.
It is a systematic review published in the Archives of Internal Medicine in 1999.
Systematic reviews are recognized as authoritative, high quality clinical evidence.
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While not being the “gold standard” reference, this systematic review represents a rel-
evant and very good answer option for Question (8.12). The most relevant sentences
in Example (8.14) are highlighted in italics. Like for Question (8.9), RetroRank failed
to rank the “gold standard” reference in the top 10 but instead ranked another abstract
first, which provides an authoritative answer.
This error analysis shows that RetroRank overall provides relevant answers to clin-
ical comparison questions even though it does not always achieve the optimal result.
The overall best strategy “isi” does not always perform best for all questions. How-
ever, Question (8.9) and especially Question (8.12) illustrate examples, where “isi”
ranks relevant, good quality abstracts at the top of the result set, which could be poten-
tial “gold standard” reference candidates if a human evaluation was performed on the
results. Question (8.1) and Question (8.6) illustrate examples where the post-retrieval
ranking module of RetroRank suffers from problems associated with the less restricted
retrieval strategy employed in the retrieval module of RetroRank. However, a certain
trade-off between recall and precision is to be expected for any automated system.
8.2 Post-retrieval Ranking on Corpus 3
8.2.1 System Implementation
In order to fully evaluate the post-retrieval ranking strategies described in Chapter 7,
the RetroRank system was extended to deal with the different data structure of Corpus
3 (c.f. Section 4.3). Figure 8.2 shows the system diagram of the extended system.
The first step in the evaluation system involves parsing a .csv file consisting of ques-
tions marked-up by LT-TTT2 as described Section 6.1 and their associated Cochrane
review IDs to create two maps. Table 8.9 shows an example from the input file. The
rest of the questions in Corpus 3 can be found in Appendix F.
Cochrane ID Question
CD008418 How efficient and safe is <drug> Formoterol</drug> versus short-
acting <drug>beta-agonists</drug> as relief medication for adults
and children with <disease>asthma</disease> ?
Table 8.9: Extract from the input file for ranking system for Corpus 3.
The first map consists of the Cochrane ID and the list of query terms (drugs and
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Input File 
[CochraneID, Question]
Cochrane ID TermMap Cochrane ID QueryMap
Create Gold Standard from PubMED IDs of included 
references and review title.
[GoldStandard]
Retrieve PubMed IDs for all questions.
[QuestionPubMed ID | Recency]
Get abstract and title from Question PubMed ID
[ID | Abstract and ID | Ttile]
Get CitationCount from Google Scholar and ISI .
[Pubmed ID | Google | ISI]
Parse abstracts to build a database table.
[Question ID | Recency | TermCount | TermFrequency | PercentLast |Google| ISI 
| MSW | GoldStandard]
Calcuate "Backing Off" and "Expert Voting" and reorder table by ranking criteria.







Figure 8.2: System diagram of the ranking system for Corpus 3.
diseases). The second map consists of the Cochrane ID and the E-Utilities query cor-
responding to the question. The query terms are used later on to calculate some of the
ranking strategies. The E-Utilities query is used to retrieve PubMed abstracts for each
question and their associated MeSH terms.
The second step is to create a list of PMIDs of “gold standard” articles. “Gold
standard” articles are the Cochrane review itself and the references in the “references
included” section of the Cochrane review. Because Cochrane reviews consist of con-
trolled, high-quality clinical evidence, the references included in them present a good
“gold standard” for a full evaluation of the different ranking strategies.
Creating the gold standard file involves two stages. In the first stage, the Cochrane
review abstract is retrieved for each Cochrane ID from the input file. The abstract in-
cludes the title of the review which is looked up in PubMed. If the review is indexed
in PubMed, its PMID is retrieved and stored. By knowing the PMID of the Cochrane
review it can later be checked if it was retrieved by the retrieval component of Retro-
Rank.
During the second stage all references that are included in the Cochrane review
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are retrieved. These can be found under “references” in the bibliography section. For
each retrieved reference it is checked, whether it is indexed in PubMed. If it has a
PMID, the ID is retrieved and stored. References from other biomedical databases
such as Embase, which do not have a PMID are discarded, because the evaluation of
RetroRank is only performed for PubMed articles. At the end of both stages a list
of gold standard PMIDs exists for each question, which will be used to evaluate the
retrieved articles.
During the third step the retrieval system introduced in Chapter 6 is used to get a
list of all the PMIDs for the PubMed abstracts retrieved for the query terms in each
question. In a fourth step, the abstracts and abstract titles are associated with their
corresponding PMIDs.
During the fifth step the citation count for all retrieved articles is obtained by
searching for the abstract title in Google Scholar and for the PMID of each abstract
in the ISI Web of Knowledge. The PMID and the corresponding Google Scholar and
ISI citation count numbers are stored in a map.
Step number six involves parsing the abstracts. During this stage a number of
processes take place:
• Stop words are removed using the PubMed stop word list (see Appendix C).
• The number of words and keywords is counted.
• The term frequency of the query terms is determined.
• The number of query terms in the last 20% of the abstracts is calculated.
• Cosine Minimum Span Weighting (“msw”) is calculated.
• The citation count is applied.
• The position of the abstracts ordered by recency as retrieved by PubMed is
recorded as the baseline (”recency”).
• It is checked whether an abstract is a “gold standard”.
In addition, the table in Example 8.10 is created which contains the following
fields:
The fields contain the following information:
• “Question ID”: The question ID for each question.
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Question ID Recency tf tf/idf PercentLast Google CitationCount ISI Citation Count MSW GoldStandard
Table 8.10: Table generated by parsing the abstracts in Corpus 3.
• “Recency”: Contains a PMID.
• “tf” : Contains the absolute number of query terms per abstract.
• “tf/idf”: Contains the number of query terms divided by the number of words in
the abstracts over all words in the corpus.
• “PercentLast”: Contains the number of query terms in the last 20% of the ab-
stract.
• “Google CitationCount”: Contains the number of citations for each abstract as
given by Google Scholar.
• “ISI Citation Count”: Contains the number of citations for each abstract as given
by ISI.
• “MSW”: Contains the cosine adjusted minimal span weighting information.
• “GoldStandard”: Contains a “0” or “1”, where a “0” indicates the abstract is no
“gold standard” and a “1” indicates an abstract is on the list of “gold standard”
articles for the question. The position of the “gold standard” articles is recorded
for the recency baseline. This is required to evaluate the post-retrieval ranking
strategies.
During the last step the “tf/idf - isi voting” and “voting” strategies are calculated
based on the results from step six and the table containing the abstract IDs is reordered
applying each of the different strategies. The position of the “gold standard” articles
after reranking is recorded to determine where the “gold standard” references are after
ranking in comparison to the baseline position. Using this data, the following evalua-
tion metrics are calculated.
• Average Precision (AP): The average precision value.
• Mean Average Precision (MAP): The average of the precision values after each
relevant document is retrieved (Baeza-Yates, Ricardo A. and Ribeiro-Neto, B.,
1999).
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• Bpref: A preference-based measure that depends on the number of judged non-
relevant documents retrieved before the judged relevant ones (“gold standard”
documents).
• Mean Rank Precision (MRP): The mean value of the rank positions calculated
over all questions at a certain rank.
• P@10: The fraction of relevant documents in the top ten results.
• Mean Reciprocal Rank (MRR): Measures how far down on a list the first rele-
vant abstract is.
• Total Document Reciprocal Rank (TDRR): The sum of the reciprocal ranks
of all relevant documents. Unlike MRR it captures the ranks of all relevant
documents.
8.2.2 Rank-ordered List of MEDLINE® Abstracts for Corpus 3
This section shows an example of the rank-ordered database tables of MEDLINE®
abstracts for Corpus 3. These tables determine the order in which the abstracts would
be displayed to a clinician to serve as answer candidates for her clinical comparison
question in a front end for RetroRank.
Table 8.11 shows the database table for the “gold standard” PMIDs for all the
ranking strategies for Question CD006015. The number in the recency column refers
to a “gold standard” PMID’s original ranking position in the PubMed recency baseline.
The numbers in the other colums refer to a “gold standard” PMID’s ranking position
after applying the different post-retrieval ranking strategies.
The first “gold standard” reference would be displayed on position 23 in the ex-
ample in Table 8.11 using the recency baseline before reordering the table with the
post-retrieval ranking strategies developed for RetroRank. After applying the “isi”
strategy, the same reference would be displayed on position 2.
Table 8.12 and Table 8.135 show the reordered tables for the first 20 PMIDs after
applying the “isi” and “google” post-retrieval ranking strategies respectively.
Both citation count-based strategies bring a “gold standard” reference to the first
position in the result set. “isi”, which is the best individual post-retrieval strategy
overall, outperforms “google” and brings eight “gold standard” references into the top
5The column headings for “recency” and “isi” have been changed to “Baseline Rank” and “ISI
citation count” respectively in both tables for clarity.
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PMID recency tf tf/idf Last20% google isi msw tf-isi voting voting
16406915 23 4 7 9 5 2 4 2 6
1383816 174 153 103 160 n/a n/a 150 144 87
7678871 167 117 73 124 115 78 103 78 67
11377309 73 43 19 32 24 16 29 16 16
14681504 40 5 11 10 12 3 13 3 7
12639651 51 19 16 16 16 11 21 11 10
1283370 179 165 133 167 n/a n/a 161 146 118
7684524 170 135 89 131 125 98 109 95 75
12559281 53 29 18 23 21 13 23 13 12
9475762 122 60 32 65 42 35 58 35 42
9152564 128 87 48 75 67 50 70 52 54
9751354 109 57 28 44 35 27 47 26 36
8911291 136 88 58 80 68 51 73 53 55
8595647 151 97 66 114 109 63 89 64 61
7495111 148 93 64 89 80 61 88 61 60
10737482 84 55 22 35 27 22 33 22 20
10210385 100 56 27 42 34 25 42 25 26
9610579 115 59 31 51 41 28 55 28 41
7542109 156 113 71 116 112 67 93 66 66
17869295 13 2 3 3 1 1 2 1 1
9146609 125 63 40 72 58 43 69 42 50
7678931 171 141 102 139 n/a n/a 121 133 85
8684407 139 92 63 86 78 59 77 59 58
11018616 82 44 21 33 26 18 32 18 17
12796667 47 12 14 14 14 10 19 10 9
Table 8.11: Database table showing the rank position of the “gold standard” PMIDs for
Question CD006015.
20 as opposed to five “gold standard” references for “google”. The “gold standard”
reference brought to the first position is not the same for the two metrics. As stated
above, it is not relevant which “gold standard” reference is displayed first because all
“gold standard” references provide high quality, relevant clinical evidence. However, a
post-retrieval ranking strategy is more successful if it can bring more “gold standard”
references to the top of the result set, which is the case for “isi”.
Table 8.14 shows the database table after reordering it using the “tf” strategy. While
this strategy also brings five “gold standard” references into the top 20 and displays the
first “gold standard” ranked highly on position 2, it is interesting to see that it has far
less discriminative power than the citation-based strategies. This is evident in several
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Question PMID goldstandard Baseline Rank ISI citation count
CD006015 1383816 1 174 707
CD006015 9475762 1 122 516
CD006015 14681504 1 40 511
CD006015 8804493 0 138 257
CD006015 1371291 0 177 217
CD006015 9820264 0 108 183
CD006015 7510911 0 161 152
CD006015 10096369 0 103 152
CD006015 1373779 0 176 137
CD006015 12559281 1 53 123
CD006015 8911291 1 136 113
CD006015 15126539 0 36 111
CD006015 7495111 1 148 105
CD006015 10510925 0 89 96
CD006015 9187688 0 124 92
CD006015 9610579 1 115 91
CD006015 9697781 0 112 86
CD006015 9751354 1 109 84
CD006015 8922564 0 135 75
CD006015 8636309 0 144 71
Table 8.12: Database table for the top 20 PMIDs for Question CD006015 after applying
the “isi” post-retrieval ranking strategy.
PMIDs having the same term frequency result, which is not surprising given the nature
of the retrieved abstracts, which are all short texts about the same topic containing the
same query terms, and are therefore much more similar to each other than abstracts
retrieved with partial matches or full-text documents. This problem does not exist for
the citation-based strategies which reorder the abstracts using external sources.
8.2.3 Results & Evaluation
RetroRank retrieved a total of 22,916 MEDLINE® abstracts for the 45 questions in
Corpus 3. “Gold standard” references were retieved for 38 out of 45 test questions
from Corpus 3. Seven questions did not have PubMed articles listed as references,
which means they were not considered because retrieval was only done for PubMed
articles. RetroRank retrieved “gold-standard” articles for 31 from the 38 questions
with “gold standard” references. The retrieval accuracy on Corpus 3 is 81.6%, which
is 11.8% higher than on Corpus 2. The seven questions that did not retrieve the “gold
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Question PMID goldstandard Baseline Rank Google citation count
CD006015 14681504 1 40 728
CD006015 20927745 0 1 653
CD006015 8804493 0 138 332
CD006015 1371291 0 177 202
CD006015 12559281 1 53 175
CD006015 8659328 0 143 150
CD006015 10796790 0 83 132
CD006015 19370565 0 3 132
CD006015 12137626 0 61 132
CD006015 8922564 0 135 121
CD006015 9187688 0 124 121
CD006015 8911291 1 136 116
CD006015 7510911 0 161 95
CD006015 9475762 1 122 90
CD006015 8636309 0 144 85
CD006015 8684407 1 139 75
CD006015 15142149 0 35 68
CD006015 12670567 0 49 66
CD006015 16516013 0 20 65
CD006015 11276294 0 75 63
Table 8.13: Database table for the top 20 PMIDs for Question CD006015 after applying
the “google” post-retrieval ranking strategy.
standard” references were mostly “other” or “placebo” questions, meaning that a drug
was compared to another drug that was not named or to a placebo. This type of question
is more difficult for an automated system than an explicit comparison question naming
all compared entities.
Table 8.15 shows the total number of abstracts retrieved and the position of the first
”gold-standard” abstract for each ranking strategy. The first column shows the question
ID, the second column the number of abstracts retrieved per question, the third column
shows the recency baseline followed by the columns for “tf”, “tf/idf”, “Last 20%”,
“google”, “isi”, “msw”, “tf/idf - isi voting” and “voting”. Results are shown in terms
of absolute improvement in rank over the rank of the “gold standard” in the baseline,
and in percentage of improvement over the baseline. In the case of “n/a” none of the
retrieved abstracts were the “gold standard” reference.
The average rank of the “gold standard” abstract in Table 8.15 for the recency base-
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Question pubmedid goldstandard recency tf
CD006015 1371291 0 177 4.295837
CD006015 7684524 1 170 4.218876
CD006015 10235693 0 99 4.178054
CD006015 8595647 1 151 4.135494
CD006015 10025034 0 105 4.044522
CD006015 7542109 1 156 4.044522
CD006015 7545721 0 155 3.995732
CD006015 9824790 0 107 3.995732
CD006015 11750255 0 69 3.995732
CD006015 1373779 0 176 3.944439
CD006015 9530536 0 120 3.890372
CD006015 7692110 0 165 3.890372
CD006015 9152564 1 128 3.890372
CD006015 10165827 0 131 3.833213
CD006015 8928243 0 137 3.833213
CD006015 7513437 0 166 3.833213
CD006015 7512661 0 160 3.833213
CD006015 7678871 1 167 3.772589
CD006015 9011975 0 134 3.772589
Table 8.14: Database table for the top 20 PMIDs for Question CD006015 after applying
the “tf” post-retrieval ranking strategy.
line is rank 179. The best ranking strategy, “isi”6, ranks the “gold standard” on position
7 on average, which is a 96.1% improvement over the baseline. The Google Scholar
citation-based strategy “google” performs 7.4% worse than “isi” over the baseline on
Corpus 3 giving an 88.7% improvement. While the performance gap between the two
citation-based strategies is smaller than on Corpus 2 (c.f. Section 8.1.3), the ISI Web
of Science still is a more valuable resource for citation count information than Google
Scholar for the medical domain. The second best strategy, “voting”, which is based
on a weighted combination of all the individual ranking strategies, ranks the “gold
standard” on rank 9 on average, giving a 94.8% improvement over the baseline.
The purely term frequency based strategies “tf” and “Last20%”, as well as the
vector-based term proximity approach “msw”, achieve very similar results with an
improvement between 86.8% and 89.5% over the baseline. “tf/idf”, which looks at
term frequency in regards to the whole corpus performs slightly worse, achieving an
6Because there is only one “gold standard” per question and the “gold standard” always received an
ISI citation count, “isi” and “tf/idf - isi voting” are identical since it was not necessary to back off to
“tf/idf” to make up for a lack of citation count information.
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Question # of Abstracts recency tf tf/idf Last20% google isi msw tf-isi voting voting
CD006626 985 753 45 112 73 15 6 30 6 22
CD003462 97 93 14 71 9 48 36 17 36 32
CD004707 52 49 18 6 22 1 1 7 1 1
CD006654 2335 655 34 90 36 3 1 85 1 1
CD006015 180 13 2 3 3 1 1 2 1 1
CD002258 580 180 53 41 30 153 4 48 4 14
CD006918 53 37 21 13 14 2 1 22 1 1
CD003082 3077 930 82 13 50 11 4 39 4 15
CD002960 13 13 3 13 2 9 1 3 1 1
CD000128 30 16 2 6 1 11 1 1 1 1
CD008418 427 170 11 33 19 7 10 136 10 42
CD001439 15 7 2 1 1 4 1 1 1 1
CD000127 33 18 2 2 2 10 1 1 1 1
CD006117 1343 308 8 76 1 45 11 1 11 2
CD000284 227 40 1 4 4 5 2 2 2 3
CD003135 48 34 2 7 1 6 5 4 5 3
CD000067 985 372 10 30 4 n/a 1 17 1 1
CD006352 106 24 6 1 4 18 4 6 4 3
CD003492 89 76 61 2 26 23 14 22 14 8
CD007022 539 203 1 18 1 28 16 4 16 2
CD001387 43 34 1 27 2 n/a 15 7 15 3
CD003615 146 127 23 53 83 n/a 3 32 3 9
CD001281 235 174 70 163 159 41 13 69 13 49
CD006628 112 77 3 40 2 11 9 4 9 5
CD005967 164 4 9 10 11 6 11 3 11 12
CD001031 587 421 4 42 6 86 1 5 1 1
CD001211 29 12 5 9 2 2 1 5 1 1
CD006453 35 4 17 16 33 4 6 32 6 17
CD004278 352 275 23 9 37 62 36 45 36 37
CD001100 608 421 40 33 43 4 1 77 1 1
CD002310 28 21 9 10 9 17 1 8 1 1
Average Rank 179.387 18.774 30.774 22.258 20.323 7.032 23.710 7.032 9.387
Improvement
# of ranks 160.613 148.613 157.129 159.065 172.355 155.677 172.355 170.000
Improvement (%) 0.895 0.828 0.876 0.887 0.961 0.868 0.961 0.948
Table 8.15: Rank of 1st relevant abstract for each strategy for Corpus 3.
82.8% improvement over the recency baseline.
While the ISI citation-based strategies are consistently the most successful strate-
gies for both corpora, the strategies relying purely on information intrinsic to the ab-
stracts perform better on Corpus 3 than on Corpus 2. There is also a general increase
in performance on Corpus 3, which is most likely due to the higher number of “gold
standard” references that are retrieved and ranked per question. Also the average rank
of the first relevant abstract in the baseline is lower than for Corpus 2, which leaves
more room for improvement.
Table 8.16 shows the average precision (AP) and the mean average precision (MAP)
for each ranking strategy on Corpus 3. A higher percentage indicates better retrieval
of the “gold standard” references, i.e., a percentage of 50% means half the “gold stan-
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dard” references were retrieved or one in two documents is a “gold standard” reference,
whereas a low percentage of 10% indicates that only 10% of the “gold standard” refer-
ences were retrieved or that one in ten documents is a “gold standard” reference. The
PubMed recency baseline has a MAP of only 5.6%.
recency tf tf/idf Last20% google isi msw tf-isi voting voting
CD003492 0.013 0.016 0.500 0.038 0.043 0.071 0.045 0.071 0.125
CD003462 0.011 0.071 0.014 0.111 0.021 0.028 0.059 0.028 0.031
CD004707 0.020 0.056 0.167 0.045 1.000 1.000 0.143 1.000 1.000
CD006654 0.019 0.029 0.027 0.026 0.073 0.121 0.024 0.121 0.059
CD006015 0.110 0.234 0.311 0.220 0.261 0.393 0.241 0.414 0.371
CD002258 0.016 0.025 0.032 0.026 0.001 0.064 0.018 0.066 0.032
CD006918 0.027 0.048 0.077 0.071 0.500 1.000 0.045 1.000 1.000
CD003082 0.006 0.015 0.019 0.016 0.046 0.075 0.014 0.075 0.035
CD002960 0.077 0.333 0.077 0.500 0.111 1.000 0.333 1.000 1.000
CD000128 0.102 0.482 0.155 0.608 0.156 0.250 0.813 0.347 0.649
CD008418 0.009 0.043 0.027 0.029 0.090 0.059 0.009 0.059 0.025
CD001439 0.348 0.628 0.515 0.675 0.324 0.657 0.764 0.748 0.740
CD000127 0.097 0.515 0.247 0.546 0.131 0.313 0.833 0.386 0.618
CD006117 0.023 0.121 0.048 0.140 0.063 0.077 0.111 0.080 0.107
CD000284 0.142 0.215 0.227 0.222 0.220 0.242 0.225 0.282 0.254
CD003135 0.081 0.307 0.174 0.381 0.193 0.323 0.307 0.323 0.212
CD000067 0.004 0.067 0.019 0.090 0.000 0.395 0.043 0.402 0.237
CD006352 0.047 0.103 0.337 0.099 0.064 0.085 0.140 0.097 0.166
CD006626 0.013 0.028 0.025 0.024 0.051 0.084 0.020 0.084 0.037
CD007022 0.019 0.425 0.086 0.331 0.055 0.078 0.138 0.083 0.197
CD001387 0.029 1.000 0.037 0.500 0.000 0.067 0.143 0.067 0.333
CD003615 0.012 0.063 0.026 0.018 0.000 0.417 0.046 0.417 0.146
CD001281 0.006 0.014 0.006 0.006 0.024 0.077 0.014 0.077 0.020
CD006628 0.013 0.333 0.025 0.500 0.091 0.111 0.250 0.111 0.200
CD005967 0.114 0.109 0.132 0.091 0.106 0.042 0.250 0.057 0.117
CD001031 0.003 0.142 0.016 0.090 0.012 0.512 0.105 0.512 0.505
CD001211 0.130 0.234 0.186 0.281 0.444 0.583 0.187 0.631 0.440
CD006453 0.250 0.059 0.063 0.030 0.250 0.167 0.031 0.167 0.059
CD004278 0.010 0.038 0.052 0.030 0.018 0.021 0.026 0.023 0.025
CD001100 0.005 0.012 0.024 0.019 0.185 0.621 0.017 0.621 0.383
CD002310 0.060 0.146 0.106 0.118 0.029 0.500 0.146 0.548 0.543
MAP 0.056 0.191 0.121 0.190 0.147 0.304 0.179 0.319 0.312
Table 8.16: Average precision (%) per metric and MAP (%) for Corpus 3
Consistent with the results shown in Table 8.15, the ISI citation-based strategies
have a good MAP. The best combined strategy “tf/idf - isi voting” has a MAP of 31.9%,
while the best individual ranking strategy “isi” has a MAP of 30.4%. This means that
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the MAP of the best post-retrieval ranking strategy in RetroRank is 26.3% higher than
for the PubMed baseline.
The MAP of the “google” strategy is only half as good as the MAP for the “isi”
strategy. This finding is consistent with the other results in which “isi” achieves much
better performance, and reinforces that the ISI Web of Knowledge is a valuable re-
source for the biomedical domain. The MAP of the strategies relying on information
intrinsic to the abstracts varies between 12.1% and 19%, which is much lower than the
MAP that can be achieved by using external information for post-retrieval ranking.
recency tf tf/idf Last20% google isi msw tf-isi voting voting
CD006626 0.000 0.000 0.000 0.000 0.030 0.085 0.007 0.085 0.011
CD003462 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD004707 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD006654 0.000 0.007 0.000 0.006 0.061 0.107 0.000 0.107 0.031
CD006015 0.024 0.150 0.246 0.144 0.184 0.307 0.136 0.309 0.274
CD002258 0.000 0.000 0.000 0.000 0.000 0.063 0.000 0.063 0.000
CD006918 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD003082 0.000 0.000 0.036 0.000 0.051 0.107 0.000 0.107 0.023
CD002960 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD000128 0.000 0.250 0.000 0.313 0.000 0.188 0.563 0.188 0.375
CD008418 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD001439 0.000 0.490 0.204 0.510 0.143 0.571 0.612 0.612 0.592
CD000127 0.000 0.375 0.125 0.375 0.000 0.188 0.563 0.188 0.188
CD006117 0.000 0.139 0.000 0.091 0.000 0.042 0.104 0.042 0.062
CD000284 0.003 0.094 0.174 0.151 0.147 0.195 0.106 0.196 0.184
CD003135 0.000 0.194 0.000 0.139 0.000 0.083 0.056 0.083 0.083
CD000067 0.000 0.000 0.000 0.056 0.000 0.139 0.000 0.167 0.139
CD006352 0.000 0.000 0.160 0.040 0.000 0.040 0.000 0.040 0.080
CD003492 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD007022 0.000 0.313 0.000 0.258 0.000 0.000 0.129 0.000 0.133
CD001387 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD003615 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD001281 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD006628 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD005967 0.056 0.000 0.000 0.000 0.000 0.000 0.194 0.000 0.000
CD001031 0.000 0.000 0.000 0.000 0.000 0.250 0.000 0.250 0.250
CD001211 0.000 0.000 0.000 0.125 0.250 0.375 0.000 0.375 0.188
CD006453 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD004278 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
CD001100 0.000 0.000 0.000 0.000 0.000 0.375 0.000 0.375 0.188
CD002310 0.000 0.000 0.000 0.000 0.000 0.250 0.000 0.250 0.250
Average Bref 0.003 0.065 0.030 0.071 0.028 0.109 0.080 0.111 0.098
Table 8.17: Bpref per Question and Average Bpref for Corpus 3
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Table 8.17 shows the bpref values per question and the average bref value for the
whole corpus. Although bpref is highly correlated with average precision when the
judgments are effectively complete, the value of bpref deviates from average precision
and from its own value as the judgment set becomes smaller (Buckley and Voorhees,
2004), especially at very low levels of assessment. Corpus 3 contains a number of
questions, which have very few ”gold standards” relative to the number of abstracts
retrieved for a question, which makes bpref an unreliable metric for the task in this
research illustrated in the results for bpref which range from 57.1% for “isi” for Ques-
tion CD001439 with many ”gold standard” references to 0% for the questions with
very few ”gold standard” references.
Table 8.18 shows the MAP and MRP at rank 5, 10 and 20. The MRP at a certain
rank is the mean value of the rank positions calculated over all questions. The cut-off
was chosen at position 20 because it is assumed a clinician would likely like to find a
relevant document within at most 20 documents. The MRP therefore expresses how
useful a ranking strategy is in practice. The results again suggest that the ISI citation-
based strategies are the most successful considering the number of retrieved relevant
documents at the given ranks. The difference between the best ranking strategies and
the baseline strategy is again considerable with the baseline performance being con-
siderably worse across all cut-off points.
Rank Strategy MAP MRP Top 5 MRP Top 10 MRP Top 20
Recency 0.058 0.013 0.026 0.039
tf 0.19 0.167 0.162 0.156
tf/idf 0.121 0.070 0.089 0.101
Last 20% 0.189 0.167 0.155 0.154
google 0.147 0.116 0.130 0.142
isi 0.304 0.317 0.323 0.311
msw 0.178 0.137 0.127 0.130
tf-isi voting 0.319 0.269 0.260 0.243
voting 0.312 0.265 0.236 0.236
Table 8.18: Mean Rank Precisions at Rank 5, 10 and 20 for Corpus 3.
The last section of the evaluation compares mean recall and precision. Graph 8.3
shows the interpolated recall/precision graph for all questions in Corpus 3. When the
curve is in the upper-right portion of the graph a strategy performs well. A curve in
the lower-left portion of the graph indicates that the strategies’ overall performance is
poor. The “x” axis shows recall and the “y” axis shows precision. Recall describes the
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ratio of relevant abstracts retrieved to the total number of relevant abstracts available.
Precision is the ratio of the number of relevant abstracts retrieved to the total number
of retrieved abstracts. Recall and precision are inversely related and recall goes up
while precision goes down and vice versa. To increase recall the search needs to be
widened, which often leads to the retrieval of material that is not relevant and thereby
negatively affects precision. In this analysis, the total number of relevant abstracts
equals the number of “gold standards” for all questions. Recall equals “1” means all
“gold standard” abstracts were retrieved.

























Figure 8.3: Interpolated recall/precision graph over all questions.
The “isi” strategy, as well as the two ISI citation-based voting strategies perform
significantly better than the other strategies relying purely on information from the ab-
stracts. Their initial precision is approximately 60% going down to around 18% when
recall equals 100%. The baseline only has approximately 18% precision in the begin-
ning and precision goes down to almost 0% when recall equals 30%. The graph illus-
trates that the ISI citation-based strategies are highly successful at identifying impor-
tant articles compared to non-citation based strategies and have a good recall/precision
ratio.
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The evaluation in this chapter could only be performed in terms of retrieval of “gold
standard” abstracts because no human judges were involved in the system evaluation.
The results suggest that other abstracts that would be relevant to a clinician are brought
to the top of the result set given the very good performance of the post-retrieval ranking
strategies. A second, human, evaluation under a lenient condition that also considers
abstracts that are not the official “gold standard” but have been judged as relevant by
clinicians would be a useful avenue in future work.
8.2.4 System Comparison
The final two tables (Table 8.19 and Table 8.20) in this evaluation compare the re-
sults of RetroRank to the performance of the post-retrieval ranking system developed
by Demner-Fushman and Lin (2007). The comparison is made for the therapy task
described in Section 2.4.4, which is the task that best corresponds to the task of Retro-
Rank. Demner-Fushman and Lin (2007) used PICO query frames and assessed the
relevance of the retrieved abstracts by a medical doctor, whereas RetroRank works on
natural language queries and does not require a doctor to evaluate the relevance of the
retrieved abstracts because the corpus has a set of “gold standard” references for each
question. In order to compare the two systems, the results for RetroRank were put into
the same format used by Demner-Fushman and Lin (2007), namely Precision at Rank
10 (P@10), Mean Average Precision (MAP), Mean Reciprocal Rank (MRR) and Total
Document Reciprocal Rank (TDRR), which is the sum of the reciprocal ranks of all
relevant documents.
Ranking Strategy P@10 MAP MRR TDRR
PubMed 0.180 0.061 0.282 0.495
Term 0.192 0.082 0.368 0.700
EBM 0.233 0.109 0.397 0.807
Combo 0.258 0.120 0.556 0.969
Table 8.19: Performance of all systems on the test set for the therapy task (Demner-
Fushman and Lin, 2007).
The results show that Demner-Fushman and Lin (2007)’s PubMed baseline is higher
than the PubMed baseline for RetroRank. This is likely due to the more restricted way
the query was manually constructed. The best ranking system in Demner-Fushman
and Lin (2007) is the “Combo” system (A combination of the term-based reranker and
the EBM scorer normalised using weighted linear interpolation). For P@10 it achieves
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Ranking Strategy P@10 MAP MRR TDRR
recency 0.056 0.058 0.042 0.113
tf 0.261 0.19 0.250 0.495
tf/idf 0.163 0.121 0.165 0.313
Last 20% 0.289 0.189 0.305 0.522
google 0.222 0.147 0.200 0.345
isi 0.390 0.304 0.510 0.788
msw 0.305 0.178 0.252 0.485
tf - isi voting 0.390 0.319 0.510 0.805
voting 0.390 0.312 0.516 0.765
Table 8.20: P@10, MAP, MRR and TDRR for each strategy for Corpus 3.
25.8%, whereas “isi”, the best overall ranking strategy in RetroRank, achieves 39%.
The MAP value for “Combo” is 12% compared to a MAP of 30.4% for “isi”. The
MRR of 55.6% for “Combo” is comparable to the MRR of 51% for “isi”. The only
metric in which “Combo” cleary performs better than “isi” is TDRR, where “Combo”
achieves a score of 96.9% and “isi” only 78.8%. This metric is not as telling as the
other metrics, though, because the main task for a good post-retrieval ranking system
is to present the first relevant abstracts as high in the result set as possible - a task in
which RetroRank outperforms the system in Demner-Fushman and Lin (2007). While
the results of Demner-Fushman and Lin (2007) are a significant improvement over the
PubMed baseline, the performance of RetroRank shows that it is possible to success-
fully use natural language input and a fully automated approach to achieve very good
results.
8.2.5 Error Analysis for Corpus 3
Although the overall performance of RetroRank on Corpus 3 is very good, some ques-
tions prove more challenging than others. The following section shows the two ques-
tions for which the overall best strategy “isi” failed to bring a “gold standard” reference
into the top 20 of the result set. The query terms are highlighted in bold and additional
important information in the abstracts is highlighted in italics.
The first question is Question CD003462 shown in Example (8.15), in which the
drug heparin is compared to a placebo.
(8.15) What are the effects of heparin versus placebo for acute coronary syn-
dromes? (Question CD003462 in Corpus 3)
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For this question only one “gold standard” reference out of the existing eight “gold
standard” references was retrieved on position 36 after reranking the result set using
the isi” strategy. The abstract for the “gold standard” reference is shown in Example
(8.16). It is the abstract for a randomized controlled trial published in the American
Journal of Cardiology in 1997 and has 16 ISI citations.
(8.16)
PMID: 9296466
Title: Low-molecular-weight heparin (Fragmin) during instability in coronary
artery disease (FRISC). FRISC Study Group.
Abstract
This study evaluated whether the low-molecular-weight (LMW) heparin dal-
teparin sodium (Fragmin) had protective effects against cardiac events in aspirin-
treated patients with unstable coronary artery syndromes. Patients (n = 1,506)
with unstable angina or non-Q-wave myocardial infarction were randomized to
double-blind, placebo-controlled treatment with LMW heparin. The treatment
was given as subcutaneous injections: 120 U/kg body weight/12 hours during the
first 5-7 days and 7,500 U once daily during the following 35-45 days. The pri-
mary endpoint, death or myocardial infarction after 6 days, showed a 3% (4.7%-
1.7%) absolute and a 65% relative reduction in the LMW heparin group. There
was a 6.8% (15.5%-8.7%) absolute and a 47% relative reduction of urgent revas-
cularization or need for heparin or nitroglycerin infusions in combination with the
primary endpoint. After 40 days there was an absolute reduction of death or my-
ocardial infarction of 2.8% (10.7%-7.9%) and its combination with incapacitating
angina was reduced by 5.9% (30.7%-24.8%). The survival analysis indicated a
reactivation of the instability soon after lowering the dose at 5-7 days. With long-
term follow-up, 3-4 months after termination of LMW heparin, the differences
between groups were no longer statistically significant. However, the cumula-
tive reduction in death, myocardial infarction, and revascularization because of
incapacitating angina of 5.1% (25.3%-20.4%) was maintained. No cerebral and
few major bleeds occurred. Compliance was adequate. Thus, subcutaneous LMW
heparin protects against cardiac events in the acute phase of unstable coronary
artery disease. The subcutaneous regimen also allows prolongation of treatment
in the outpatient setting, which might maintain the initial benefits over a longer
period.
The abstract chosen as a “gold standard” by the Cochrane Group discusses heparin
in a placebo-controlled trial as specified in the question, whereas the abstract ranked
1st by RetroRank shown in Example (8.17) does address the question but the placebo-
controlled trial also includes aspirin and a combination of heparin and aspirin treat-
ment. It is the abstract for a randomized controlled trial published in the New England
Journal of Medicine in 1992.
(8.17)
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PMID: 1608405
Title: Reactivation of unstable angina after the discontinuation of heparin.
Abstract
BACKGROUND:
Heparin is an effective, widely used treatment for unstable angina. Among pa-
tients enrolled in a double-blind, randomized, placebo-controlled trial comparing
intravenous heparin, aspirin, both treatments, and neither during the acute phase
of unstable angina, we encountered patients in whom unstable angina was reacti-
vated after heparin was discontinued.
METHODS:
The study population included 403 of the original 479 patients in the trial who
had completed six days of blinded therapy without refractory angina or myocar-
dial infarction. After the discontinuation of therapy, clinical events, including re-
activation of unstable angina and myocardial infarction occurring within 96 hours
after hospitalization, were closely monitored.
RESULTS:
Early reactivation occurred in 14 of the 107 patients who received heparin alone,
as compared with only 5 patients in each of the other three study groups (P less
than 0.01). These reactivations required urgent intervention (thrombolysis, an-
gioplasty, or coronary-bypass surgery) in 11 patients treated with heparin alone,
but in only 2 patients in the other groups combined (P less than 0.01). Four of the
six patients who had a myocardial infarction during a reactivation of their disease
were in the heparin group. Reactivations in this group occurred in a cluster a
mean (+/- SD) of 9.5 +/- 5 hours after the discontinuation of the study drug but
were randomly distributed over the initial 96 hours in the other three groups.
CONCLUSIONS:
Although heparin is beneficial in treating unstable angina, the disease process
may be reactivated within hours of the discontinuation of this drug. Concomitant
therapy with aspirin may prevent this withdrawal phenomenon.
The study ranked first by RetroRank has been cited 380 times as opposed to 16
times for the “gold standard” reference. While the remit of the study is wider than
in the “gold standard” study, it does provide a valuable answer in the “Conclusion”
section and its high citation count suggests that it is a high impact study. Nevertheless,
it fails to address the exact question. RetroRank also only retrieved one out of eight
possible “gold standards” references for this question.
The second question for which the “isi” strategy failed to bring a “gold standard”
reference into the top 20 is Question CD004278 shown in Example (8.18), which is a
question in which haloperidol is compared to chlorpromazine without specifying in
what respect the two drugs should be compared.
(8.18) How does haloperidol compare to chlorpromazine for people with schizophre-
nia? (Question CD004278 in Corpus 3)
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For this question RetroRank retrieved 50% of the known “gold standards” but failed
to rank any “gold standard” higher than position 36. The “gold standard” reference
shown in Example (8.19) addresses the comparison in a clear and succinct manner. It
is a randomized clinical trial published in Diseases of the Nervous System in 1974.
(8.19)
PMID: 17894080
Title: Parenteral haloperidol for rapid control of severe, disruptive symptoms of
acute schizophrenia.
Abstract
Intramuscular haloperidol, at three dose levels, (5 mg, 2 mg, and 1 mg) chlor-
promazine (25 mg), and placebo were compared for efficacy, rapidity of thera-
peutic onset, and safety in 50 acute psychotic patients requiring rapid control. The
drugs were administered parenterally under double-blind conditions at half-hour
intervals until successful control of moderate to very severe symptomatology was
achieved or a maximum of four injections had been given. Global evaluation,
BPRS, and target symptom ratings were performed. The overall results indicated
that the 5 mg and 2 mg haloperidol doses were significantly superior to the 1
mg haloperidol and 25 mg chlorpromazine doses and to placebo. Transfer of
patients to oral haloperidol was satisfactorily accomplished. Side effects for all
medications were minimal and included slight to moderate EPS and drowsiness.
The use of anti-parkinson drugs completely controlled the extrapyramidal symp-
toms.
While the “gold standard” abstract clearly addressed the question, the reference
ranked first by RetroRank’s “isi” strategy fails to do so. The focus of the study in Ex-
ample (8.20), a randomized clinical trial published in the Archives of General Psychia-
try in 1988, is on assessing the efficacy of clozapine in comparison to chlorpromazine.
The drug Haloperidol is mentioned in the abstract but is not part of the comparison.
While the abstract contains all keywords from the query and is very highly cited with
2486 ISI citations, it does not answer the question.
(8.20)
PMID: 3046553
Title: Clozapine for the treatment-resistant schizophrenic. A double-blind com-
parison with chlorpromazine.
Abstract
The treatment of schizophrenic patients who fail to respond to adequate trials of
neuroleptics is a major challenge. Clozapine, an atypical antipsychotic drug, has
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long been of scientific interest, but its clinical development has been delayed be-
cause of an associated risk of agranulocytosis. This report describes a multicenter
clinical trial to assess clozapine’s efficacy in the treatment of patients who are re-
fractory to neuroleptics. DSM-III schizophrenics who had failed to respond to
at least three different neuroleptics underwent a prospective, single-blind trial of
haloperidol (mean dosage, 61 +/- 14 mg/d) for six weeks. Patients whose condi-
tion remained unimproved were then randomly assigned, in a double-blind man-
ner, to clozapine (up to 900 mg/d) or chlorpromazine (up to 1800 mg/d) for six
weeks. Two hundred sixty-eight patients were entered in the double-blind com-
parison. When a priori criteria were used, 30% of the clozapine-treated patients
were categorized as responders compared with 4% of chlorpromazine-treated
patients. Clozapine produced significantly greater improvement on the Brief Psy-
chiatric Rating Scale, Clinical Global Impression Scale, and Nurses’ Observation
Scale for Inpatient Evaluation; this improvement included ”negative” as well as
positive symptom areas. Although no cases of agranulocytosis occurred during
this relatively brief study, in our view, the apparently increased comparative risk
requires that the use of clozapine be limited to selected treatment-resistant pa-
tients.
Example (8.18) illustrates the shortcomings of an automated system, which can
only retrieve abstracts based on the query terms in the question but lacks the human
insight necessary to determine the actual relevance of an abstract that contains all the
query terms but not in the right combination. In such cases even a human-based,
external strategy such as the ISI Web of Science citation count fails to rank the most
relevant abstracts first, because it is not enough to know a reference provides high
quality evidence if it does not deal with the exact problem in the question.
8.3 Review of the Post-Retrieval Ranking Strategies
RetroRank utilizes different post-retrieval ranking strategies. The evaluation on Corpus
2 and Corpus 3 has shown that there is a marked difference between the performance of
strategies that use information purely inherent to a MEDLINE® abstract such as term
frequency, term proximity or the appearance of the query terms in the “Outcome” or
“Conclusion” section of the abstracts and strategies that use external information such
as the citation count.
While ranking strategies that are based purely on the text of an abstract and the
MeSH terms associated with that abstract provide a very good improvement over
the PubMed recency baseline, they still perform less well than the best overall post-
retrieval ranking strategy “isi”, which reranks abstracts based on their citation count
as indexed by the ISI Web of Science, which is the most trusted database for peer-
reviewed content.
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The MEDLINE® abstracts retrieved for a query are all short texts containing the
query terms and share the same general topic. This makes it harder to discriminate
between abstracts using strategies that rely only on the abstract content. While it holds
true that abstracts with a higher density of query terms or a high density of query terms
in the “Outcome” or “Conclusion” section tend to be more relevant, the evaluation
shows that there is a limit to what can be done relying on information that can be
determined from an abstract.
This problem can be solved using external sources to rerank the abstract set re-
trieved for a query. External sources, such as the ISI citation count, benefit from
making use of expert knowledge and human judgement, i.e., the knowledge of re-
searchers in the clinical domain, who show the impact and value of studies by citing
them frequently. By using the citation count from the ISI Web of Knowledge, one
can also make sure that only articles from journals that have a good reputation and
are peer-reviewed are used for post-retrieval ranking. The “isi” strategy outperforms
the “google” strategy, which uses the citation count information from Google Scholar,
which includes a wider range of publications and has a less complete coverage for the
biomedical domain.
It can be concluded that post-retrieval ranking based on the ISI citation count is a
very successful means of displaying relevant and high quality research in the top 10
of the result set. The “isi” strategy achieves a 96.1% improvement over the PubMed
baseline for Corpus 3 regarding the rank of the first “gold standard” abstract in the
result set. The MAP of “isi” is a respectable 30.4% compared to a MAP of only
12% achieved by the best ranking system in the research by Demner-Fushman and Lin
(2007).
The value of the ISI citation count is also evident in the “voting” strategy which
reranks the abstracts by majority voting using all individual strategies but placing a
higher weight on the results produced by “isi”. The “voting” strategy achieves the
second best overall improvement with 94.8% for Corpus 3 regarding the rank of the
first “gold standard” abstract and has a MAP of 31.2% for Corpus 3.
8.4 Summary
In this chapter the implementation and evaluation of the post-retrieval ranking mod-
ule of RetroRank was described. Firstly, the implementation and testing of the post-
retrieval ranking strategies described in Chapter 7 was shown for Corpus 2. Secondly,
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the implementation of the ranking strategies was described for Corpus 3, which al-
lowed a full evaluation with standard IR metrics and a comparison with the post-
retrieval ranking system developed in Demner-Fushman and Lin (2007). It was shown
that the automatic ISI-citation based strategies “isi” and “voting” are a significant im-
provement over the PubMed recency baseline and are a strong contender to the strate-
gies based on query frames and annotated data developed by Demner-Fushman and
Lin (2007). The performance of RetroRank shows that it is possible to successfully
use natural language input and a fully automated approach to retrieve answer candi-
dates for clinical drug comparison questions.
Chapter 9
Summary and Conclusion
This chapter summarise the work presented in this thesis, assesses its contributions,
points out some limitations and concludes with ideas for further research.
9.1 Summary
This thesis proposed a new QA system for clinical comparison questions called Retro-
Rank that provides clinicians with a rank-ordered list of MEDLINE® abstracts targeted
to clinical questions framed in natural language. RetroRank takes the clinician’s plain
text question as input, processes it and outputs a rank-ordered list of potential answer
candidates, i.e., MEDLINE® abstracts. The rank-ordered list is reordered using sev-
eral post-retrieval ranking strategies to ensure the most topically-relevant abstracts are
displayed as high in the ranking as possible.
Chapter 1 introduced the research question of automatically answering clinicial
comparison questions and outlined the scope and contributions of the thesis.
Chapter 2 provided a foundation and motivation for the research undertaken in this
thesis by giving background knowledge about the information needs of clinicians and
the domain of Evidence Based Medicine (EBM) as well as an overview of Information
Retrieval (IR) and Question Answering (QA) techniques in the biomedical domain
and existing clinical QA services and applications, which served as a basis for the
evaluation of the performance of the RetroRank.
Chapter 3 introduced the characteristics of clinical comparison questions and showed
the types of different comparative constructions that appear in clinical questions. Also
the lexical items indicative of comparison questions were introduced, which were used
for the creation of Corpus 1.
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Chapter 4 described the creation and preprocessing of the three corpora of clinical
questions that were used to develop and evaluate the performance of RetroRank. Cor-
pus 1 (NLH QAS) was used for the manual exploration of the best strategy for abstract
retrieval in Chapter 5 and for the development of the automated abstract retrieval com-
ponent of RetroRank in Chapter 6. Corpus 2 (Essential Evidence Plus POEMs) was
used for the evaluation of the retrieval component in Chapter 6 according to the same
criteria used for the evaluation of askMedline by Fontelo et al. (2005), and for devel-
oping the post-retrieval ranking strategies described in Chapter 7. Corpus 3 (Cochrane
Systematic Reviews), which provides multiple “gold standard” references per ques-
tion, was used for a full evaluation of RetroRank according to standard IR metrics.
Chapter 5 presented the initial experiment on manual query construction, abstract
retrieval, and evaluation to determine the best search strategy and to evaluate it us-
ing human judges. The findings in this chapter were used to develop the automatic
RetroRank QA system introduced in Chapter 6.
Chapter 6 described the implementation and evaluation of the query construction
and abstract retrieval component of RetroRank. The retrieval component of RetroRank
was developed on Corpus 1 (Section 4.1) and evaluated in terms of retrieval accuracy
using Corpus 2 (Section 4.2).
Chapter 7 introduced the different post-retrieval ranking strategies which were used
to rerank the MEDLINE® abstracts retrieved for each question in Corpus 2 and Corpus
3 in order to display the most relevant abstracts as high in the result set as possible to
improve over the PubMed recency baseline, which does not display results by rele-
vance. Post-retrieval ranking is an important feature in a system that is geared towards
providing the most relevant abstracts at the top of the result set to enable clinicians to
find the most relevant information in a quick and reliable way.
Chapter 8 described the implementation and evaluation of the post-retrieval ranking
module of RetroRank. The post-retrieval ranking component was developed and tested
on Corpus 2 and fully evaluated on Corpus 3. The evaluation showed how the different
post-retrieval ranking strategies perform on the different corpora and in comparison
to the post-retrieval ranking system developed in Demner-Fushman and Lin (2007).
It was shown that the automatic ISI-citation based strategies and the Expert Voting
strategy are a significant improvement over the PubMed recency baseline and are a
strong contender to the strategies based on query frames and annotated data developed
by Demner-Fushman and Lin (2007).
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9.2 Contributions
The main contribution of this thesis are new automated QA methods for clinical com-
parison questions posed in natural language, which are implemented in the RetroRank
system. Enabling natural language input removes the burden of having to translate clin-
cial questions into PICO query frames and is a more natural way of asking questions.
RetroRank implements new post-retrieval ranking strategies and achieves a signifi-
cant improvement over the PubMed baseline and performs better or equally well than
previous approaches to post-retrieval ranking relying on query frames and annotated
MEDLINE® data such as the approach by Demner-Fushman and Lin (2007). The per-
formance of RetroRank shows that it is possible to successfully use natural language
input and a fully automated approach to obtain answers to clinical drug comparison
questions.
The RetroRank prototype addresses the problem time-pressed clinicians have when
requiring answers to clinical comparison questions in a timely and concise manner.
Clinicians need to keep up with a vast amount of ever changing research to be able to
use the current best evidence in individual patient care (Sackett et al., 1996). While
clinical search engines or electronic clinical decision support systems can be used to
facilitate the retrieval and presentation of clinical evidence, there are limits concern-
ing their usability and accessibility when timely guidance is of the essence and clini-
cans are reluctant to use electronic resources, because these present multiple problems.
Converting a clinical question into a searchable strategy can be challenging and often
leads to the retrieval of incomplete or non-useful information (Verhoeven et al., 1995;
Davies, 2007). RetroRank facilitates the search process by using natural language
questions to return relevant MEDLINE® abstracts that address the question.
The second contribution are two new evaluation corpora of clinical comparison
questions with “gold standard” references, which can be used as test collections in
future research in medical QA. Previously no “gold standard” corpora for clinical
comparison question existed, which allowed an automated evaluation. The two new
corpora are available on request.
9.3 Future Work
This section outlines future work which addresses the limitations of this research and
presents further development of the ideas described in this thesis.
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The main focus of this work is on developing new methods for answering clini-
cal comparison questions and implementing a prototype QA system. This work only
describes the back-end of RetroRank, while the front-end in form of a graphical user
interface (GUI) was not addressed. Adding a user interface will be important to im-
plement RetroRank as a publicly used system. The system architecture of RetroRank
rank allows it to be used as part of a client-server application, where a central back-end
server will be able to cache all MEDLINE® articles, perform the question processing
and answer generation and the front-end GUI will present the results.
Another interesting avenue for future work concerns the display of the answer can-
didates retrieved by RetroRank using different forms of visualisation techniques such
as multi-dimensional scaling or spring models (Morrison et al., 2003), that allow the
user to group similar results and visualise the links between the abstracts.
As far as the performance of RetroRank is concerned, there are two components
that can be augmented to improve the system. The first component is the retrieval mod-
ule. The retrieval module in RetroRank employs a fairly unrestricted retrieval strategy
to maximise recall and achieve a high retrieval accuracy. While a more restricted query
has been found to negatively affect retrieval accuracy, it might still be worthwhile to
consider expanding the query with additional information such as the dosage of a drug
or methods of administering a drug, e.g., oral or topical to make the result set more
relevant. In addition, a link between a generic drug name and its possible brand names
in the lexicon has not been made in the current research. It might be useful to add such
a link and introduce a retrieval step in which the alternative names for the drugs in the
question are added to the query by using the associations between generic and brand
names from. To implement an augmented drug recogniser, RxNorm1, a normalized
naming system for generic and branded drugs, which also includes drug strength and
dose form, would be a valuable resource. However, with any change to the retrieval
strategy, the trade-off between recall and precision will need to be considered. In ad-
dition the use of a relevance ranking engine such as Lucence2, a search engine that
implements TF-IDF weighting, could be explored as a stronger baseline for abstract
retrieval instead of using PubMed’s reverse chronological order as a baseline.
The second component of RetroRank that can be augmented is the post-retrieval
module. The post-retrieval ranking strategies used in RetroRank are very successful
but still do not produce the best result for all questions. While the “isi” strategy is
1http://www.nlm.nih.gov/research/umls/rxnorm/
2http://lucene.apache.org/core/
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a very strong strategy, there is potential to enhance it. One strategy that could be
explored is to weigh the citation count with the publication date to favour more recent
articles similar to the strategy used by Demner-Fushman and Lin (2007). It might
also be worth investigating if adding a weight for the journal impact factor leads to a
performance gain. Another strategy could be to investigate if a newer article with a
lower citation count references a top ranked article, which is older and has a higher
citation count and to boost its position by factor “x” if it does as shown in Example
(9.1). Factor “x” would need to be determined in future experiments.
(9.1)
“isi” citation count article “A” > “isi” citation count Article “B”
“A” is newer and references “B”
“B” is a top-ranked article
“A” is in the top 20 but ranked lower than “B”
The rank of “A” should be improved by factor “x”
Another way to augment the “isi” stategy could be to look at the articles related
to the top ranked articles, which are published in high-impact journals and have a
high “isi” citation count. Potentially this approach could be extended to other external
sources, because it was shown that the strategy that used external sources performed
significantly better than other strategies.
In conclusion, this thesis addressed a new research question concerning an auto-
mated natural language approach for answering clinical comparison questions. The re-
sults show that the prototype of an end-to-end QA system implemented in RetroRank
achieves a significant improvement over the PubMed recency baseline and performs
better or equally well than previous approaches to post-retrieval ranking using query
frames and annotated data. The performance of RetroRank shows that it is possible to
successfully use natural language input and a fully automated approach to obtain an-
swers to clinical drug comparison questions. It was demonstrated that expert domain
knowlege can be successfully implemented in an automated system by using external
sources such as the ISI Web of Science, which provides high quality clinical evidence.
The work in this thesis opens new avenues for future research on automated retrieval
and post-retrieval ranking strategies for therapy questions in the clinical domain. There
is also scope to extend the approach developed in this thesis to answer questions about
other clinical tasks such as treatment questions.
Appendix A
Comparative Questions used by
Demner-Fushman (2006)
Questions in the FPIN collection
Questions marked with (P) are from the Parkhurst Exchange Forum. The remaining
questions are from FPIN.
What is the best treatment for analgesic rebound headaches?
First- or second-generation antihistamines: which are more eective at controlling pru-
ritus?
What is the most eective nicotine replacement therapy?
(P) What are the best medications for panic disorder?
What is the most eective treatment for ADHD in children?
Other than anticoagulation, what is the best therapy for those with atrial fibrillation?
Do acetaminophen and an NSAID combined relieve osteoarthritis pain better than ei-
ther alone?
(P) Whats the best treatment for epididymitis?
Is the ThinPrep better than conventional Pap smear at detecting cervical cancer?
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Appendix B
Patterns Used by Fiszman et al. (2007)
to Augment SemRep
comp1: Compared terms
C1: Term1 BE compare with/to Term2
C2: compare Term1 with/to Term2
C3: compare Term1 and/versus Term2
C4a: Term1 comparison with/to Term2
C4b: comparison of Term1 with/to Term2
C4c: comparison of Term1 and/versus Term2
C5 Term1 versus Term2
comp2: Scalar patterns
S1: Term1 BE as ADJ as BE Term2
S2a: Term1 BE more ADJ than BE Term2
S2b: Term1 BE ADJer than BETerm2
S2c: Term1 BE less ADJ than BE Term2
S4: Term1 BE superior to Term2
S5: Term1 BE inferior to Term2
{BE} means that some form of be is optional. The slash indicates disjunction.
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List of PubMed stop words






s1 How safe and effective are aspirin and warfarin therapy in the prevention of
stroke in patients with atrial fibrillation?
s2 In adults or children with moderate to severe atopic dermatitis, is either tacrolimus
(Protopic) or pimecrolimus (Elidel) more effective than topical corticosteroids?
s3 In patients with chronic obstructive pulmonary disease, do anticholinergics pro-
vide better benefit than beta-2 agonists?
s4 Do intranasal steroids control symptoms of allergic rhinitis better than antihis-
tamines?
s5 Which nasal spray, budesonide (Rhinocort) or fluticasone propionate (Flonase),
is superior for once daily treatment of allergic rhinitis?
s6 Is the long-acting anticholinergic drug tiotropium more effective than salmeterol
in patients with chronic obstructive pulmonary disease?
s7 Is eletriptan more effective and at least as safe as sumatriptan for the treatment
of acute migraine headache?
s8 Is the analgesic dextropropoxyphene-acetaminophen more effective than ac-
etaminophen alone?
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s9 Which is better for the treatment of pneumonia in hospitalized patients: lev-
ofloxacin (Levaquin) or ceftriaxone (Rocephin)?
s10 Is enoxaparin as effective as unfractionated heparin in patients with non-ST-
segment elevation acute coronary syndromes?
s11 In patients with acute ST-elevation myocardial infarction who receive fibrinoly-
sis and subsequent percutaneous intervention, is enoxaparin superior to unfractionated
heparin?
s12 Is carvedilol better than metoprolol in the treatment of chronic heart failure?
s13 Is oral ketoprofen an effective treatment for acute migraine, and how does it
compare with zolmitriptan?
s14 Is oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treat-
ment of overactive bladder?
s15 Is ximelagatran as effective as warfarin in preventing stroke in patients with
nonvalvular atrial fibrillation?
s16 Is ivermectin more effective than lindane for treating scabies?
s17 Which is better tolerated: Tolterodine (Detrol) or oxybutynin (Ditropan)?
s18 Can stress ulcers in critical patients be prevented with the use of sucralfate or
ranitidine?
s19 Is the long-acting anticholinergic drug tiotropium more effective than salme-
terol in patients with chronic obstructive pulmonary disease?
s20 Is cilostazol (Pletal) more effective than pentoxifylline (Trental) in the treat-
ment of symptoms of intermittent claudication?
s21 Which intranasal formulation is most effective in the treatment of acute mi-
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graine: sumatriptan (Imitrex) or dihydroergotamine (DHE)?
s22 Is losartan comparable to captopril in CHF?
s23 Is either omeprazole or cisapride effective in the control of heartburn symp-
toms?
s24 Which inhaled corticosteroid is most effective in the treatment of persistent
asthma: fluticasone (Flovent) or beclomethasone (Beclovent, Vanceril)?
s25 Which is more effective for the treatment of Crohn’s disease, a controlled re-
lease form of budesonide or a slow release form of mesalamine
s26 Is tramadol (Ultram) more effective than hydrocodone-Acetaminophen (Vi-
codin) in the treatment of acute musculoskeletal pain?
s27 Is losartan (Cozaar) more effective at preventing bad outcomes than atenolol
(Tenormin) in patients with isolated systolic hypertension and left ventricular hyper-
trophy?
s28 Does fondaparinux improve outcomes better than enoxaparin in patients with
acute coronary syndrome?
s29 Is hydroxyurea or anagrelide more effective for the treatment of essential
thrombocythemia?
s30 Is caspofungin a safe and effective alternative to amphotericin B for invasive
candida infections?
Appendix E
Extract from List of WHO INN Stems
2009





CD000067 What is the efficacy of azathioprine compared to 6-mercaptopurine
for maintenance of remission in quiescent Crohn’s disease?
CD000127 What are the effects of magnesium sulphate compared with diazepam
when used for the care of women with eclampsia?
CD000128 What are the effects of magnesium sulphate versus phenytoin for eclamp-
sia?
CD000284 What are the effects of chlorpromazine for schizophreniain comparison
with placebo?
CD001031 How does lamotrigine compare to carbamazepine monotherapy for
epilepsy?
CD001100 What is the effect of fixed dose subcutaneous low molecular weight
heparins versus adjusted dose unfractionated heparin for venous thromboembolism?
CD001211 What are the benefits and harms of antibiotics versus placebo for acute
bacterial conjunctivitis?
CD001281 What are the comparative efficacy safety and side-effects of long-acting
beta-2 agonists and theophylline in the maintenance treatment of adults and adoles-
cents with asthma?
138
Appendix F. Corpus 3 139
CD001387 What is the efficacy and safety of ipratropium bromide versus short act-
ing beta-2 agonists for stable chronic obstructive pulmonary disease?
CD001439 Are there benefits of using antibiotics instead of placebo for the pre-
vention of postoperative infection after an appendicectomy?
CD001895 What is the effectiveness and acceptability of progestogens alone and
oestrogens and progestogens in combination in the management of irregular bleeding
associated with anovulation?
CD002258 What is the efficacy and safety of bromocriptine monotherapy for de-
laying the onset of motor complications associated with levodopa therapy in patients
with Parkinson’s disease?
CD002310 What is the the efficacy and safety of fluticasone versus beclometha-
sone or budesonide for chronic asthma in adults and children?
CD002314 What is the safety and efficacy of anti-leukotriene agents compared to
inhaled glucocorticoids?
CD002738 What is the efficacy of beclomethasone compared to placebo for chronic
asthma?
CD002960 What are the effects of magnesium sulphate compared with lytic cock-
tail when used for the care of women with eclampsia?
CD003082 What are the clinical effects of haloperidol for the management of
schizophreniaand other similar serious mental illnesses compared to placebo?
CD003135 How does the efficacy and safety of Fluticasone compare to the use of
a placebo for chronic asthma in adults and children?
CD003462 What are the effects of heparin versus placebo for acute coronary syn-
dromes?
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CD003492 What are the effects of lithium versus antidepressants for the long-term
treatment of unipolar affective disorder?
CD003530 How does beclomethasone compare to budesonide for chronic asthma?
CD003615 What is the best evidence for oxcarbazepine versus phenytoin monother-
apy for epilepsy?
CD004278 How does haloperidol compare to chlorpromazine for people with schizophre-
nia?
CD004707 What are the benefits and harms of voriconazole compared to ampho-
tericin B when used for prevention or treatment of invasive fungal infectionsin cancer-
patients with neutropenia?
CD005154 What are the effects of adenosine versus intravenous calcium channel
antagonists for the treatment of supraventricular tachycardia in adults?
CD005309 How does fluticasone compare to extrafine HFA beclomethasone dipro-
pionate for chronicasthmain adults and children?
CD005535 What are the effects of addition of long-acting beta2-agonists to inhaled
corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults
and children?
CD005967 How does artesunate compare to quinine for treating severe malaria?
CD006015 How do the clinical effectiveness and harms of finasteride compare to
placebo and active controls in the treatment of benign prostatic hyperplasia?
CD006114 How does fluvoxamine compare to other anti-depressive agents for de-
pressionin terms of effectiveness, tolerability and side effects?
CD006117 What is the the efficacy acceptability and tolerability of sertraline in
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comparison with other antidepressive agents for depression?
CD006217 What is the efficacy of ciclesonide versus placebo for chronicasthmain
adults and children?
CD006300 What is the possible effectiveness of cyclophosphamide compared with
that of ifosfamide for paediatric and young adult patients with sarcoma?
CD006352 What are the effects of oral fluphenazine for schizophreniain compari-
son with placebo?
CD006453 How do the efficacy and tolerability of carbamazepine and oxcarbazepine
monotherapy compare for partial onset seizures?
CD006626 What are the effects of risperidone versus other atypical antipsychotics
for schizophrenia?
CD006628 What are the effects of zotepine compared with other second generation
antipsychotic drugs for people suffering from schizophrenia?
CD006654 What are the effects of olanzapine versus other atypical antipsychotics
for schizophrenia?
CD006918 What are the clinical effects of oral risperidone for people with schizophre-
nia and schizophrenia-like psychosesin comparison with placebo?
CD007022 What is the efficacy and safety of vancomycin versus teicoplanin in pa-
tients with proven or suspected infection?
CD007570 Is Lactulose or Polyethylene Glycol more effective at treating chronic-
constipationand faecal impaction?
CD007695 What are the serious adverse effects for regular treatment with for-
moterol versus regular treatment with salmeterol for chronic asthma?
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CD007811 What are the effects of sulpiride for schizophreniaand other similar se-
rious mental illnesses in comparison with placebo?
CD007891 What are the effects of combination inhaled steroid and long-acting
beta2-agonist therapy versus tiotropium for chronic obstructive pulmonary disease?
CD008418 How efficient and safe is Formoterol versus short-acting beta-agonists
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